Motif 749 (n=206)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A0A0B4J293 | None | S315 | ochoa | RNF31 protein | None |
A5A3E0 | POTEF | S939 | ochoa | POTE ankyrin domain family member F (ANKRD26-like family C member 1B) (Chimeric POTE-actin protein) | None |
A5YM69 | ARHGEF35 | S57 | ochoa | Rho guanine nucleotide exchange factor 35 (Rho guanine nucleotide exchange factor 5-like protein) | None |
B2RPK0 | HMGB1P1 | S121 | ochoa | High mobility group protein B1-like 1 (High mobility group protein 1-like 1) (HMG-1L1) | Binds preferentially single-stranded DNA and unwinds double-stranded DNA. {ECO:0000250}. |
B4DGG1 | FAM234A | S21 | ochoa | Protein FAM234A (Protein ITFG3) | None |
O00592 | PODXL | S519 | ochoa | Podocalyxin (GCTM-2 antigen) (Gp200) (Podocalyxin-like protein 1) (PC) (PCLP-1) | Involved in the regulation of both adhesion and cell morphology and cancer progression. Functions as an anti-adhesive molecule that maintains an open filtration pathway between neighboring foot processes in the podocyte by charge repulsion. Acts as a pro-adhesive molecule, enhancing the adherence of cells to immobilized ligands, increasing the rate of migration and cell-cell contacts in an integrin-dependent manner. Induces the formation of apical actin-dependent microvilli. Involved in the formation of a preapical plasma membrane subdomain to set up initial epithelial polarization and the apical lumen formation during renal tubulogenesis. Plays a role in cancer development and aggressiveness by inducing cell migration and invasion through its interaction with the actin-binding protein EZR. Affects EZR-dependent signaling events, leading to increased activities of the MAPK and PI3K pathways in cancer cells. {ECO:0000269|PubMed:17616675, ECO:0000269|PubMed:18456258}. |
O14976 | GAK | S817 | ochoa | Cyclin-G-associated kinase (EC 2.7.11.1) (DnaJ homolog subfamily C member 26) | Associates with cyclin G and CDK5. Seems to act as an auxilin homolog that is involved in the uncoating of clathrin-coated vesicles by Hsc70 in non-neuronal cells. Expression oscillates slightly during the cell cycle, peaking at G1 (PubMed:10625686). May play a role in clathrin-mediated endocytosis and intracellular trafficking, and in the dynamics of clathrin assembly/disassembly (PubMed:18489706). {ECO:0000269|PubMed:10625686, ECO:0000269|PubMed:18489706}. |
O43432 | EIF4G3 | S1218 | ochoa | Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII) | Component of the protein complex eIF4F, which is involved in the recognition of the mRNA cap, ATP-dependent unwinding of 5'-terminal secondary structure and recruitment of mRNA to the ribosome (PubMed:9418880). Functional homolog of EIF4G1 (PubMed:9418880). {ECO:0000269|PubMed:9418880}. |
O43707 | ACTN4 | S62 | ochoa | Alpha-actinin-4 (Non-muscle alpha-actinin 4) | F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein (Probable). Probably involved in vesicular trafficking via its association with the CART complex. The CART complex is necessary for efficient transferrin receptor recycling but not for EGFR degradation (PubMed:15772161). Involved in tight junction assembly in epithelial cells probably through interaction with MICALL2. Links MICALL2 to the actin cytoskeleton and recruits it to the tight junctions (By similarity). May also function as a transcriptional coactivator, stimulating transcription mediated by the nuclear hormone receptors PPARG and RARA (PubMed:22351778). Association with IGSF8 regulates the immune synapse formation and is required for efficient T-cell activation (PubMed:22689882). {ECO:0000250|UniProtKB:P57780, ECO:0000269|PubMed:15772161, ECO:0000269|PubMed:22351778, ECO:0000269|PubMed:22689882, ECO:0000305|PubMed:9508771}. |
O43709 | BUD23 | S240 | ochoa | 18S rRNA (guanine-N(7))-methyltransferase (EC 2.1.1.-) (Bud site selection protein 23 homolog) (Metastasis-related methyltransferase 1) (Williams-Beuren syndrome chromosomal region 22 protein) (rRNA methyltransferase and ribosome maturation factor) | S-adenosyl-L-methionine-dependent methyltransferase that specifically methylates the N(7) position of a guanine in 18S rRNA (PubMed:25851604). Requires the methyltransferase adapter protein TRM112 for full rRNA methyltransferase activity (PubMed:25851604). Involved in the pre-rRNA processing steps leading to small-subunit rRNA production independently of its RNA-modifying catalytic activity (PubMed:25851604). Important for biogenesis end export of the 40S ribosomal subunit independent on its methyltransferase activity (PubMed:24086612). Locus-specific steroid receptor coactivator. Potentiates transactivation by glucocorticoid (NR3C1), mineralocorticoid (NR3C2), androgen (AR) and progesterone (PGR) receptors (PubMed:24488492). Required for the maintenance of open chromatin at the TSC22D3/GILZ locus to facilitate NR3C1 loading on the response elements (PubMed:24488492). Required for maintenance of dimethylation on histone H3 'Lys-79' (H3K79me2), although direct histone methyltransferase activity is not observed in vitro (PubMed:24488492). {ECO:0000250, ECO:0000269|PubMed:24086612, ECO:0000269|PubMed:24488492, ECO:0000269|PubMed:25851604}. |
O43829 | ZBTB14 | S222 | ochoa | Zinc finger and BTB domain-containing protein 14 (Zinc finger protein 161 homolog) (Zfp-161) (Zinc finger protein 478) (Zinc finger protein 5 homolog) (ZF5) (Zfp-5) (hZF5) | Transcriptional activator of the dopamine transporter (DAT), binding it's promoter at the consensus sequence 5'-CCTGCACAGTTCACGGA-3'. Binds to 5'-d(GCC)(n)-3' trinucleotide repeats in promoter regions and acts as a repressor of the FMR1 gene. Transcriptional repressor of MYC and thymidine kinase promoters. {ECO:0000269|PubMed:17714511}. |
O60269 | GPRIN2 | S429 | ochoa | G protein-regulated inducer of neurite outgrowth 2 (GRIN2) | May be involved in neurite outgrowth. {ECO:0000269|PubMed:10480904}. |
O60341 | KDM1A | S111 | psp | Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2) ([histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A) | Histone demethylase that can demethylate both 'Lys-4' (H3K4me) and 'Lys-9' (H3K9me) of histone H3, thereby acting as a coactivator or a corepressor, depending on the context (PubMed:15620353, PubMed:15811342, PubMed:16079794, PubMed:16079795, PubMed:16140033, PubMed:16223729, PubMed:27292636). Acts by oxidizing the substrate by FAD to generate the corresponding imine that is subsequently hydrolyzed (PubMed:15620353, PubMed:15811342, PubMed:16079794, PubMed:21300290). Acts as a corepressor by mediating demethylation of H3K4me, a specific tag for epigenetic transcriptional activation. Demethylates both mono- (H3K4me1) and di-methylated (H3K4me2) H3K4me (PubMed:15620353, PubMed:20389281, PubMed:21300290, PubMed:23721412). May play a role in the repression of neuronal genes. Alone, it is unable to demethylate H3K4me on nucleosomes and requires the presence of RCOR1/CoREST to achieve such activity (PubMed:16079794, PubMed:16140033, PubMed:16885027, PubMed:21300290, PubMed:23721412). Also acts as a coactivator of androgen receptor (AR)-dependent transcription, by being recruited to AR target genes and mediating demethylation of H3K9me, a specific tag for epigenetic transcriptional repression. The presence of PRKCB in AR-containing complexes, which mediates phosphorylation of 'Thr-6' of histone H3 (H3T6ph), a specific tag that prevents demethylation H3K4me, prevents H3K4me demethylase activity of KDM1A (PubMed:16079795). Demethylates di-methylated 'Lys-370' of p53/TP53 which prevents interaction of p53/TP53 with TP53BP1 and represses p53/TP53-mediated transcriptional activation. Demethylates and stabilizes the DNA methylase DNMT1 (PubMed:29691401). Demethylates methylated 'Lys-42' and methylated 'Lys-117' of SOX2 (PubMed:29358331). Required for gastrulation during embryogenesis. Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development (PubMed:16079794, PubMed:16140033). Facilitates epithelial-to-mesenchymal transition by acting as an effector of SNAI1-mediated transcription repression of epithelial markers E-cadherin/CDH1, CDN7 and KRT8 (PubMed:20562920, PubMed:27292636). Required for the maintenance of the silenced state of the SNAI1 target genes E-cadherin/CDH1 and CDN7 (PubMed:20389281). Required for the repression of GIPR expression (PubMed:34655521, PubMed:34906447). {ECO:0000269|PubMed:12032298, ECO:0000269|PubMed:15620353, ECO:0000269|PubMed:15811342, ECO:0000269|PubMed:16079794, ECO:0000269|PubMed:16079795, ECO:0000269|PubMed:16140033, ECO:0000269|PubMed:16223729, ECO:0000269|PubMed:16885027, ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:17805299, ECO:0000269|PubMed:20228790, ECO:0000269|PubMed:20389281, ECO:0000269|PubMed:20562920, ECO:0000269|PubMed:21300290, ECO:0000269|PubMed:23721412, ECO:0000269|PubMed:27292636, ECO:0000269|PubMed:29358331, ECO:0000269|PubMed:29691401, ECO:0000269|PubMed:34655521, ECO:0000269|PubMed:34906447}. |
O60934 | NBN | S611 | ochoa | Nibrin (Cell cycle regulatory protein p95) (Nijmegen breakage syndrome protein 1) (hNbs1) | Component of the MRN complex, which plays a central role in double-strand break (DSB) repair, DNA recombination, maintenance of telomere integrity and meiosis (PubMed:10888888, PubMed:15616588, PubMed:18411307, PubMed:18583988, PubMed:18678890, PubMed:19759395, PubMed:23115235, PubMed:28216226, PubMed:28867292, PubMed:9705271). The MRN complex is involved in the repair of DNA double-strand breaks (DSBs) via homologous recombination (HR), an error-free mechanism which primarily occurs during S and G2 phases (PubMed:19759395, PubMed:28867292, PubMed:9705271). The complex (1) mediates the end resection of damaged DNA, which generates proper single-stranded DNA, a key initial steps in HR, and is (2) required for the recruitment of other repair factors and efficient activation of ATM and ATR upon DNA damage (PubMed:19759395, PubMed:9705271). The MRN complex possesses single-strand endonuclease activity and double-strand-specific 3'-5' exonuclease activity, which are provided by MRE11, to initiate end resection, which is required for single-strand invasion and recombination (PubMed:19759395, PubMed:28867292, PubMed:9705271). Within the MRN complex, NBN acts as a protein-protein adapter, which specifically recognizes and binds phosphorylated proteins, promoting their recruitment to DNA damage sites (PubMed:12419185, PubMed:15616588, PubMed:18411307, PubMed:18582474, PubMed:18583988, PubMed:18678890, PubMed:19759395, PubMed:19804756, PubMed:23762398, PubMed:24534091, PubMed:27814491, PubMed:27889449, PubMed:33836577). Recruits MRE11 and RAD50 components of the MRN complex to DSBs in response to DNA damage (PubMed:12419185, PubMed:18411307, PubMed:18583988, PubMed:18678890, PubMed:24534091, PubMed:26438602). Promotes the recruitment of PI3/PI4-kinase family members ATM, ATR, and probably DNA-PKcs to the DNA damage sites, activating their functions (PubMed:15064416, PubMed:15616588, PubMed:15790808, PubMed:16622404, PubMed:22464731, PubMed:30952868, PubMed:35076389). Mediates the recruitment of phosphorylated RBBP8/CtIP to DSBs, leading to cooperation between the MRN complex and RBBP8/CtIP to initiate end resection (PubMed:19759395, PubMed:27814491, PubMed:27889449, PubMed:33836577). RBBP8/CtIP specifically promotes the endonuclease activity of the MRN complex to clear DNA ends containing protein adducts (PubMed:27814491, PubMed:27889449, PubMed:30787182, PubMed:33836577). The MRN complex is also required for the processing of R-loops (PubMed:31537797). NBN also functions in telomere length maintenance via its interaction with TERF2: interaction with TERF2 during G1 phase preventing recruitment of DCLRE1B/Apollo to telomeres (PubMed:10888888, PubMed:28216226). NBN also promotes DNA repair choice at dysfunctional telomeres: NBN phosphorylation by CDK2 promotes non-homologous end joining repair at telomeres, while unphosphorylated NBN promotes microhomology-mediated end-joining (MMEJ) repair (PubMed:28216226). Enhances AKT1 phosphorylation possibly by association with the mTORC2 complex (PubMed:23762398). {ECO:0000269|PubMed:10888888, ECO:0000269|PubMed:12419185, ECO:0000269|PubMed:15064416, ECO:0000269|PubMed:15616588, ECO:0000269|PubMed:15790808, ECO:0000269|PubMed:16622404, ECO:0000269|PubMed:18411307, ECO:0000269|PubMed:18582474, ECO:0000269|PubMed:18583988, ECO:0000269|PubMed:18678890, ECO:0000269|PubMed:19759395, ECO:0000269|PubMed:19804756, ECO:0000269|PubMed:22464731, ECO:0000269|PubMed:23115235, ECO:0000269|PubMed:23762398, ECO:0000269|PubMed:24534091, ECO:0000269|PubMed:26438602, ECO:0000269|PubMed:27814491, ECO:0000269|PubMed:27889449, ECO:0000269|PubMed:28216226, ECO:0000269|PubMed:28867292, ECO:0000269|PubMed:30787182, ECO:0000269|PubMed:30952868, ECO:0000269|PubMed:31537797, ECO:0000269|PubMed:33836577, ECO:0000269|PubMed:35076389, ECO:0000269|PubMed:9705271}. |
O75146 | HIP1R | S592 | ochoa | Huntingtin-interacting protein 1-related protein (HIP1-related protein) (Huntingtin-interacting protein 12) (HIP-12) | Component of clathrin-coated pits and vesicles, that may link the endocytic machinery to the actin cytoskeleton. Binds 3-phosphoinositides (via ENTH domain). May act through the ENTH domain to promote cell survival by stabilizing receptor tyrosine kinases following ligand-induced endocytosis. {ECO:0000269|PubMed:11889126, ECO:0000269|PubMed:14732715}. |
O75167 | PHACTR2 | S423 | ochoa | Phosphatase and actin regulator 2 | None |
O75170 | PPP6R2 | S427 | ochoa | Serine/threonine-protein phosphatase 6 regulatory subunit 2 (SAPS domain family member 2) | Regulatory subunit of protein phosphatase 6 (PP6). May function as a scaffolding PP6 subunit. Involved in the PP6-mediated dephosphorylation of NFKBIE opposing its degradation in response to TNF-alpha. {ECO:0000269|PubMed:16769727}. |
O75179 | ANKRD17 | S156 | ochoa | Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) | Could play pivotal roles in cell cycle and DNA regulation (PubMed:19150984). Involved in innate immune defense against viruse by positively regulating the viral dsRNA receptors DDX58 and IFIH1 signaling pathways (PubMed:22328336). Involves in NOD2- and NOD1-mediated responses to bacteria suggesting a role in innate antibacterial immune pathways too (PubMed:23711367). Target of enterovirus 71 which is the major etiological agent of HFMD (hand, foot and mouth disease) (PubMed:17276651). Could play a central role for the formation and/or maintenance of the blood vessels of the circulation system (By similarity). {ECO:0000250|UniProtKB:Q99NH0, ECO:0000269|PubMed:17276651, ECO:0000269|PubMed:19150984, ECO:0000269|PubMed:22328336, ECO:0000269|PubMed:23711367}. |
O75362 | ZNF217 | S345 | ochoa | Zinc finger protein 217 | Binds to the promoters of target genes and functions as repressor. Promotes cell proliferation and antagonizes cell death. Promotes phosphorylation of AKT1 at 'Ser-473'. {ECO:0000269|PubMed:16203743, ECO:0000269|PubMed:16940172, ECO:0000269|PubMed:17259635, ECO:0000269|PubMed:18625718}. |
O75976 | CPD | S1358 | ochoa | Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180) | None |
O76021 | RSL1D1 | S427 | ochoa | Ribosomal L1 domain-containing protein 1 (CATX-11) (Cellular senescence-inhibited gene protein) (Protein PBK1) | Regulates cellular senescence through inhibition of PTEN translation. Acts as a pro-apoptotic regulator in response to DNA damage. {ECO:0000269|PubMed:18678645, ECO:0000269|PubMed:22419112}. |
O76094 | SRP72 | S81 | ochoa | Signal recognition particle subunit SRP72 (SRP72) (Signal recognition particle 72 kDa protein) | Component of the signal recognition particle (SRP) complex, a ribonucleoprotein complex that mediates the cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum (ER) (PubMed:34020957). The SRP complex interacts with the signal sequence in nascent secretory and membrane proteins and directs them to the membrane of the ER (PubMed:34020957). The SRP complex targets the ribosome-nascent chain complex to the SRP receptor (SR), which is anchored in the ER, where SR compaction and GTPase rearrangement drive cotranslational protein translocation into the ER (PubMed:34020957). Binds the signal recognition particle RNA (7SL RNA) in presence of SRP68 (PubMed:21073748, PubMed:27899666). Can bind 7SL RNA with low affinity (PubMed:21073748, PubMed:27899666). The SRP complex possibly participates in the elongation arrest function (By similarity). {ECO:0000250|UniProtKB:P38688, ECO:0000269|PubMed:21073748, ECO:0000269|PubMed:27899666, ECO:0000269|PubMed:34020957}. |
O94880 | PHF14 | S91 | ochoa | PHD finger protein 14 | Histone-binding protein (PubMed:23688586). Binds preferentially to unmodified histone H3 but can also bind to a lesser extent to histone H3 trimethylated at 'Lys-9' (H3K9me3) as well as to histone H3 monomethylated at 'Lys-27' (H3K27ac) and trimethylated at 'Lys-27' (H3K27me3) (By similarity). Represses PDGFRA expression, thus playing a role in regulation of mesenchymal cell proliferation (By similarity). Suppresses the expression of CDKN1A/p21 by reducing the level of trimethylation of histone H3 'Lys-4', leading to enhanced proliferation of germinal center B cells (By similarity). {ECO:0000250|UniProtKB:A0A286Y9D1, ECO:0000250|UniProtKB:Q9D4H9, ECO:0000269|PubMed:23688586}. |
O94880 | PHF14 | S92 | ochoa | PHD finger protein 14 | Histone-binding protein (PubMed:23688586). Binds preferentially to unmodified histone H3 but can also bind to a lesser extent to histone H3 trimethylated at 'Lys-9' (H3K9me3) as well as to histone H3 monomethylated at 'Lys-27' (H3K27ac) and trimethylated at 'Lys-27' (H3K27me3) (By similarity). Represses PDGFRA expression, thus playing a role in regulation of mesenchymal cell proliferation (By similarity). Suppresses the expression of CDKN1A/p21 by reducing the level of trimethylation of histone H3 'Lys-4', leading to enhanced proliferation of germinal center B cells (By similarity). {ECO:0000250|UniProtKB:A0A286Y9D1, ECO:0000250|UniProtKB:Q9D4H9, ECO:0000269|PubMed:23688586}. |
O94885 | SASH1 | S721 | ochoa | SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein) | Is a positive regulator of NF-kappa-B signaling downstream of TLR4 activation. It acts as a scaffold molecule to assemble a molecular complex that includes TRAF6, MAP3K7, CHUK and IKBKB, thereby facilitating NF-kappa-B signaling activation (PubMed:23776175). Regulates TRAF6 and MAP3K7 ubiquitination (PubMed:23776175). Involved in the regulation of cell mobility (PubMed:23333244, PubMed:23776175, PubMed:25315659). Regulates lipolysaccharide (LPS)-induced endothelial cell migration (PubMed:23776175). Is involved in the regulation of skin pigmentation through the control of melanocyte migration in the epidermis (PubMed:23333244). {ECO:0000269|PubMed:23333244, ECO:0000269|PubMed:23776175, ECO:0000269|PubMed:25315659}. |
O94988 | FAM13A | S539 | ochoa | Protein FAM13A | None |
O95757 | HSPA4L | S517 | ochoa | Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Heat shock protein family H member 3) (Heat-shock protein family A member 4-like protein) (HSPA4-like protein) (Osmotic stress protein 94) | Possesses chaperone activity in vitro where it inhibits aggregation of citrate synthase. {ECO:0000250}. |
O95972 | BMP15 | S273 | psp | Bone morphogenetic protein 15 (BMP-15) (Growth/differentiation factor 9B) (GDF-9B) | May be involved in follicular development. Oocyte-specific growth/differentiation factor that stimulates folliculogenesis and granulosa cell (GC) growth. {ECO:0000269|PubMed:18227435}. |
O96017 | CHEK2 | S140 | psp | Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) | Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest, activation of DNA repair and apoptosis in response to the presence of DNA double-strand breaks. May also negatively regulate cell cycle progression during unperturbed cell cycles. Following activation, phosphorylates numerous effectors preferentially at the consensus sequence [L-X-R-X-X-S/T] (PubMed:37943659). Regulates cell cycle checkpoint arrest through phosphorylation of CDC25A, CDC25B and CDC25C, inhibiting their activity. Inhibition of CDC25 phosphatase activity leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression. May also phosphorylate NEK6 which is involved in G2/M cell cycle arrest. Regulates DNA repair through phosphorylation of BRCA2, enhancing the association of RAD51 with chromatin which promotes DNA repair by homologous recombination. Also stimulates the transcription of genes involved in DNA repair (including BRCA2) through the phosphorylation and activation of the transcription factor FOXM1. Regulates apoptosis through the phosphorylation of p53/TP53, MDM4 and PML. Phosphorylation of p53/TP53 at 'Ser-20' by CHEK2 may alleviate inhibition by MDM2, leading to accumulation of active p53/TP53. Phosphorylation of MDM4 may also reduce degradation of p53/TP53. Also controls the transcription of pro-apoptotic genes through phosphorylation of the transcription factor E2F1. Tumor suppressor, it may also have a DNA damage-independent function in mitotic spindle assembly by phosphorylating BRCA1. Its absence may be a cause of the chromosomal instability observed in some cancer cells. Promotes the CCAR2-SIRT1 association and is required for CCAR2-mediated SIRT1 inhibition (PubMed:25361978). Under oxidative stress, promotes ATG7 ubiquitination by phosphorylating the E3 ubiquitin ligase TRIM32 at 'Ser-55' leading to positive regulation of the autophagosme assembly (PubMed:37943659). {ECO:0000250|UniProtKB:Q9Z265, ECO:0000269|PubMed:10097108, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11298456, ECO:0000269|PubMed:12402044, ECO:0000269|PubMed:12607004, ECO:0000269|PubMed:12717439, ECO:0000269|PubMed:12810724, ECO:0000269|PubMed:16163388, ECO:0000269|PubMed:17101782, ECO:0000269|PubMed:17380128, ECO:0000269|PubMed:17715138, ECO:0000269|PubMed:18317453, ECO:0000269|PubMed:18644861, ECO:0000269|PubMed:18728393, ECO:0000269|PubMed:20364141, ECO:0000269|PubMed:25361978, ECO:0000269|PubMed:25619829, ECO:0000269|PubMed:37943659, ECO:0000269|PubMed:9836640, ECO:0000269|PubMed:9889122}.; FUNCTION: (Microbial infection) Phosphorylates herpes simplex virus 1/HHV-1 protein ICP0 and thus activates its SUMO-targeted ubiquitin ligase activity. {ECO:0000269|PubMed:32001251}. |
P02545 | LMNA | S277 | ochoa | Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] | [Lamin-A/C]: Lamins are intermediate filament proteins that assemble into a filamentous meshwork, and which constitute the major components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane (PubMed:10080180, PubMed:10580070, PubMed:10587585, PubMed:10814726, PubMed:11799477, PubMed:12075506, PubMed:12927431, PubMed:15317753, PubMed:18551513, PubMed:18611980, PubMed:2188730, PubMed:22431096, PubMed:2344612, PubMed:23666920, PubMed:24741066, PubMed:31434876, PubMed:31548606, PubMed:37788673, PubMed:37832547). Lamins provide a framework for the nuclear envelope, bridging the nuclear envelope and chromatin, thereby playing an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics (PubMed:10080180, PubMed:10580070, PubMed:10587585, PubMed:10814726, PubMed:11799477, PubMed:12075506, PubMed:12927431, PubMed:15317753, PubMed:18551513, PubMed:18611980, PubMed:22431096, PubMed:23666920, PubMed:24741066, PubMed:31548606, PubMed:37788673, PubMed:37832547). Lamin A and C also regulate matrix stiffness by conferring nuclear mechanical properties (PubMed:23990565, PubMed:25127216). The structural integrity of the lamina is strictly controlled by the cell cycle, as seen by the disintegration and formation of the nuclear envelope in prophase and telophase, respectively (PubMed:2188730, PubMed:2344612). Lamin A and C are present in equal amounts in the lamina of mammals (PubMed:10080180, PubMed:10580070, PubMed:10587585, PubMed:10814726, PubMed:11799477, PubMed:12075506, PubMed:12927431, PubMed:15317753, PubMed:18551513, PubMed:18611980, PubMed:22431096, PubMed:23666920, PubMed:31548606). Also invoved in DNA repair: recruited by DNA repair proteins XRCC4 and IFFO1 to the DNA double-strand breaks (DSBs) to prevent chromosome translocation by immobilizing broken DNA ends (PubMed:31548606). Required for normal development of peripheral nervous system and skeletal muscle and for muscle satellite cell proliferation (PubMed:10080180, PubMed:10814726, PubMed:11799477, PubMed:18551513, PubMed:22431096). Required for osteoblastogenesis and bone formation (PubMed:12075506, PubMed:15317753, PubMed:18611980). Also prevents fat infiltration of muscle and bone marrow, helping to maintain the volume and strength of skeletal muscle and bone (PubMed:10587585). Required for cardiac homeostasis (PubMed:10580070, PubMed:12927431, PubMed:18611980, PubMed:23666920). {ECO:0000269|PubMed:10080180, ECO:0000269|PubMed:10580070, ECO:0000269|PubMed:10587585, ECO:0000269|PubMed:10814726, ECO:0000269|PubMed:11799477, ECO:0000269|PubMed:12075506, ECO:0000269|PubMed:12927431, ECO:0000269|PubMed:15317753, ECO:0000269|PubMed:18551513, ECO:0000269|PubMed:18611980, ECO:0000269|PubMed:2188730, ECO:0000269|PubMed:22431096, ECO:0000269|PubMed:2344612, ECO:0000269|PubMed:23666920, ECO:0000269|PubMed:23990565, ECO:0000269|PubMed:24741066, ECO:0000269|PubMed:25127216, ECO:0000269|PubMed:31434876, ECO:0000269|PubMed:31548606, ECO:0000269|PubMed:37788673, ECO:0000269|PubMed:37832547}.; FUNCTION: [Prelamin-A/C]: Prelamin-A/C can accelerate smooth muscle cell senescence (PubMed:20458013). It acts to disrupt mitosis and induce DNA damage in vascular smooth muscle cells (VSMCs), leading to mitotic failure, genomic instability, and premature senescence (PubMed:20458013). {ECO:0000269|PubMed:20458013}. |
P07437 | TUBB | S40 | ochoa | Tubulin beta chain (Tubulin beta-5 chain) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P07814 | EPRS1 | S330 | ochoa | Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase)] | Multifunctional protein which primarily functions within the aminoacyl-tRNA synthetase multienzyme complex, also known as multisynthetase complex. Within the complex it catalyzes the attachment of both L-glutamate and L-proline to their cognate tRNAs in a two-step reaction where the amino acid is first activated by ATP to form a covalent intermediate with AMP. Subsequently, the activated amino acid is transferred to the acceptor end of the cognate tRNA to form L-glutamyl-tRNA(Glu) and L-prolyl-tRNA(Pro) (PubMed:23263184, PubMed:24100331, PubMed:29576217, PubMed:3290852, PubMed:37212275). Upon interferon-gamma stimulation, EPRS1 undergoes phosphorylation, causing its dissociation from the aminoacyl-tRNA synthetase multienzyme complex. It is recruited to form the GAIT complex, which binds to stem loop-containing GAIT elements found in the 3'-UTR of various inflammatory mRNAs, such as ceruloplasmin. The GAIT complex inhibits the translation of these mRNAs, allowing interferon-gamma to redirect the function of EPRS1 from protein synthesis to translation inhibition in specific cell contexts (PubMed:15479637, PubMed:23071094). Furthermore, it can function as a downstream effector in the mTORC1 signaling pathway, by promoting the translocation of SLC27A1 from the cytoplasm to the plasma membrane where it mediates the uptake of long-chain fatty acid by adipocytes. Thereby, EPRS1 also plays a role in fat metabolism and more indirectly influences lifespan (PubMed:28178239). {ECO:0000269|PubMed:15479637, ECO:0000269|PubMed:23071094, ECO:0000269|PubMed:23263184, ECO:0000269|PubMed:24100331, ECO:0000269|PubMed:28178239, ECO:0000269|PubMed:29576217, ECO:0000269|PubMed:3290852, ECO:0000269|PubMed:37212275}. |
P08151 | GLI1 | S243 | psp | Zinc finger protein GLI1 (Glioma-associated oncogene) (Oncogene GLI) | Acts as a transcriptional activator (PubMed:10806483, PubMed:19706761, PubMed:19878745, PubMed:24076122, PubMed:24217340, PubMed:24311597). Binds to the DNA consensus sequence 5'-GACCACCCA-3' (PubMed:2105456, PubMed:24217340, PubMed:8378770). Regulates the transcription of specific genes during normal development (PubMed:19706761). Plays a role in craniofacial development and digital development, as well as development of the central nervous system and gastrointestinal tract. Mediates SHH signaling (PubMed:19706761, PubMed:28973407). Plays a role in cell proliferation and differentiation via its role in SHH signaling (PubMed:11238441, PubMed:28973407). {ECO:0000269|PubMed:10806483, ECO:0000269|PubMed:11238441, ECO:0000269|PubMed:19706761, ECO:0000269|PubMed:19878745, ECO:0000269|PubMed:2105456, ECO:0000269|PubMed:24076122, ECO:0000269|PubMed:24217340, ECO:0000269|PubMed:24311597, ECO:0000269|PubMed:28973407, ECO:0000269|PubMed:8378770}.; FUNCTION: [Isoform 2]: Acts as a transcriptional activator, but activates a different set of genes than isoform 1. Activates expression of CD24, unlike isoform 1. Mediates SHH signaling. Promotes cancer cell migration. {ECO:0000269|PubMed:19706761}. |
P09429 | HMGB1 | S121 | ochoa | High mobility group protein B1 (High mobility group protein 1) (HMG-1) | Multifunctional redox sensitive protein with various roles in different cellular compartments. In the nucleus is one of the major chromatin-associated non-histone proteins and acts as a DNA chaperone involved in replication, transcription, chromatin remodeling, V(D)J recombination, DNA repair and genome stability (PubMed:33147444). Proposed to be an universal biosensor for nucleic acids. Promotes host inflammatory response to sterile and infectious signals and is involved in the coordination and integration of innate and adaptive immune responses. In the cytoplasm functions as a sensor and/or chaperone for immunogenic nucleic acids implicating the activation of TLR9-mediated immune responses, and mediates autophagy. Acts as a danger-associated molecular pattern (DAMP) molecule that amplifies immune responses during tissue injury (PubMed:27362237). Released to the extracellular environment can bind DNA, nucleosomes, IL-1 beta, CXCL12, AGER isoform 2/sRAGE, lipopolysaccharide (LPS) and lipoteichoic acid (LTA), and activates cells through engagement of multiple surface receptors (PubMed:34743181). In the extracellular compartment fully reduced HMGB1 (released by necrosis) acts as a chemokine, disulfide HMGB1 (actively secreted) as a cytokine, and sulfonyl HMGB1 (released from apoptotic cells) promotes immunological tolerance (PubMed:23446148, PubMed:23519706, PubMed:23994764, PubMed:25048472). Has proangiogdenic activity (By similarity). May be involved in platelet activation (By similarity). Binds to phosphatidylserine and phosphatidylethanolamide (By similarity). Bound to RAGE mediates signaling for neuronal outgrowth (By similarity). May play a role in accumulation of expanded polyglutamine (polyQ) proteins such as huntingtin (HTT) or TBP (PubMed:23303669, PubMed:25549101). {ECO:0000250|UniProtKB:P10103, ECO:0000250|UniProtKB:P12682, ECO:0000250|UniProtKB:P63158, ECO:0000250|UniProtKB:P63159, ECO:0000269|PubMed:23303669, ECO:0000269|PubMed:25549101, ECO:0000269|PubMed:27362237, ECO:0000269|PubMed:33147444, ECO:0000269|PubMed:34743181, ECO:0000305|PubMed:23446148, ECO:0000305|PubMed:23519706, ECO:0000305|PubMed:23994764, ECO:0000305|PubMed:25048472}.; FUNCTION: Nuclear functions are attributed to fully reduced HGMB1. Associates with chromatin and binds DNA with a preference to non-canonical DNA structures such as single-stranded DNA, DNA-containing cruciforms or bent structures, supercoiled DNA and ZDNA. Can bent DNA and enhance DNA flexibility by looping thus providing a mechanism to promote activities on various gene promoters by enhancing transcription factor binding and/or bringing distant regulatory sequences into close proximity (PubMed:20123072). May have an enhancing role in nucleotide excision repair (NER) (By similarity). However, effects in NER using in vitro systems have been reported conflictingly (PubMed:19360789, PubMed:19446504). May be involved in mismatch repair (MMR) and base excision repair (BER) pathways (PubMed:15014079, PubMed:16143102, PubMed:17803946). May be involved in double strand break repair such as non-homologous end joining (NHEJ) (By similarity). Involved in V(D)J recombination by acting as a cofactor of the RAG complex: acts by stimulating cleavage and RAG protein binding at the 23 bp spacer of conserved recombination signal sequences (RSS) (By similarity). In vitro can displace histone H1 from highly bent DNA (By similarity). Can restructure the canonical nucleosome leading to relaxation of structural constraints for transcription factor-binding (By similarity). Enhances binding of sterol regulatory element-binding proteins (SREBPs) such as SREBF1 to their cognate DNA sequences and increases their transcriptional activities (By similarity). Facilitates binding of TP53 to DNA (PubMed:23063560). Proposed to be involved in mitochondrial quality control and autophagy in a transcription-dependent fashion implicating HSPB1; however, this function has been questioned (By similarity). Can modulate the activity of the telomerase complex and may be involved in telomere maintenance (By similarity). {ECO:0000250|UniProtKB:P10103, ECO:0000250|UniProtKB:P63158, ECO:0000250|UniProtKB:P63159, ECO:0000269|PubMed:15014079, ECO:0000269|PubMed:16143102, ECO:0000269|PubMed:17803946, ECO:0000269|PubMed:19446504, ECO:0000269|PubMed:23063560, ECO:0000305|PubMed:19360789, ECO:0000305|PubMed:20123072}.; FUNCTION: In the cytoplasm proposed to dissociate the BECN1:BCL2 complex via competitive interaction with BECN1 leading to autophagy activation (PubMed:20819940). Involved in oxidative stress-mediated autophagy (PubMed:21395369). Can protect BECN1 and ATG5 from calpain-mediated cleavage and thus proposed to control their proautophagic and proapoptotic functions and to regulate the extent and severity of inflammation-associated cellular injury (By similarity). In myeloid cells has a protective role against endotoxemia and bacterial infection by promoting autophagy (By similarity). Involved in endosomal translocation and activation of TLR9 in response to CpG-DNA in macrophages (By similarity). {ECO:0000250|UniProtKB:P63158, ECO:0000269|PubMed:20819940, ECO:0000269|PubMed:21395369}.; FUNCTION: In the extracellular compartment (following either active secretion or passive release) involved in regulation of the inflammatory response. Fully reduced HGMB1 (which subsequently gets oxidized after release) in association with CXCL12 mediates the recruitment of inflammatory cells during the initial phase of tissue injury; the CXCL12:HMGB1 complex triggers CXCR4 homodimerization (PubMed:22370717). Induces the migration of monocyte-derived immature dendritic cells and seems to regulate adhesive and migratory functions of neutrophils implicating AGER/RAGE and ITGAM (By similarity). Can bind to various types of DNA and RNA including microbial unmethylated CpG-DNA to enhance the innate immune response to nucleic acids. Proposed to act in promiscuous DNA/RNA sensing which cooperates with subsequent discriminative sensing by specific pattern recognition receptors (By similarity). Promotes extracellular DNA-induced AIM2 inflammasome activation implicating AGER/RAGE (PubMed:24971542). Disulfide HMGB1 binds to transmembrane receptors, such as AGER/RAGE, TLR2, TLR4 and probably TREM1, thus activating their signal transduction pathways. Mediates the release of cytokines/chemokines such as TNF, IL-1, IL-6, IL-8, CCL2, CCL3, CCL4 and CXCL10 (PubMed:12765338, PubMed:18354232, PubMed:19264983, PubMed:20547845, PubMed:24474694). Promotes secretion of interferon-gamma by macrophage-stimulated natural killer (NK) cells in concert with other cytokines like IL-2 or IL-12 (PubMed:15607795). TLR4 is proposed to be the primary receptor promoting macrophage activation and signaling through TLR4 seems to implicate LY96/MD-2 (PubMed:20547845). In bacterial LPS- or LTA-mediated inflammatory responses binds to the endotoxins and transfers them to CD14 for signaling to the respective TLR4:LY96 and TLR2 complexes (PubMed:18354232, PubMed:21660935, PubMed:25660311). Contributes to tumor proliferation by association with ACER/RAGE (By similarity). Can bind to IL1-beta and signals through the IL1R1:IL1RAP receptor complex (PubMed:18250463). Binding to class A CpG activates cytokine production in plasmacytoid dendritic cells implicating TLR9, MYD88 and AGER/RAGE and can activate autoreactive B cells. Via HMGB1-containing chromatin immune complexes may also promote B cell responses to endogenous TLR9 ligands through a B-cell receptor (BCR)-dependent and ACER/RAGE-independent mechanism (By similarity). Inhibits phagocytosis of apoptotic cells by macrophages; the function is dependent on poly-ADP-ribosylation and involves binding to phosphatidylserine on the cell surface of apoptotic cells (By similarity). In adaptive immunity may be involved in enhancing immunity through activation of effector T cells and suppression of regulatory T (TReg) cells (PubMed:15944249, PubMed:22473704). In contrast, without implicating effector or regulatory T-cells, required for tumor infiltration and activation of T-cells expressing the lymphotoxin LTA:LTB heterotrimer thus promoting tumor malignant progression (By similarity). Also reported to limit proliferation of T-cells (By similarity). Released HMGB1:nucleosome complexes formed during apoptosis can signal through TLR2 to induce cytokine production (PubMed:19064698). Involved in induction of immunological tolerance by apoptotic cells; its pro-inflammatory activities when released by apoptotic cells are neutralized by reactive oxygen species (ROS)-dependent oxidation specifically on Cys-106 (PubMed:18631454). During macrophage activation by activated lymphocyte-derived self apoptotic DNA (ALD-DNA) promotes recruitment of ALD-DNA to endosomes (By similarity). {ECO:0000250|UniProtKB:P10103, ECO:0000250|UniProtKB:P63158, ECO:0000250|UniProtKB:P63159, ECO:0000269|PubMed:12765338, ECO:0000269|PubMed:15607795, ECO:0000269|PubMed:15944249, ECO:0000269|PubMed:18250463, ECO:0000269|PubMed:18354232, ECO:0000269|PubMed:18631454, ECO:0000269|PubMed:19064698, ECO:0000269|PubMed:19264983, ECO:0000269|PubMed:20547845, ECO:0000269|PubMed:21660935, ECO:0000269|PubMed:22370717, ECO:0000269|PubMed:22473704, ECO:0000269|PubMed:24474694, ECO:0000269|PubMed:24971542, ECO:0000269|PubMed:25660311, ECO:0000269|Ref.8}.; FUNCTION: (Microbial infection) Critical for entry of human coronaviruses SARS-CoV and SARS-CoV-2, as well as human coronavirus NL63/HCoV-NL63 (PubMed:33147444). Regulates the expression of the pro-viral genes ACE2 and CTSL through chromatin modulation (PubMed:33147444). Required for SARS-CoV-2 ORF3A-induced reticulophagy which induces endoplasmic reticulum stress and inflammatory responses and facilitates viral infection (PubMed:35239449). {ECO:0000269|PubMed:33147444, ECO:0000269|PubMed:35239449}.; FUNCTION: (Microbial infection) Associates with the influenza A viral protein NP in the nucleus of infected cells, promoting viral growth and enhancing the activity of the viral polymerase. {ECO:0000269|PubMed:22696656}.; FUNCTION: (Microbial infection) Promotes Epstein-Barr virus (EBV) latent-to-lytic switch by sustaining the expression of the viral transcription factor BZLF1 that acts as a molecular switch to induce the transition from the latent to the lytic or productive phase of the virus cycle. Mechanistically, participates in EBV reactivation through the NLRP3 inflammasome. {ECO:0000269|PubMed:34922257}.; FUNCTION: (Microbial infection) Facilitates dengue virus propagation via interaction with the untranslated regions of viral genome. In turn, this interaction with viral RNA may regulate secondary structure of dengue RNA thus facilitating its recognition by the replication complex. {ECO:0000269|PubMed:34971702}. |
P09651 | HNRNPA1 | S22 | ochoa | Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed] | Involved in the packaging of pre-mRNA into hnRNP particles, transport of poly(A) mRNA from the nucleus to the cytoplasm and modulation of splice site selection (PubMed:17371836). Plays a role in the splicing of pyruvate kinase PKM by binding repressively to sequences flanking PKM exon 9, inhibiting exon 9 inclusion and resulting in exon 10 inclusion and production of the PKM M2 isoform (PubMed:20010808). Binds to the IRES and thereby inhibits the translation of the apoptosis protease activating factor APAF1 (PubMed:31498791). May bind to specific miRNA hairpins (PubMed:28431233). {ECO:0000269|PubMed:17371836, ECO:0000269|PubMed:20010808, ECO:0000269|PubMed:28431233, ECO:0000269|PubMed:31498791}.; FUNCTION: (Microbial infection) May play a role in HCV RNA replication. {ECO:0000269|PubMed:17229681}.; FUNCTION: (Microbial infection) Cleavage by Enterovirus 71 protease 3C results in increased translation of apoptosis protease activating factor APAF1, leading to apoptosis. {ECO:0000269|PubMed:17229681}. |
P12814 | ACTN1 | S43 | ochoa | Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1) | F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. Association with IGSF8 regulates the immune synapse formation and is required for efficient T-cell activation (PubMed:22689882). {ECO:0000269|PubMed:22689882}. |
P13521 | SCG2 | S268 | ochoa | Secretogranin-2 (Chromogranin-C) (Secretogranin II) (SgII) [Cleaved into: Secretoneurin (SN); Manserin] | Neuroendocrine protein of the granin family that regulates the biogenesis of secretory granules. {ECO:0000269|PubMed:19357184}. |
P15382 | KCNE1 | S102 | psp | Potassium voltage-gated channel subfamily E member 1 (Delayed rectifier potassium channel subunit IsK) (IKs producing slow voltage-gated potassium channel subunit beta Mink) (Minimal potassium channel) (MinK) | Ancillary protein that functions as a regulatory subunit of the voltage-gated potassium (Kv) channel complex composed of pore-forming and potassium-conducting alpha subunits and of regulatory beta subunits. KCNE1 beta subunit modulates the gating kinetics and enhances stability of the channel complex (PubMed:19219384, PubMed:20533308, PubMed:9230439). Alters the gating of the delayed rectifier Kv channel containing KCNB1 alpha subunit (PubMed:19219384). Associates with KCNQ1/KVLQT1 alpha subunit to form the slowly activating delayed rectifier cardiac potassium (IKs) channel responsible for ventricular muscle action potential repolarization (PubMed:20533308). The outward current reaches its steady state only after 50 seconds (Probable). Assembly with KCNH2/HERG alpha subunit Kv channel may regulate the rapidly activating component of the delayed rectifying potassium current (IKr) in heart (PubMed:9230439). {ECO:0000269|PubMed:19219384, ECO:0000269|PubMed:20533308, ECO:0000269|PubMed:9230439, ECO:0000305}. |
P16591 | FER | S408 | ochoa | Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer) | Tyrosine-protein kinase that acts downstream of cell surface receptors for growth factors and plays a role in the regulation of the actin cytoskeleton, microtubule assembly, lamellipodia formation, cell adhesion, cell migration and chemotaxis. Acts downstream of EGFR, KIT, PDGFRA and PDGFRB. Acts downstream of EGFR to promote activation of NF-kappa-B and cell proliferation. May play a role in the regulation of the mitotic cell cycle. Plays a role in the insulin receptor signaling pathway and in activation of phosphatidylinositol 3-kinase. Acts downstream of the activated FCER1 receptor and plays a role in FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. Plays a role in the regulation of mast cell degranulation. Plays a role in leukocyte recruitment and diapedesis in response to bacterial lipopolysaccharide (LPS). Plays a role in synapse organization, trafficking of synaptic vesicles, the generation of excitatory postsynaptic currents and neuron-neuron synaptic transmission. Plays a role in neuronal cell death after brain damage. Phosphorylates CTTN, CTNND1, PTK2/FAK1, GAB1, PECAM1 and PTPN11. May phosphorylate JUP and PTPN1. Can phosphorylate STAT3, but the biological relevance of this depends on cell type and stimulus. {ECO:0000269|PubMed:12972546, ECO:0000269|PubMed:14517306, ECO:0000269|PubMed:19147545, ECO:0000269|PubMed:19339212, ECO:0000269|PubMed:19738202, ECO:0000269|PubMed:20111072, ECO:0000269|PubMed:21518868, ECO:0000269|PubMed:22223638, ECO:0000269|PubMed:7623846, ECO:0000269|PubMed:9722593}. |
P16615 | ATP2A2 | S504 | ochoa | Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) | This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen (PubMed:12542527, PubMed:16402920). Involved in autophagy in response to starvation. Upon interaction with VMP1 and activation, controls ER-isolation membrane contacts for autophagosome formation (PubMed:28890335). Also modulates ER contacts with lipid droplets, mitochondria and endosomes (PubMed:28890335). In coordination with FLVCR2 mediates heme-stimulated switching from mitochondrial ATP synthesis to thermogenesis (By similarity). {ECO:0000250|UniProtKB:O55143, ECO:0000269|PubMed:12542527, ECO:0000269|PubMed:16402920, ECO:0000269|PubMed:28890335}.; FUNCTION: [Isoform 2]: Involved in the regulation of the contraction/relaxation cycle. Acts as a regulator of TNFSF11-mediated Ca(2+) signaling pathways via its interaction with TMEM64 which is critical for the TNFSF11-induced CREB1 activation and mitochondrial ROS generation necessary for proper osteoclast generation. Association between TMEM64 and SERCA2 in the ER leads to cytosolic Ca(2+) spiking for activation of NFATC1 and production of mitochondrial ROS, thereby triggering Ca(2+) signaling cascades that promote osteoclast differentiation and activation. {ECO:0000250|UniProtKB:O55143}. |
P17936 | IGFBP3 | S204 | ochoa | Insulin-like growth factor-binding protein 3 (IBP-3) (IGF-binding protein 3) (IGFBP-3) | Multifunctional protein that plays a critical role in regulating the availability of IGFs such as IGF1 and IGF2 to their receptors and thereby regulates IGF-mediated cellular processes including proliferation, differentiation, and apoptosis in a cell-type specific manner (PubMed:10874028, PubMed:19556345). Also exhibits IGF-independent antiproliferative and apoptotic effects mediated by its receptor TMEM219/IGFBP-3R (PubMed:20353938). Inhibits the positive effect of humanin on insulin sensitivity (PubMed:19623253). Promotes testicular germ cell apoptosis (PubMed:19952275). Acts via LRP-1/alpha2M receptor, also known as TGF-beta type V receptor, to mediate cell growth inhibition independent of IGF1 (PubMed:9252371). Mechanistically, induces serine-specific dephosphorylation of IRS1 or IRS2 upon ligation to its receptor, leading to the inhibitory cascade (PubMed:15371331). In the nucleus, interacts with transcription factors such as retinoid X receptor-alpha/RXRA to regulate transcriptional signaling and apoptosis (PubMed:10874028). {ECO:0000269|PubMed:10874028, ECO:0000269|PubMed:15371331, ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19556345, ECO:0000269|PubMed:19623253, ECO:0000269|PubMed:19952275, ECO:0000269|PubMed:20353938}. |
P20700 | LMNB1 | S278 | ochoa | Lamin-B1 | Lamins are intermediate filament proteins that assemble into a filamentous meshwork, and which constitute the major components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane (PubMed:28716252, PubMed:32910914). Lamins provide a framework for the nuclear envelope, bridging the nuclear envelope and chromatin, thereby playing an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics (PubMed:28716252, PubMed:32910914). The structural integrity of the lamina is strictly controlled by the cell cycle, as seen by the disintegration and formation of the nuclear envelope in prophase and telophase, respectively (PubMed:28716252, PubMed:32910914). {ECO:0000269|PubMed:28716252, ECO:0000269|PubMed:32910914}. |
P20807 | CAPN3 | S636 | psp | Calpain-3 (EC 3.4.22.54) (Calcium-activated neutral proteinase 3) (CANP 3) (Calpain L3) (Calpain p94) (Muscle-specific calcium-activated neutral protease 3) (New calpain 1) (nCL-1) | Calcium-regulated non-lysosomal thiol-protease. Proteolytically cleaves CTBP1 at 'His-409'. Mediates, with UTP25, the proteasome-independent degradation of p53/TP53 (PubMed:23357851, PubMed:27657329). {ECO:0000269|PubMed:23357851, ECO:0000269|PubMed:23707407, ECO:0000269|PubMed:27657329}. |
P22626 | HNRNPA2B1 | S29 | ochoa | Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1) | Heterogeneous nuclear ribonucleoprotein (hnRNP) that associates with nascent pre-mRNAs, packaging them into hnRNP particles. The hnRNP particle arrangement on nascent hnRNA is non-random and sequence-dependent and serves to condense and stabilize the transcripts and minimize tangling and knotting. Packaging plays a role in various processes such as transcription, pre-mRNA processing, RNA nuclear export, subcellular location, mRNA translation and stability of mature mRNAs (PubMed:19099192). Forms hnRNP particles with at least 20 other different hnRNP and heterogeneous nuclear RNA in the nucleus. Involved in transport of specific mRNAs to the cytoplasm in oligodendrocytes and neurons: acts by specifically recognizing and binding the A2RE (21 nucleotide hnRNP A2 response element) or the A2RE11 (derivative 11 nucleotide oligonucleotide) sequence motifs present on some mRNAs, and promotes their transport to the cytoplasm (PubMed:10567417). Specifically binds single-stranded telomeric DNA sequences, protecting telomeric DNA repeat against endonuclease digestion (By similarity). Also binds other RNA molecules, such as primary miRNA (pri-miRNAs): acts as a nuclear 'reader' of the N6-methyladenosine (m6A) mark by specifically recognizing and binding a subset of nuclear m6A-containing pri-miRNAs. Binding to m6A-containing pri-miRNAs promotes pri-miRNA processing by enhancing binding of DGCR8 to pri-miRNA transcripts (PubMed:26321680). Involved in miRNA sorting into exosomes following sumoylation, possibly by binding (m6A)-containing pre-miRNAs (PubMed:24356509). Acts as a regulator of efficiency of mRNA splicing, possibly by binding to m6A-containing pre-mRNAs (PubMed:26321680). Plays a role in the splicing of pyruvate kinase PKM by binding repressively to sequences flanking PKM exon 9, inhibiting exon 9 inclusion and resulting in exon 10 inclusion and production of the PKM M2 isoform (PubMed:20010808). Also plays a role in the activation of the innate immune response (PubMed:31320558). Mechanistically, senses the presence of viral DNA in the nucleus, homodimerizes and is demethylated by JMJD6 (PubMed:31320558). In turn, translocates to the cytoplasm where it activates the TBK1-IRF3 pathway, leading to interferon alpha/beta production (PubMed:31320558). {ECO:0000250|UniProtKB:A7VJC2, ECO:0000269|PubMed:10567417, ECO:0000269|PubMed:20010808, ECO:0000269|PubMed:24356509, ECO:0000269|PubMed:26321680, ECO:0000303|PubMed:19099192}.; FUNCTION: (Microbial infection) Involved in the transport of HIV-1 genomic RNA out of the nucleus, to the microtubule organizing center (MTOC), and then from the MTOC to the cytoplasm: acts by specifically recognizing and binding the A2RE (21 nucleotide hnRNP A2 response element) sequence motifs present on HIV-1 genomic RNA, and promotes its transport. {ECO:0000269|PubMed:15294897, ECO:0000269|PubMed:17004321}. |
P25686 | DNAJB2 | S264 | psp | DnaJ homolog subfamily B member 2 (Heat shock 40 kDa protein 3) (Heat shock protein J1) (HSJ-1) | Functions as a co-chaperone, regulating the substrate binding and activating the ATPase activity of chaperones of the HSP70/heat shock protein 70 family (PubMed:22219199, PubMed:7957263). In parallel, also contributes to the ubiquitin-dependent proteasomal degradation of misfolded proteins (PubMed:15936278, PubMed:21625540). Thereby, may regulate the aggregation and promote the functional recovery of misfolded proteins like HTT, MC4R, PRKN, RHO and SOD1 and be crucial for many biological processes (PubMed:12754272, PubMed:20889486, PubMed:21719532, PubMed:22396390, PubMed:24023695). Isoform 1 which is localized to the endoplasmic reticulum membranes may specifically function in ER-associated protein degradation of misfolded proteins (PubMed:15936278). {ECO:0000269|PubMed:12754272, ECO:0000269|PubMed:15936278, ECO:0000269|PubMed:20889486, ECO:0000269|PubMed:21625540, ECO:0000269|PubMed:21719532, ECO:0000269|PubMed:22219199, ECO:0000269|PubMed:22396390, ECO:0000269|PubMed:24023695, ECO:0000269|PubMed:7957263}. |
P26583 | HMGB2 | S121 | ochoa | High mobility group protein B2 (High mobility group protein 2) (HMG-2) | Multifunctional protein with various roles in different cellular compartments. May act in a redox sensitive manner. In the nucleus is an abundant chromatin-associated non-histone protein involved in transcription, chromatin remodeling and V(D)J recombination and probably other processes. Binds DNA with a preference to non-canonical DNA structures such as single-stranded DNA. Can bent DNA and enhance DNA flexibility by looping thus providing a mechanism to promote activities on various gene promoters by enhancing transcription factor binding and/or bringing distant regulatory sequences into close proximity (PubMed:11909973, PubMed:18413230, PubMed:19522541, PubMed:19965638, PubMed:20123072, PubMed:7797075). Involved in V(D)J recombination by acting as a cofactor of the RAG complex: acts by stimulating cleavage and RAG protein binding at the 23 bp spacer of conserved recombination signal sequences (RSS) (By similarity). Proposed to be involved in the innate immune response to nucleic acids by acting as a promiscuous immunogenic DNA/RNA sensor which cooperates with subsequent discriminative sensing by specific pattern recognition receptors (By similarity). In the extracellular compartment acts as a chemokine. Promotes proliferation and migration of endothelial cells implicating AGER/RAGE (PubMed:19811285). Has antimicrobial activity in gastrointestinal epithelial tissues (PubMed:23877675). Involved in inflammatory response to antigenic stimulus coupled with pro-inflammatory activity (By similarity). Involved in modulation of neurogenesis probably by regulation of neural stem proliferation (By similarity). Involved in articular cartilage surface maintenance implicating LEF1 and the Wnt/beta-catenin pathway (By similarity). {ECO:0000250|UniProtKB:P09429, ECO:0000250|UniProtKB:P30681, ECO:0000269|PubMed:11909973, ECO:0000269|PubMed:18413230, ECO:0000269|PubMed:19522541, ECO:0000269|PubMed:19811285, ECO:0000269|PubMed:19965638, ECO:0000269|PubMed:23877675, ECO:0000269|PubMed:7797075, ECO:0000305|PubMed:20123072}. |
P28698 | MZF1 | S177 | ochoa | Myeloid zinc finger 1 (MZF-1) (Zinc finger and SCAN domain-containing protein 6) (Zinc finger protein 42) | Binds to target promoter DNA and functions as a transcription regulator. Regulates transcription from the PADI1 and CDH2 promoter. May be one regulator of transcriptional events during hemopoietic development. {ECO:0000269|PubMed:15541732, ECO:0000269|PubMed:17851584}. |
P29350 | PTPN6 | S250 | ochoa | Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase) (Protein-tyrosine phosphatase 1C) (PTP-1C) (Protein-tyrosine phosphatase SHP-1) (SH-PTP1) | Tyrosine phosphatase enzyme that plays important roles in controlling immune signaling pathways and fundamental physiological processes such as hematopoiesis (PubMed:14739280, PubMed:29925997). Dephosphorylates and negatively regulate several receptor tyrosine kinases (RTKs) such as EGFR, PDGFR and FGFR, thereby modulating their signaling activities (PubMed:21258366, PubMed:9733788). When recruited to immunoreceptor tyrosine-based inhibitory motif (ITIM)-containing receptors such as immunoglobulin-like transcript 2/LILRB1, programmed cell death protein 1/PDCD1, CD3D, CD22, CLEC12A and other receptors involved in immune regulation, initiates their dephosphorylation and subsequently inhibits downstream signaling events (PubMed:11907092, PubMed:14739280, PubMed:37932456, PubMed:38166031). Modulates the signaling of several cytokine receptors including IL-4 receptor (PubMed:9065461). Additionally, targets multiple cytoplasmic signaling molecules including STING1, LCK or STAT1 among others involved in diverse cellular processes including modulation of T-cell activation or cGAS-STING signaling (PubMed:34811497, PubMed:38532423). Within the nucleus, negatively regulates the activity of some transcription factors such as NFAT5 via direct dephosphorylation. Also acts as a key transcriptional regulator of hepatic gluconeogenesis by controlling recruitment of RNA polymerase II to the PCK1 promoter together with STAT5A (PubMed:37595871). {ECO:0000269|PubMed:10574931, ECO:0000269|PubMed:11266449, ECO:0000269|PubMed:11907092, ECO:0000269|PubMed:14739280, ECO:0000269|PubMed:21258366, ECO:0000269|PubMed:29925997, ECO:0000269|PubMed:34811497, ECO:0000269|PubMed:37595871, ECO:0000269|PubMed:37932456, ECO:0000269|PubMed:38166031, ECO:0000269|PubMed:38532423, ECO:0000269|PubMed:9065461, ECO:0000269|PubMed:9733788}. |
P30622 | CLIP1 | S973 | ochoa | CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin) | Binds to the plus end of microtubules and regulates the dynamics of the microtubule cytoskeleton. Promotes microtubule growth and microtubule bundling. Links cytoplasmic vesicles to microtubules and thereby plays an important role in intracellular vesicle trafficking. Plays a role macropinocytosis and endosome trafficking. {ECO:0000269|PubMed:12433698, ECO:0000269|PubMed:17563362, ECO:0000269|PubMed:17889670}. |
P34932 | HSPA4 | S546 | ochoa | Heat shock 70 kDa protein 4 (HSP70RY) (Heat shock 70-related protein APG-2) (Heat shock protein family H member 2) | None |
P35442 | THBS2 | S258 | ochoa | Thrombospondin-2 | Adhesive glycoprotein that mediates cell-to-cell and cell-to-matrix interactions. Ligand for CD36 mediating antiangiogenic properties. {ECO:0000269|PubMed:20714802}. |
P35555 | FBN1 | S2564 | ochoa | Fibrillin-1 [Cleaved into: Asprosin] | [Fibrillin-1]: Structural component of the 10-12 nm diameter microfibrils of the extracellular matrix, which conveys both structural and regulatory properties to load-bearing connective tissues (PubMed:15062093, PubMed:1860873). Fibrillin-1-containing microfibrils provide long-term force bearing structural support (PubMed:27026396). In tissues such as the lung, blood vessels and skin, microfibrils form the periphery of the elastic fiber, acting as a scaffold for the deposition of elastin (PubMed:27026396). In addition, microfibrils can occur as elastin-independent networks in tissues such as the ciliary zonule, tendon, cornea and glomerulus where they provide tensile strength and have anchoring roles (PubMed:27026396). Fibrillin-1 also plays a key role in tissue homeostasis through specific interactions with growth factors, such as the bone morphogenetic proteins (BMPs), growth and differentiation factors (GDFs) and latent transforming growth factor-beta-binding proteins (LTBPs), cell-surface integrins and other extracellular matrix protein and proteoglycan components (PubMed:27026396). Regulates osteoblast maturation by controlling TGF-beta bioavailability and calibrating TGF-beta and BMP levels, respectively (By similarity). Negatively regulates osteoclastogenesis by binding and sequestering an osteoclast differentiation and activation factor TNFSF11 (PubMed:24039232). This leads to disruption of TNFSF11-induced Ca(2+) signaling and impairment of TNFSF11-mediated nuclear translocation and activation of transcription factor NFATC1 which regulates genes important for osteoclast differentiation and function (PubMed:24039232). Mediates cell adhesion via its binding to cell surface receptors integrins ITGAV:ITGB3 and ITGA5:ITGB1 (PubMed:12807887, PubMed:17158881). Binds heparin and this interaction has an important role in the assembly of microfibrils (PubMed:11461921). {ECO:0000250|UniProtKB:Q61554, ECO:0000269|PubMed:11461921, ECO:0000269|PubMed:12807887, ECO:0000269|PubMed:15062093, ECO:0000269|PubMed:17158881, ECO:0000269|PubMed:1860873, ECO:0000269|PubMed:24039232, ECO:0000303|PubMed:27026396}.; FUNCTION: [Asprosin]: Adipokine secreted by white adipose tissue that plays an important regulatory role in the glucose metabolism of liver, muscle and pancreas (PubMed:27087445, PubMed:30853600). Hormone that targets the liver in response to fasting to increase plasma glucose levels (PubMed:27087445). Binds the olfactory receptor OR4M1 at the surface of hepatocytes and promotes hepatocyte glucose release by activating the protein kinase A activity in the liver, resulting in rapid glucose release into the circulation (PubMed:27087445, PubMed:31230984). May act as a regulator of adaptive thermogenesis by inhibiting browning and energy consumption, while increasing lipid deposition in white adipose tissue (By similarity). Also acts as an orexigenic hormone that increases appetite: crosses the blood brain barrier and exerts effects on the hypothalamus (By similarity). In the arcuate nucleus of the hypothalamus, asprosin directly activates orexigenic AgRP neurons and indirectly inhibits anorexigenic POMC neurons, resulting in appetite stimulation (By similarity). Activates orexigenic AgRP neurons via binding to the olfactory receptor OR4M1 (By similarity). May also play a role in sperm motility in testis via interaction with OR4M1 receptor (By similarity). {ECO:0000250|UniProtKB:Q61554, ECO:0000269|PubMed:27087445, ECO:0000269|PubMed:30853600, ECO:0000269|PubMed:31230984}. |
P35609 | ACTN2 | S50 | ochoa | Alpha-actinin-2 (Alpha-actinin skeletal muscle isoform 2) (F-actin cross-linking protein) | F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein. |
P46100 | ATRX | S1236 | ochoa | Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX) | Involved in transcriptional regulation and chromatin remodeling. Facilitates DNA replication in multiple cellular environments and is required for efficient replication of a subset of genomic loci. Binds to DNA tandem repeat sequences in both telomeres and euchromatin and in vitro binds DNA quadruplex structures. May help stabilizing G-rich regions into regular chromatin structures by remodeling G4 DNA and incorporating H3.3-containing nucleosomes. Catalytic component of the chromatin remodeling complex ATRX:DAXX which has ATP-dependent DNA translocase activity and catalyzes the replication-independent deposition of histone H3.3 in pericentric DNA repeats outside S-phase and telomeres, and the in vitro remodeling of H3.3-containing nucleosomes. Its heterochromatin targeting is proposed to involve a combinatorial readout of histone H3 modifications (specifically methylation states of H3K9 and H3K4) and association with CBX5. Involved in maintaining telomere structural integrity in embryonic stem cells which probably implies recruitment of CBX5 to telomeres. Reports on the involvement in transcriptional regulation of telomeric repeat-containing RNA (TERRA) are conflicting; according to a report, it is not sufficient to decrease chromatin condensation at telomeres nor to increase expression of telomeric RNA in fibroblasts (PubMed:24500201). May be involved in telomere maintenance via recombination in ALT (alternative lengthening of telomeres) cell lines. Acts as a negative regulator of chromatin incorporation of transcriptionally repressive histone MACROH2A1, particularily at telomeres and the alpha-globin cluster in erythroleukemic cells. Participates in the allele-specific gene expression at the imprinted IGF2/H19 gene locus. On the maternal allele, required for the chromatin occupancy of SMC1 and CTCTF within the H19 imprinting control region (ICR) and involved in esatblishment of histone tails modifications in the ICR. May be involved in brain development and facial morphogenesis. Binds to zinc-finger coding genes with atypical chromatin signatures and regulates its H3K9me3 levels. Forms a complex with ZNF274, TRIM28 and SETDB1 to facilitate the deposition and maintenance of H3K9me3 at the 3' exons of zinc-finger genes (PubMed:27029610). {ECO:0000269|PubMed:12953102, ECO:0000269|PubMed:14990586, ECO:0000269|PubMed:20504901, ECO:0000269|PubMed:20651253, ECO:0000269|PubMed:21029860, ECO:0000269|PubMed:22391447, ECO:0000269|PubMed:22829774, ECO:0000269|PubMed:24500201, ECO:0000269|PubMed:27029610}. |
P46100 | ATRX | S1418 | ochoa | Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX) | Involved in transcriptional regulation and chromatin remodeling. Facilitates DNA replication in multiple cellular environments and is required for efficient replication of a subset of genomic loci. Binds to DNA tandem repeat sequences in both telomeres and euchromatin and in vitro binds DNA quadruplex structures. May help stabilizing G-rich regions into regular chromatin structures by remodeling G4 DNA and incorporating H3.3-containing nucleosomes. Catalytic component of the chromatin remodeling complex ATRX:DAXX which has ATP-dependent DNA translocase activity and catalyzes the replication-independent deposition of histone H3.3 in pericentric DNA repeats outside S-phase and telomeres, and the in vitro remodeling of H3.3-containing nucleosomes. Its heterochromatin targeting is proposed to involve a combinatorial readout of histone H3 modifications (specifically methylation states of H3K9 and H3K4) and association with CBX5. Involved in maintaining telomere structural integrity in embryonic stem cells which probably implies recruitment of CBX5 to telomeres. Reports on the involvement in transcriptional regulation of telomeric repeat-containing RNA (TERRA) are conflicting; according to a report, it is not sufficient to decrease chromatin condensation at telomeres nor to increase expression of telomeric RNA in fibroblasts (PubMed:24500201). May be involved in telomere maintenance via recombination in ALT (alternative lengthening of telomeres) cell lines. Acts as a negative regulator of chromatin incorporation of transcriptionally repressive histone MACROH2A1, particularily at telomeres and the alpha-globin cluster in erythroleukemic cells. Participates in the allele-specific gene expression at the imprinted IGF2/H19 gene locus. On the maternal allele, required for the chromatin occupancy of SMC1 and CTCTF within the H19 imprinting control region (ICR) and involved in esatblishment of histone tails modifications in the ICR. May be involved in brain development and facial morphogenesis. Binds to zinc-finger coding genes with atypical chromatin signatures and regulates its H3K9me3 levels. Forms a complex with ZNF274, TRIM28 and SETDB1 to facilitate the deposition and maintenance of H3K9me3 at the 3' exons of zinc-finger genes (PubMed:27029610). {ECO:0000269|PubMed:12953102, ECO:0000269|PubMed:14990586, ECO:0000269|PubMed:20504901, ECO:0000269|PubMed:20651253, ECO:0000269|PubMed:21029860, ECO:0000269|PubMed:22391447, ECO:0000269|PubMed:22829774, ECO:0000269|PubMed:24500201, ECO:0000269|PubMed:27029610}. |
P46821 | MAP1B | S977 | ochoa | Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain; MAP1 light chain LC1] | Facilitates tyrosination of alpha-tubulin in neuronal microtubules (By similarity). Phosphorylated MAP1B is required for proper microtubule dynamics and plays a role in the cytoskeletal changes that accompany neuronal differentiation and neurite extension (PubMed:33268592). Possibly MAP1B binds to at least two tubulin subunits in the polymer, and this bridging of subunits might be involved in nucleating microtubule polymerization and in stabilizing microtubules. Acts as a positive cofactor in DAPK1-mediated autophagic vesicle formation and membrane blebbing. {ECO:0000250, ECO:0000269|PubMed:18195017, ECO:0000269|PubMed:33268592}. |
P49321 | NASP | S210 | ochoa | Nuclear autoantigenic sperm protein (NASP) | Component of the histone chaperone network (PubMed:22195965). Binds and stabilizes histone H3-H4 not bound to chromatin to maintain a soluble reservoir and modulate degradation by chaperone-mediated autophagy (PubMed:22195965). Required for DNA replication, normal cell cycle progression and cell proliferation. Forms a cytoplasmic complex with HSP90 and H1 linker histones and stimulates HSP90 ATPase activity. NASP and H1 histone are subsequently released from the complex and translocate to the nucleus where the histone is released for binding to DNA. {ECO:0000250|UniProtKB:Q99MD9, ECO:0000269|PubMed:22195965}.; FUNCTION: [Isoform 1]: Stabilizes soluble histone H3-H4. {ECO:0000269|PubMed:22195965}.; FUNCTION: [Isoform 2]: Stabilizes soluble histone H3-H4. {ECO:0000269|PubMed:22195965}. |
P49643 | PRIM2 | S170 | ochoa | DNA primase large subunit (DNA primase 58 kDa subunit) (p58) | Regulatory subunit of the DNA primase complex and component of the DNA polymerase alpha complex (also known as the alpha DNA polymerase-primase complex) which play an essential role in the initiation of DNA synthesis (PubMed:17893144, PubMed:25550159, PubMed:26975377, PubMed:9705292). During the S phase of the cell cycle, the DNA polymerase alpha complex (composed of a catalytic subunit POLA1, an accessory subunit POLA2 and two primase subunits, the catalytic subunit PRIM1 and the regulatory subunit PRIM2) is recruited to DNA at the replicative forks via direct interactions with MCM10 and WDHD1 (By similarity). The primase subunit of the polymerase alpha complex initiates DNA synthesis by oligomerising short RNA primers on both leading and lagging strands (PubMed:17893144). These primers are initially extended by the polymerase alpha catalytic subunit and subsequently transferred to polymerase delta and polymerase epsilon for processive synthesis on the lagging and leading strand, respectively (By similarity). In the primase complex, both subunits are necessary for the initial di-nucleotide formation, but the extension of the primer depends only on the catalytic subunit (PubMed:17893144, PubMed:25550159). Binds RNA:DNA duplex and coordinates the catalytic activities of PRIM1 and POLA2 during primase-to-polymerase switch. {ECO:0000250|UniProtKB:P09884, ECO:0000250|UniProtKB:P33610, ECO:0000269|PubMed:17893144, ECO:0000269|PubMed:25550159, ECO:0000269|PubMed:26975377, ECO:0000269|PubMed:9705292}. |
P51003 | PAPOLA | S681 | ochoa | Poly(A) polymerase alpha (PAP-alpha) (EC 2.7.7.19) (Polynucleotide adenylyltransferase alpha) | Polymerase that creates the 3'-poly(A) tail of mRNA's. Also required for the endoribonucleolytic cleavage reaction at some polyadenylation sites. May acquire specificity through interaction with a cleavage and polyadenylation specificity factor (CPSF) at its C-terminus. {ECO:0000269|PubMed:19224921}. |
P51797 | CLCN6 | S683 | ochoa | H(+)/Cl(-) exchange transporter 6 (Chloride channel protein 6) (ClC-6) (Chloride transport protein 6) | Voltage-gated channel mediating the exchange of chloride ions against protons. Functions as antiporter and contributes to the acidification of the late endosome lumen. The CLC channel family contains both chloride channels and proton-coupled anion transporters that exchange chloride or another anion for protons. The presence of conserved gating glutamate residues is typical for family members that function as antiporters. {ECO:0000269|PubMed:20466723}. |
P51991 | HNRNPA3 | S43 | ochoa | Heterogeneous nuclear ribonucleoprotein A3 (hnRNP A3) | Plays a role in cytoplasmic trafficking of RNA. Binds to the cis-acting response element, A2RE. May be involved in pre-mRNA splicing. {ECO:0000269|PubMed:11886857}. |
P52789 | HK2 | Y686 | psp | Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) (Hexokinase-B) (Muscle form hexokinase) | Catalyzes the phosphorylation of hexose, such as D-glucose and D-fructose, to hexose 6-phosphate (D-glucose 6-phosphate and D-fructose 6-phosphate, respectively) (PubMed:23185017, PubMed:26985301, PubMed:29298880). Mediates the initial step of glycolysis by catalyzing phosphorylation of D-glucose to D-glucose 6-phosphate (PubMed:29298880). Plays a key role in maintaining the integrity of the outer mitochondrial membrane by preventing the release of apoptogenic molecules from the intermembrane space and subsequent apoptosis (PubMed:18350175). {ECO:0000269|PubMed:18350175, ECO:0000269|PubMed:23185017, ECO:0000269|PubMed:26985301, ECO:0000269|PubMed:29298880}. |
P54296 | MYOM2 | S1388 | ochoa | Myomesin-2 (165 kDa connectin-associated protein) (165 kDa titin-associated protein) (M-protein) (Myomesin family member 2) | Major component of the vertebrate myofibrillar M band. Binds myosin, titin, and light meromyosin. This binding is dose dependent. |
P55895 | RAG2 | S365 | psp | V(D)J recombination-activating protein 2 (RAG-2) | Core component of the RAG complex, a multiprotein complex that mediates the DNA cleavage phase during V(D)J recombination. V(D)J recombination assembles a diverse repertoire of immunoglobulin and T-cell receptor genes in developing B and T-lymphocytes through rearrangement of different V (variable), in some cases D (diversity), and J (joining) gene segments. DNA cleavage by the RAG complex occurs in 2 steps: a first nick is introduced in the top strand immediately upstream of the heptamer, generating a 3'-hydroxyl group that can attack the phosphodiester bond on the opposite strand in a direct transesterification reaction, thereby creating 4 DNA ends: 2 hairpin coding ends and 2 blunt, 5'-phosphorylated ends. The chromatin structure plays an essential role in the V(D)J recombination reactions and the presence of histone H3 trimethylated at 'Lys-4' (H3K4me3) stimulates both the nicking and haipinning steps. The RAG complex also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B-lymphocytes. The introduction of DNA breaks by the RAG complex on one immunoglobulin allele induces ATM-dependent repositioning of the other allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. In the RAG complex, RAG2 is not the catalytic component but is required for all known catalytic activities mediated by RAG1. It probably acts as a sensor of chromatin state that recruits the RAG complex to H3K4me3 (By similarity). {ECO:0000250}. |
P56945 | BCAR1 | S694 | ochoa | Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (Cas scaffolding protein family member 1) (p130cas) | Docking protein which plays a central coordinating role for tyrosine kinase-based signaling related to cell adhesion (PubMed:12432078, PubMed:12832404). Implicated in induction of cell migration and cell branching (PubMed:12432078, PubMed:12832404, PubMed:17038317). Involved in the BCAR3-mediated inhibition of TGFB signaling (By similarity). {ECO:0000250|UniProtKB:Q61140, ECO:0000269|PubMed:12432078, ECO:0000269|PubMed:12832404, ECO:0000269|PubMed:17038317}. |
P57737 | CORO7 | S807 | ochoa | Coronin-7 (Crn7) (70 kDa WD repeat tumor rejection antigen homolog) | F-actin regulator involved in anterograde Golgi to endosome transport: upon ubiquitination via 'Lys-33'-linked ubiquitin chains by the BCR(KLHL20) E3 ubiquitin ligase complex, interacts with EPS15 and localizes to the trans-Golgi network, where it promotes actin polymerization, thereby facilitating post-Golgi trafficking. May play a role in the maintenance of the Golgi apparatus morphology. {ECO:0000269|PubMed:16905771, ECO:0000269|PubMed:24768539}. |
P61981 | YWHAG | S149 | ochoa | 14-3-3 protein gamma (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein gamma, N-terminally processed] | Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways (PubMed:15696159, PubMed:16511572, PubMed:36732624). Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif (PubMed:15696159, PubMed:16511572, PubMed:36732624). Binding generally results in the modulation of the activity of the binding partner (PubMed:16511572). Promotes inactivation of WDR24 component of the GATOR2 complex by binding to phosphorylated WDR24 (PubMed:36732624). Participates in the positive regulation of NMDA glutamate receptor activity by promoting the L-glutamate secretion through interaction with BEST1 (PubMed:29121962). Reduces keratinocyte intercellular adhesion, via interacting with PKP1 and sequestering it in the cytoplasm, thereby reducing its incorporation into desmosomes (PubMed:29678907). Plays a role in mitochondrial protein catabolic process (also named MALM) that promotes the degradation of damaged proteins inside mitochondria (PubMed:22532927). {ECO:0000269|PubMed:15696159, ECO:0000269|PubMed:16511572, ECO:0000269|PubMed:22532927, ECO:0000269|PubMed:29121962, ECO:0000269|PubMed:29678907, ECO:0000269|PubMed:36732624}. |
P78345 | RPP38 | S235 | ochoa | Ribonuclease P protein subunit p38 (RNaseP protein p38) | Component of ribonuclease P, a ribonucleoprotein complex that generates mature tRNA molecules by cleaving their 5'-ends (PubMed:10444065, PubMed:30454648, PubMed:9037013, PubMed:9630247). Also a component of the MRP ribonuclease complex, which cleaves pre-rRNA sequences (PubMed:28115465). {ECO:0000269|PubMed:10444065, ECO:0000269|PubMed:28115465, ECO:0000269|PubMed:30454648, ECO:0000269|PubMed:9037013, ECO:0000269|PubMed:9630247}. |
P78536 | ADAM17 | S791 | ochoa|psp | Disintegrin and metalloproteinase domain-containing protein 17 (ADAM 17) (EC 3.4.24.86) (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD antigen CD156b) | Transmembrane metalloprotease which mediates the ectodomain shedding of a myriad of transmembrane proteins including adhesion proteins, growth factor precursors and cytokines important for inflammation and immunity (PubMed:24226769, PubMed:24227843, PubMed:28060820, PubMed:28923481). Cleaves the membrane-bound precursor of TNF-alpha to its mature soluble form (PubMed:36078095, PubMed:9034191). Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface (PubMed:20592283). Responsible for the proteolytic release of several other cell-surface proteins, including p75 TNF-receptor, interleukin 1 receptor type II, p55 TNF-receptor, transforming growth factor-alpha, L-selectin, growth hormone receptor, MUC1 and the amyloid precursor protein (PubMed:12441351). Acts as an activator of Notch pathway by mediating cleavage of Notch, generating the membrane-associated intermediate fragment called Notch extracellular truncation (NEXT) (PubMed:24226769). Plays a role in the proteolytic processing of ACE2 (PubMed:24227843). Plays a role in hemostasis through shedding of GP1BA, the platelet glycoprotein Ib alpha chain (By similarity). Mediates the proteolytic cleavage of LAG3, leading to release the secreted form of LAG3 (By similarity). Mediates the proteolytic cleavage of IL6R, leading to the release of secreted form of IL6R (PubMed:26876177, PubMed:28060820). Mediates the proteolytic cleavage and shedding of FCGR3A upon NK cell stimulation, a mechanism that allows for increased NK cell motility and detachment from opsonized target cells. Cleaves TREM2, resulting in shedding of the TREM2 ectodomain (PubMed:28923481). {ECO:0000250|UniProtKB:Q9Z0F8, ECO:0000269|PubMed:12441351, ECO:0000269|PubMed:20592283, ECO:0000269|PubMed:24226769, ECO:0000269|PubMed:24227843, ECO:0000269|PubMed:24337742, ECO:0000269|PubMed:26876177, ECO:0000269|PubMed:28060820, ECO:0000269|PubMed:28923481, ECO:0000269|PubMed:36078095, ECO:0000269|PubMed:9034191}. |
P78559 | MAP1A | S771 | ochoa | Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain; MAP1 light chain LC2] | Structural protein involved in the filamentous cross-bridging between microtubules and other skeletal elements. |
P82094 | TMF1 | S197 | ochoa | TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa) | Potential coactivator of the androgen receptor. Mediates STAT3 degradation. May play critical roles in two RAB6-dependent retrograde transport processes: one from endosomes to the Golgi and the other from the Golgi to the ER. This protein binds the HIV-1 TATA element and inhibits transcriptional activation by the TATA-binding protein (TBP). {ECO:0000269|PubMed:10428808, ECO:0000269|PubMed:1409643, ECO:0000269|PubMed:15467733, ECO:0000269|PubMed:17698061}. |
Q02410 | APBA1 | S263 | ochoa | Amyloid-beta A4 precursor protein-binding family A member 1 (Adapter protein X11alpha) (Neuron-specific X11 protein) (Neuronal Munc18-1-interacting protein 1) (Mint-1) | Putative function in synaptic vesicle exocytosis by binding to Munc18-1, an essential component of the synaptic vesicle exocytotic machinery. May modulate processing of the amyloid-beta precursor protein (APP) and hence formation of APP-beta. Component of the LIN-10-LIN-2-LIN-7 complex, which associates with the motor protein KIF17 to transport vesicles containing N-methyl-D-aspartate (NMDA) receptor subunit NR2B along microtubules (By similarity). {ECO:0000250|UniProtKB:B2RUJ5}. |
Q02952 | AKAP12 | S1712 | ochoa | A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen) | Anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA) and protein kinase C (PKC). |
Q03164 | KMT2A | S3644 | ochoa | Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.364) (ALL-1) (CXXC-type zinc finger protein 7) (Cysteine methyltransferase KMT2A) (EC 2.1.1.-) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] | Histone methyltransferase that plays an essential role in early development and hematopoiesis (PubMed:12453419, PubMed:15960975, PubMed:19187761, PubMed:19556245, PubMed:20677832, PubMed:21220120, PubMed:26886794). Catalytic subunit of the MLL1/MLL complex, a multiprotein complex that mediates both methylation of 'Lys-4' of histone H3 (H3K4me) complex and acetylation of 'Lys-16' of histone H4 (H4K16ac) (PubMed:12453419, PubMed:15960975, PubMed:19187761, PubMed:19556245, PubMed:20677832, PubMed:21220120, PubMed:24235145, PubMed:26886794). Catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) via a non-processive mechanism. Part of chromatin remodeling machinery predominantly forms H3K4me1 and H3K4me2 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:12453419, PubMed:15960975, PubMed:19187761, PubMed:19556245, PubMed:20677832, PubMed:21220120, PubMed:25561738, PubMed:26886794). Has weak methyltransferase activity by itself, and requires other component of the MLL1/MLL complex to obtain full methyltransferase activity (PubMed:19187761, PubMed:26886794). Has no activity toward histone H3 phosphorylated on 'Thr-3', less activity toward H3 dimethylated on 'Arg-8' or 'Lys-9', while it has higher activity toward H3 acetylated on 'Lys-9' (PubMed:19187761). Binds to unmethylated CpG elements in the promoter of target genes and helps maintain them in the nonmethylated state (PubMed:20010842). Required for transcriptional activation of HOXA9 (PubMed:12453419, PubMed:20010842, PubMed:20677832). Promotes PPP1R15A-induced apoptosis (PubMed:10490642). Plays a critical role in the control of circadian gene expression and is essential for the transcriptional activation mediated by the CLOCK-BMAL1 heterodimer (By similarity). Establishes a permissive chromatin state for circadian transcription by mediating a rhythmic methylation of 'Lys-4' of histone H3 (H3K4me) and this histone modification directs the circadian acetylation at H3K9 and H3K14 allowing the recruitment of CLOCK-BMAL1 to chromatin (By similarity). Also has auto-methylation activity on Cys-3882 in absence of histone H3 substrate (PubMed:24235145). {ECO:0000250|UniProtKB:P55200, ECO:0000269|PubMed:10490642, ECO:0000269|PubMed:12453419, ECO:0000269|PubMed:15960975, ECO:0000269|PubMed:19187761, ECO:0000269|PubMed:19556245, ECO:0000269|PubMed:20010842, ECO:0000269|PubMed:21220120, ECO:0000269|PubMed:24235145, ECO:0000269|PubMed:26886794, ECO:0000305|PubMed:20677832}. |
Q03252 | LMNB2 | S292 | ochoa | Lamin-B2 | Lamins are intermediate filament proteins that assemble into a filamentous meshwork, and which constitute the major components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane (PubMed:33033404). Lamins provide a framework for the nuclear envelope, bridging the nuclear envelope and chromatin, thereby playing an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics (PubMed:33033404). The structural integrity of the lamina is strictly controlled by the cell cycle, as seen by the disintegration and formation of the nuclear envelope in prophase and telophase, respectively (PubMed:33033404). {ECO:0000269|PubMed:33033404}. |
Q08043 | ACTN3 | S57 | ochoa | Alpha-actinin-3 (Alpha-actinin skeletal muscle isoform 3) (F-actin cross-linking protein) | F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein. |
Q08AD1 | CAMSAP2 | S715 | ochoa | Calmodulin-regulated spectrin-associated protein 2 (Calmodulin-regulated spectrin-associated protein 1-like protein 1) | Key microtubule-organizing protein that specifically binds the minus-end of non-centrosomal microtubules and regulates their dynamics and organization (PubMed:23169647, PubMed:24486153, PubMed:24706919). Specifically recognizes growing microtubule minus-ends and autonomously decorates and stabilizes microtubule lattice formed by microtubule minus-end polymerization (PubMed:24486153, PubMed:24706919). Acts on free microtubule minus-ends that are not capped by microtubule-nucleating proteins or other factors and protects microtubule minus-ends from depolymerization (PubMed:24486153, PubMed:24706919). In addition, it also reduces the velocity of microtubule polymerization (PubMed:24486153, PubMed:24706919). Through the microtubule cytoskeleton, also regulates the organization of cellular organelles including the Golgi and the early endosomes (PubMed:27666745). Essential for the tethering, but not for nucleation of non-centrosomal microtubules at the Golgi: together with Golgi-associated proteins AKAP9 and PDE4DIP, required to tether non-centrosomal minus-end microtubules to the Golgi, an important step for polarized cell movement (PubMed:27666745). Also acts as a regulator of neuronal polarity and development: localizes to non-centrosomal microtubule minus-ends in neurons and stabilizes non-centrosomal microtubules, which is required for neuronal polarity, axon specification and dendritic branch formation (PubMed:24908486). Through the microtubule cytoskeleton, regulates the autophagosome transport (PubMed:28726242). {ECO:0000269|PubMed:23169647, ECO:0000269|PubMed:24486153, ECO:0000269|PubMed:24706919, ECO:0000269|PubMed:24908486, ECO:0000269|PubMed:27666745, ECO:0000269|PubMed:28726242}. |
Q0ZGT2 | NEXN | S218 | ochoa | Nexilin (F-actin-binding protein) (Nelin) | Involved in regulating cell migration through association with the actin cytoskeleton. Has an essential role in the maintenance of Z line and sarcomere integrity. {ECO:0000269|PubMed:12053183, ECO:0000269|PubMed:15823560, ECO:0000269|PubMed:19881492}. |
Q12774 | ARHGEF5 | S57 | ochoa | Rho guanine nucleotide exchange factor 5 (Ephexin-3) (Guanine nucleotide regulatory protein TIM) (Oncogene TIM) (Transforming immortalized mammary oncogene) (p60 TIM) | Guanine nucleotide exchange factor which activates Rho GTPases (PubMed:15601624). Strongly activates RHOA (PubMed:15601624). Also strongly activates RHOB, weakly activates RHOC and RHOG and shows no effect on RHOD, RHOV, RHOQ or RAC1 (By similarity). Involved in regulation of cell shape and actin cytoskeletal organization (PubMed:15601624). Plays a role in actin organization by generating a loss of actin stress fibers and the formation of membrane ruffles and filopodia (PubMed:14662653). Required for SRC-induced podosome formation (By similarity). Involved in positive regulation of immature dendritic cell migration (By similarity). {ECO:0000250|UniProtKB:E9Q7D5, ECO:0000269|PubMed:14662653, ECO:0000269|PubMed:15601624}. |
Q12873 | CHD3 | S604 | ochoa | Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.-) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH) | ATP-dependent chromatin-remodeling factor that binds and distorts nucleosomal DNA (PubMed:28977666). Acts as a component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin (PubMed:16428440, PubMed:28977666, PubMed:30397230, PubMed:9804427). Involved in transcriptional repression as part of the NuRD complex (PubMed:27068747). Required for anchoring centrosomal pericentrin in both interphase and mitosis, for spindle organization and centrosome integrity (PubMed:17626165). {ECO:0000269|PubMed:16428440, ECO:0000269|PubMed:17626165, ECO:0000269|PubMed:27068747, ECO:0000269|PubMed:28977666, ECO:0000269|PubMed:30397230, ECO:0000269|PubMed:9804427}. |
Q12888 | TP53BP1 | S507 | ochoa | TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1) | Double-strand break (DSB) repair protein involved in response to DNA damage, telomere dynamics and class-switch recombination (CSR) during antibody genesis (PubMed:12364621, PubMed:17190600, PubMed:21144835, PubMed:22553214, PubMed:23333306, PubMed:27153538, PubMed:28241136, PubMed:31135337, PubMed:37696958). Plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs and specifically counteracting the function of the homologous recombination (HR) repair protein BRCA1 (PubMed:22553214, PubMed:23333306, PubMed:23727112, PubMed:27153538, PubMed:31135337). In response to DSBs, phosphorylation by ATM promotes interaction with RIF1 and dissociation from NUDT16L1/TIRR, leading to recruitment to DSBs sites (PubMed:28241136). Recruited to DSBs sites by recognizing and binding histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites (PubMed:17190600, PubMed:23760478, PubMed:27153538, PubMed:28241136). Required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (PubMed:23345425). Participates in the repair and the orientation of the broken DNA ends during CSR (By similarity). In contrast, it is not required for classic NHEJ and V(D)J recombination (By similarity). Promotes NHEJ of dysfunctional telomeres via interaction with PAXIP1 (PubMed:23727112). {ECO:0000250|UniProtKB:P70399, ECO:0000269|PubMed:12364621, ECO:0000269|PubMed:17190600, ECO:0000269|PubMed:21144835, ECO:0000269|PubMed:22553214, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:23345425, ECO:0000269|PubMed:23727112, ECO:0000269|PubMed:23760478, ECO:0000269|PubMed:27153538, ECO:0000269|PubMed:28241136, ECO:0000269|PubMed:31135337, ECO:0000269|PubMed:37696958}. |
Q12888 | TP53BP1 | S765 | ochoa | TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1) | Double-strand break (DSB) repair protein involved in response to DNA damage, telomere dynamics and class-switch recombination (CSR) during antibody genesis (PubMed:12364621, PubMed:17190600, PubMed:21144835, PubMed:22553214, PubMed:23333306, PubMed:27153538, PubMed:28241136, PubMed:31135337, PubMed:37696958). Plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs and specifically counteracting the function of the homologous recombination (HR) repair protein BRCA1 (PubMed:22553214, PubMed:23333306, PubMed:23727112, PubMed:27153538, PubMed:31135337). In response to DSBs, phosphorylation by ATM promotes interaction with RIF1 and dissociation from NUDT16L1/TIRR, leading to recruitment to DSBs sites (PubMed:28241136). Recruited to DSBs sites by recognizing and binding histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites (PubMed:17190600, PubMed:23760478, PubMed:27153538, PubMed:28241136). Required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (PubMed:23345425). Participates in the repair and the orientation of the broken DNA ends during CSR (By similarity). In contrast, it is not required for classic NHEJ and V(D)J recombination (By similarity). Promotes NHEJ of dysfunctional telomeres via interaction with PAXIP1 (PubMed:23727112). {ECO:0000250|UniProtKB:P70399, ECO:0000269|PubMed:12364621, ECO:0000269|PubMed:17190600, ECO:0000269|PubMed:21144835, ECO:0000269|PubMed:22553214, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:23345425, ECO:0000269|PubMed:23727112, ECO:0000269|PubMed:23760478, ECO:0000269|PubMed:27153538, ECO:0000269|PubMed:28241136, ECO:0000269|PubMed:31135337, ECO:0000269|PubMed:37696958}. |
Q12888 | TP53BP1 | S1037 | ochoa | TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1) | Double-strand break (DSB) repair protein involved in response to DNA damage, telomere dynamics and class-switch recombination (CSR) during antibody genesis (PubMed:12364621, PubMed:17190600, PubMed:21144835, PubMed:22553214, PubMed:23333306, PubMed:27153538, PubMed:28241136, PubMed:31135337, PubMed:37696958). Plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs and specifically counteracting the function of the homologous recombination (HR) repair protein BRCA1 (PubMed:22553214, PubMed:23333306, PubMed:23727112, PubMed:27153538, PubMed:31135337). In response to DSBs, phosphorylation by ATM promotes interaction with RIF1 and dissociation from NUDT16L1/TIRR, leading to recruitment to DSBs sites (PubMed:28241136). Recruited to DSBs sites by recognizing and binding histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites (PubMed:17190600, PubMed:23760478, PubMed:27153538, PubMed:28241136). Required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (PubMed:23345425). Participates in the repair and the orientation of the broken DNA ends during CSR (By similarity). In contrast, it is not required for classic NHEJ and V(D)J recombination (By similarity). Promotes NHEJ of dysfunctional telomeres via interaction with PAXIP1 (PubMed:23727112). {ECO:0000250|UniProtKB:P70399, ECO:0000269|PubMed:12364621, ECO:0000269|PubMed:17190600, ECO:0000269|PubMed:21144835, ECO:0000269|PubMed:22553214, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:23345425, ECO:0000269|PubMed:23727112, ECO:0000269|PubMed:23760478, ECO:0000269|PubMed:27153538, ECO:0000269|PubMed:28241136, ECO:0000269|PubMed:31135337, ECO:0000269|PubMed:37696958}. |
Q12905 | ILF2 | S68 | ochoa | Interleukin enhancer-binding factor 2 (Nuclear factor of activated T-cells 45 kDa) | Chromatin-interacting protein that forms a stable heterodimer with interleukin enhancer-binding factor 3/ILF3 and plays a role in several biological processes including transcription, innate immunity or cell growth (PubMed:18458058, PubMed:31212927). Essential for the efficient reshuttling of ILF3 (isoform 1 and isoform 2) into the nucleus. Together with ILF3, forms an RNA-binding complex that is required for mitotic progression and cytokinesis by regulating the expression of a cluster of mitotic genes. Mechanistically, competes with STAU1/STAU2-mediated mRNA decay (PubMed:32433969). Also plays a role in the inhibition of various viruses including Japanese encephalitis virus or enterovirus 71. {ECO:0000269|PubMed:10574923, ECO:0000269|PubMed:11739746, ECO:0000269|PubMed:18458058, ECO:0000269|PubMed:21123651, ECO:0000269|PubMed:31212927, ECO:0000269|PubMed:32433969, ECO:0000269|PubMed:9442054}.; FUNCTION: (Microbial infection) Plays a positive role in HIV-1 virus production by binding to and thereby stabilizing HIV-1 RNA, together with ILF3. {ECO:0000269|PubMed:26891316}. |
Q13061 | TRDN | S418 | ochoa | Triadin | Contributes to the regulation of lumenal Ca2+ release via the sarcoplasmic reticulum calcium release channels RYR1 and RYR2, a key step in triggering skeletal and heart muscle contraction. Required for normal organization of the triad junction, where T-tubules and the sarcoplasmic reticulum terminal cisternae are in close contact (By similarity). Required for normal skeletal muscle strength. Plays a role in excitation-contraction coupling in the heart and in regulating the rate of heart beats. {ECO:0000250|UniProtKB:E9Q9K5, ECO:0000269|PubMed:22422768}. |
Q13201 | MMRN1 | S522 | ochoa | Multimerin-1 (EMILIN-4) (Elastin microfibril interface located protein 4) (Elastin microfibril interfacer 4) (Endothelial cell multimerin) [Cleaved into: Platelet glycoprotein Ia*; 155 kDa platelet multimerin (p-155) (p155)] | Carrier protein for platelet (but not plasma) factor V/Va. Plays a role in the storage and stabilization of factor V in platelets. Upon release following platelet activation, may limit platelet and plasma factor Va-dependent thrombin generation. Ligand for integrin alpha-IIb/beta-3 and integrin alpha-V/beta-3 on activated platelets, and may function as an extracellular matrix or adhesive protein. {ECO:0000269|PubMed:16363244, ECO:0000269|PubMed:19132231, ECO:0000269|PubMed:7629143}. |
Q13416 | ORC2 | S143 | ochoa | Origin recognition complex subunit 2 | Component of the origin recognition complex (ORC) that binds origins of replication. DNA-binding is ATP-dependent. The specific DNA sequences that define origins of replication have not been identified yet. ORC is required to assemble the pre-replication complex necessary to initiate DNA replication. Binds histone H3 and H4 trimethylation marks H3K9me3, H3K20me3 and H4K27me3. Stabilizes LRWD1, by protecting it from ubiquitin-mediated proteasomal degradation. Also stabilizes ORC3. {ECO:0000269|PubMed:22427655, ECO:0000269|PubMed:22935713}. |
Q13422 | IKZF1 | S261 | ochoa | DNA-binding protein Ikaros (Ikaros family zinc finger protein 1) (Lymphoid transcription factor LyF-1) | Transcription regulator of hematopoietic cell differentiation (PubMed:17934067). Binds gamma-satellite DNA (PubMed:17135265, PubMed:19141594). Plays a role in the development of lymphocytes, B- and T-cells. Binds and activates the enhancer (delta-A element) of the CD3-delta gene. Repressor of the TDT (fikzfterminal deoxynucleotidyltransferase) gene during thymocyte differentiation. Regulates transcription through association with both HDAC-dependent and HDAC-independent complexes. Targets the 2 chromatin-remodeling complexes, NuRD and BAF (SWI/SNF), in a single complex (PYR complex), to the beta-globin locus in adult erythrocytes. Increases normal apoptosis in adult erythroid cells. Confers early temporal competence to retinal progenitor cells (RPCs) (By similarity). Function is isoform-specific and is modulated by dominant-negative inactive isoforms (PubMed:17135265, PubMed:17934067). {ECO:0000250|UniProtKB:Q03267, ECO:0000269|PubMed:10204490, ECO:0000269|PubMed:17135265, ECO:0000269|PubMed:17934067, ECO:0000269|PubMed:19141594}. |
Q14493 | SLBP | S221 | psp | Histone RNA hairpin-binding protein (Histone stem-loop-binding protein) | RNA-binding protein involved in the histone pre-mRNA processing (PubMed:12588979, PubMed:19155325, PubMed:8957003, PubMed:9049306). Binds the stem-loop structure of replication-dependent histone pre-mRNAs and contributes to efficient 3'-end processing by stabilizing the complex between histone pre-mRNA and U7 small nuclear ribonucleoprotein (snRNP), via the histone downstream element (HDE) (PubMed:12588979, PubMed:19155325, PubMed:8957003, PubMed:9049306). Plays an important role in targeting mature histone mRNA from the nucleus to the cytoplasm and to the translation machinery (PubMed:12588979, PubMed:19155325, PubMed:8957003, PubMed:9049306). Stabilizes mature histone mRNA and could be involved in cell-cycle regulation of histone gene expression (PubMed:12588979, PubMed:19155325, PubMed:8957003, PubMed:9049306). Involved in the mechanism by which growing oocytes accumulate histone proteins that support early embryogenesis (By similarity). Binds to the 5' side of the stem-loop structure of histone pre-mRNAs (By similarity). {ECO:0000250|UniProtKB:P97440, ECO:0000269|PubMed:12588979, ECO:0000269|PubMed:19155325, ECO:0000269|PubMed:8957003, ECO:0000269|PubMed:9049306}. |
Q15020 | SART3 | S769 | ochoa | Spliceosome associated factor 3, U4/U6 recycling protein (Squamous cell carcinoma antigen recognized by T-cells 3) (SART-3) (Tat-interacting protein of 110 kDa) (Tip110) (p110 nuclear RNA-binding protein) | U6 snRNP-binding protein that functions as a recycling factor of the splicing machinery. Promotes the initial reassembly of U4 and U6 snRNPs following their ejection from the spliceosome during its maturation (PubMed:12032085). Also binds U6atac snRNPs and may function as a recycling factor for U4atac/U6atac spliceosomal snRNP, an initial step in the assembly of U12-type spliceosomal complex. The U12-type spliceosomal complex plays a role in the splicing of introns with non-canonical splice sites (PubMed:14749385). May also function as a substrate-targeting factor for deubiquitinases like USP4 and USP15. Recruits USP4 to ubiquitinated PRPF3 within the U4/U5/U6 tri-snRNP complex, promoting PRPF3 deubiquitination and thereby regulating the spliceosome U4/U5/U6 tri-snRNP spliceosomal complex disassembly (PubMed:20595234). May also recruit the deubiquitinase USP15 to histone H2B and mediate histone deubiquitination, thereby regulating gene expression and/or DNA repair (PubMed:24526689). May play a role in hematopoiesis probably through transcription regulation of specific genes including MYC (By similarity). {ECO:0000250|UniProtKB:Q9JLI8, ECO:0000269|PubMed:12032085, ECO:0000269|PubMed:14749385, ECO:0000269|PubMed:20595234, ECO:0000269|PubMed:24526689}.; FUNCTION: Regulates Tat transactivation activity through direct interaction. May be a cellular factor for HIV-1 gene expression and viral replication. {ECO:0000269|PubMed:11959860}. |
Q15311 | RALBP1 | S463 | ochoa | RalA-binding protein 1 (RalBP1) (76 kDa Ral-interacting protein) (Dinitrophenyl S-glutathione ATPase) (DNP-SG ATPase) (EC 7.6.2.2, EC 7.6.2.3) (Ral-interacting protein 1) | Multifunctional protein that functions as a downstream effector of RALA and RALB (PubMed:7673236). As a GTPase-activating protein/GAP can inactivate CDC42 and RAC1 by stimulating their GTPase activity (PubMed:7673236). As part of the Ral signaling pathway, may also regulate ligand-dependent EGF and insulin receptors-mediated endocytosis (PubMed:10910768, PubMed:12775724). During mitosis, may act as a scaffold protein in the phosphorylation of EPSIN/EPN1 by the mitotic kinase cyclin B-CDK1, preventing endocytosis during that phase of the cell cycle (PubMed:12775724). During mitosis, also controls mitochondrial fission as an effector of RALA (PubMed:21822277). Recruited to mitochondrion by RALA, acts as a scaffold to foster the mitotic kinase cyclin B-CDK1-mediated phosphorylation and activation of DNM1L (PubMed:21822277). {ECO:0000269|PubMed:10910768, ECO:0000269|PubMed:12775724, ECO:0000269|PubMed:21822277, ECO:0000269|PubMed:7673236}.; FUNCTION: Could also function as a primary ATP-dependent active transporter for glutathione conjugates of electrophiles. May also actively catalyze the efflux of a wide range of substrates including xenobiotics like doxorubicin (DOX) contributing to cell multidrug resistance. {ECO:0000269|PubMed:10924126, ECO:0000269|PubMed:11300797, ECO:0000269|PubMed:11437348, ECO:0000269|PubMed:9548755}. |
Q15424 | SAFB | S384 | ochoa | Scaffold attachment factor B1 (SAF-B) (SAF-B1) (HSP27 estrogen response element-TATA box-binding protein) (HSP27 ERE-TATA-binding protein) | Binds to scaffold/matrix attachment region (S/MAR) DNA and forms a molecular assembly point to allow the formation of a 'transcriptosomal' complex (consisting of SR proteins and RNA polymerase II) coupling transcription and RNA processing (PubMed:9671816). Functions as an estrogen receptor corepressor and can also bind to the HSP27 promoter and decrease its transcription (PubMed:12660241). Thereby acts as a negative regulator of cell proliferation (PubMed:12660241). When associated with RBMX, binds to and stimulates transcription from the SREBF1 promoter (By similarity). {ECO:0000250|UniProtKB:D3YXK2, ECO:0000269|PubMed:12660241, ECO:0000269|PubMed:9671816}. |
Q15475 | SIX1 | S204 | ochoa | Homeobox protein SIX1 (Sine oculis homeobox homolog 1) | Transcription factor that is involved in the regulation of cell proliferation, apoptosis and embryonic development (By similarity). Plays an important role in the development of several organs, including kidney, muscle and inner ear (By similarity). Depending on context, functions as a transcriptional repressor or activator (By similarity). Lacks an activation domain, and requires interaction with EYA family members for transcription activation (PubMed:15141091). Mediates nuclear translocation of EYA1 and EYA2 (PubMed:19497856). Binds the 5'-TCA[AG][AG]TTNC-3' motif present in the MEF3 element in the MYOG promoter and CIDEA enhancer (PubMed:15141091, PubMed:19497856, PubMed:23435380, PubMed:27923061). Regulates the expression of numerous genes, including MYC, CCND1 and EZR (By similarity). Acts as an activator of the IGFBP5 promoter, probably coactivated by EYA2 (By similarity). Repression of precursor cell proliferation in myoblasts is switched to activation through recruitment of EYA3 to the SIX1-DACH1 complex (By similarity). During myogenesis, seems to act together with EYA2 and DACH2 (By similarity). Regulates the expression of CCNA1 (PubMed:15123840). Promotes brown adipocyte differentiation (By similarity). {ECO:0000250|UniProtKB:Q62231, ECO:0000269|PubMed:15123840, ECO:0000269|PubMed:15141091, ECO:0000269|PubMed:19497856, ECO:0000269|PubMed:23435380, ECO:0000269|PubMed:27923061}. |
Q15744 | CEBPE | S21 | ochoa | CCAAT/enhancer-binding protein epsilon (C/EBP epsilon) | Transcriptional activator (PubMed:26019275). C/EBP are DNA-binding proteins that recognize two different motifs: the CCAAT homology common to many promoters and the enhanced core homology common to many enhancers. Required for the promyelocyte-myelocyte transition in myeloid differentiation (PubMed:10359588). {ECO:0000269|PubMed:10359588, ECO:0000269|PubMed:26019275}. |
Q15785 | TOMM34 | S231 | ochoa | Mitochondrial import receptor subunit TOM34 (hTom34) (Translocase of outer membrane 34 kDa subunit) | Plays a role in the import of cytosolically synthesized preproteins into mitochondria. Binds the mature portion of precursor proteins. Interacts with cellular components, and possesses weak ATPase activity. May be a chaperone-like protein that helps to keep newly synthesized precursors in an unfolded import compatible state. {ECO:0000269|PubMed:10101285, ECO:0000269|PubMed:11913975, ECO:0000269|PubMed:9324309}. |
Q16649 | NFIL3 | S210 | ochoa | Nuclear factor interleukin-3-regulated protein (E4 promoter-binding protein 4) (Interleukin-3 promoter transcriptional activator) (Interleukin-3-binding protein 1) (Transcriptional activator NF-IL3A) | Acts as a transcriptional regulator that recognizes and binds to the sequence 5'-[GA]TTA[CT]GTAA[CT]-3', a sequence present in many cellular and viral promoters. Represses transcription from promoters with activating transcription factor (ATF) sites. Represses promoter activity in osteoblasts (By similarity). Represses transcriptional activity of PER1 (By similarity). Represses transcriptional activity of PER2 via the B-site on the promoter (By similarity). Activates transcription from the interleukin-3 promoter in T-cells. Competes for the same consensus-binding site with PAR DNA-binding factors (DBP, HLF and TEF) (By similarity). Component of the circadian clock that acts as a negative regulator for the circadian expression of PER2 oscillation in the cell-autonomous core clock (By similarity). Protects pro-B cells from programmed cell death (By similarity). Represses the transcription of CYP2A5 (By similarity). Positively regulates the expression and activity of CES2 by antagonizing the repressive action of NR1D1 on CES2 (By similarity). Required for the development of natural killer cell precursors (By similarity). {ECO:0000250|UniProtKB:O08750, ECO:0000269|PubMed:1620116, ECO:0000269|PubMed:7565758, ECO:0000269|PubMed:8836190}. |
Q16891 | IMMT | S528 | psp | MICOS complex subunit MIC60 (Cell proliferation-inducing gene 4/52 protein) (Mitochondrial inner membrane protein) (Mitofilin) (p87/89) | Component of the MICOS complex, a large protein complex of the mitochondrial inner membrane that plays crucial roles in the maintenance of crista junctions, inner membrane architecture, and formation of contact sites to the outer membrane (PubMed:22114354, PubMed:25781180, PubMed:32567732, PubMed:33130824). Plays an important role in the maintenance of the MICOS complex stability and the mitochondrial cristae morphology (PubMed:22114354, PubMed:25781180, PubMed:32567732, PubMed:33130824). {ECO:0000269|PubMed:22114354, ECO:0000269|PubMed:25781180, ECO:0000269|PubMed:32567732, ECO:0000269|PubMed:33130824}. |
Q29RF7 | PDS5A | S1233 | ochoa | Sister chromatid cohesion protein PDS5 homolog A (Cell proliferation-inducing gene 54 protein) (Sister chromatid cohesion protein 112) (SCC-112) | Probable regulator of sister chromatid cohesion in mitosis which may stabilize cohesin complex association with chromatin. May couple sister chromatid cohesion during mitosis to DNA replication. Cohesion ensures that chromosome partitioning is accurate in both meiotic and mitotic cells and plays an important role in DNA repair. {ECO:0000269|PubMed:15855230, ECO:0000269|PubMed:19907496}. |
Q2KHR3 | QSER1 | S607 | ochoa | Glutamine and serine-rich protein 1 | Plays an essential role in the protection and maintenance of transcriptional and developmental programs. Protects many bivalent promoters and poised enhancers from hypermethylation, showing a marked preference for these regulatory elements over other types of promoters or enhancers. Mechanistically, cooperates with TET1 and binds to DNA in a common complex to inhibit the binding of DNMT3A/3B and therefore de novo methylation. {ECO:0000269|PubMed:33833093}. |
Q32MZ4 | LRRFIP1 | S638 | ochoa | Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1) (GC-binding factor 2) (TAR RNA-interacting protein) | Transcriptional repressor which preferentially binds to the GC-rich consensus sequence (5'-AGCCCCCGGCG-3') and may regulate expression of TNF, EGFR and PDGFA. May control smooth muscle cells proliferation following artery injury through PDGFA repression. May also bind double-stranded RNA. Positively regulates Toll-like receptor (TLR) signaling in response to agonist probably by competing with the negative FLII regulator for MYD88-binding. {ECO:0000269|PubMed:10364563, ECO:0000269|PubMed:14522076, ECO:0000269|PubMed:16199883, ECO:0000269|PubMed:19265123, ECO:0000269|PubMed:9705290}. |
Q32P51 | HNRNPA1L2 | S22 | ochoa | Heterogeneous nuclear ribonucleoprotein A1-like 2 (hnRNP A1-like 2) (hnRNP core protein A1-like 2) | Involved in the packaging of pre-mRNA into hnRNP particles, transport of poly(A) mRNA from the nucleus to the cytoplasm and may modulate splice site selection. {ECO:0000250}. |
Q4VC05 | BCL7A | S164 | ochoa | B-cell CLL/lymphoma 7 protein family member A | None |
Q562R1 | ACTBL2 | S240 | ochoa | Beta-actin-like protein 2 (Kappa-actin) | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. {ECO:0000250}. |
Q5F1R6 | DNAJC21 | S283 | ochoa | DnaJ homolog subfamily C member 21 (DnaJ homolog subfamily A member 5) (Protein GS3) | May act as a co-chaperone for HSP70. May play a role in ribosomal RNA (rRNA) biogenesis, possibly in the maturation of the 60S subunit. Binds the precursor 45S rRNA. {ECO:0000269|PubMed:27346687}. |
Q5H9R7 | PPP6R3 | S665 | ochoa | Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL) | Regulatory subunit of protein phosphatase 6 (PP6). May function as a scaffolding PP6 subunit. May have an important role in maintaining immune self-tolerance. {ECO:0000269|PubMed:11401438, ECO:0000269|PubMed:16769727}. |
Q5JSL3 | DOCK11 | S306 | ochoa | Dedicator of cytokinesis protein 11 (Activated Cdc42-associated guanine nucleotide exchange factor) (ACG) (Zizimin-2) | Guanine nucleotide-exchange factor (GEF) that activates CDC42 by exchanging bound GDP for free GTP (PubMed:37342957). Required for marginal zone (MZ) B-cell development, is associated with early bone marrow B-cell development, MZ B-cell formation, MZ B-cell number and marginal metallophilic macrophages morphology (By similarity). Facilitates filopodia formation through the activation of CDC42 (PubMed:37342957). {ECO:0000250|UniProtKB:A2AF47, ECO:0000269|PubMed:37342957}. |
Q5SW79 | CEP170 | S269 | ochoa | Centrosomal protein of 170 kDa (Cep170) (KARP-1-binding protein) (KARP1-binding protein) | Plays a role in microtubule organization (PubMed:15616186). Required for centriole subdistal appendage assembly (PubMed:28422092). {ECO:0000269|PubMed:15616186, ECO:0000269|PubMed:28422092}. |
Q5T8I3 | EEIG2 | S276 | ochoa | EEIG family member 2 (EEIG2) | None |
Q5TB80 | CEP162 | S24 | ochoa | Centrosomal protein of 162 kDa (Cep162) (Protein QN1 homolog) | Required to promote assembly of the transition zone in primary cilia. Acts by specifically recognizing and binding the axonemal microtubule. Localizes to the distal ends of centrioles before ciliogenesis and directly binds to axonemal microtubule, thereby promoting and restricting transition zone formation specifically at the cilia base. Required to mediate CEP290 association with microtubules. {ECO:0000269|PubMed:23644468}. |
Q5VTR2 | RNF20 | S545 | psp | E3 ubiquitin-protein ligase BRE1A (BRE1-A) (hBRE1) (EC 2.3.2.27) (RING finger protein 20) (RING-type E3 ubiquitin transferase BRE1A) | Component of the RNF20/40 E3 ubiquitin-protein ligase complex that mediates monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1). H2BK120ub1 gives a specific tag for epigenetic transcriptional activation and is also prerequisite for histone H3 'Lys-4' and 'Lys-79' methylation (H3K4me and H3K79me, respectively). It thereby plays a central role inb histone code and gene regulation. The RNF20/40 complex forms a H2B ubiquitin ligase complex in cooperation with the E2 enzyme UBE2A or UBE2B; reports about the cooperation with UBE2E1/UBCH are contradictory. Required for transcriptional activation of Hox genes. Recruited to the MDM2 promoter, probably by being recruited by p53/TP53, and thereby acts as a transcriptional coactivator. Mediates the polyubiquitination of isoform 2 of PA2G4 in cancer cells leading to its proteasome-mediated degradation. {ECO:0000269|PubMed:16307923, ECO:0000269|PubMed:16337599, ECO:0000269|PubMed:19037095, ECO:0000269|PubMed:19410543}.; FUNCTION: (Microbial infection) Promotes the human herpesvirus 8 (KSHV) lytic cycle by inducing the expression of lytic viral genes including the latency switch gene RTA/ORF50. {ECO:0000269|PubMed:37888983}. |
Q5VYK3 | ECPAS | S1666 | psp | Proteasome adapter and scaffold protein ECM29 (Ecm29 proteasome adapter and scaffold) (Proteasome-associated protein ECM29 homolog) | Adapter/scaffolding protein that binds to the 26S proteasome, motor proteins and other compartment specific proteins. May couple the proteasome to different compartments including endosome, endoplasmic reticulum and centrosome. May play a role in ERAD and other enhanced proteolysis (PubMed:15496406). Promotes proteasome dissociation under oxidative stress (By similarity). {ECO:0000250|UniProtKB:Q6PDI5, ECO:0000269|PubMed:15496406, ECO:0000269|PubMed:20682791}. |
Q66GS9 | CEP135 | S253 | ochoa | Centrosomal protein of 135 kDa (Cep135) (Centrosomal protein 4) | Centrosomal microtubule-binding protein involved in centriole biogenesis (PubMed:27477386). Acts as a scaffolding protein during early centriole biogenesis. Required for the targeting of centriole satellite proteins to centrosomes such as of PCM1, SSX2IP and CEP290 and recruitment of WRAP73 to centrioles. Also required for centriole-centriole cohesion during interphase by acting as a platform protein for CEP250 at the centriole. Required for the recruitment of CEP295 to the proximal end of new-born centrioles at the centriolar microtubule wall during early S phase in a PLK4-dependent manner (PubMed:27185865). {ECO:0000269|PubMed:17681131, ECO:0000269|PubMed:18851962, ECO:0000269|PubMed:26675238, ECO:0000269|PubMed:27185865, ECO:0000269|PubMed:27477386}. |
Q6IEG0 | SNRNP48 | S277 | ochoa | U11/U12 small nuclear ribonucleoprotein 48 kDa protein (U11/U12 snRNP 48 kDa protein) (U11/U12-48K) | Likely involved in U12-type 5' splice site recognition. {ECO:0000269|PubMed:19217400}. |
Q6P444 | MTFR2 | S343 | ochoa | Mitochondrial fission regulator 2 (DUF729 domain-containing protein 1) | May play a role in mitochondrial aerobic respiration essentially in the testis. Can also promote mitochondrial fission (By similarity). {ECO:0000250}. |
Q6PL18 | ATAD2 | S1276 | ochoa | ATPase family AAA domain-containing protein 2 (EC 3.6.1.-) (AAA nuclear coregulator cancer-associated protein) (ANCCA) | May be a transcriptional coactivator of the nuclear receptor ESR1 required to induce the expression of a subset of estradiol target genes, such as CCND1, MYC and E2F1. May play a role in the recruitment or occupancy of CREBBP at some ESR1 target gene promoters. May be required for histone hyperacetylation. Involved in the estrogen-induced cell proliferation and cell cycle progression of breast cancer cells. {ECO:0000269|PubMed:17998543}. |
Q6WCQ1 | MPRIP | S326 | ochoa | Myosin phosphatase Rho-interacting protein (M-RIP) (Rho-interacting protein 3) (RIP3) (p116Rip) | Targets myosin phosphatase to the actin cytoskeleton. Required for the regulation of the actin cytoskeleton by RhoA and ROCK1. Depletion leads to an increased number of stress fibers in smooth muscle cells through stabilization of actin fibers by phosphorylated myosin. Overexpression of MRIP as well as its F-actin-binding region leads to disassembly of stress fibers in neuronal cells. {ECO:0000250|UniProtKB:P97434, ECO:0000269|PubMed:15545284, ECO:0000269|PubMed:16257966}. |
Q6YHK3 | CD109 | S1129 | ochoa | CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109) | Modulates negatively TGFB1 signaling in keratinocytes. {ECO:0000269|PubMed:16754747}. |
Q7Z2K8 | GPRIN1 | S116 | ochoa | G protein-regulated inducer of neurite outgrowth 1 (GRIN1) | May be involved in neurite outgrowth. {ECO:0000250}. |
Q7Z5K2 | WAPL | S1069 | ochoa | Wings apart-like protein homolog (Friend of EBNA2 protein) (WAPL cohesin release factor) | Regulator of sister chromatid cohesion in mitosis which negatively regulates cohesin association with chromatin (PubMed:26299517). Involved in both sister chromatid cohesion during interphase and sister-chromatid resolution during early stages of mitosis. Couples DNA replication to sister chromatid cohesion. Cohesion ensures that chromosome partitioning is accurate in both meiotic and mitotic cells and plays an important role in DNA repair. {ECO:0000269|PubMed:15150110, ECO:0000269|PubMed:17112726, ECO:0000269|PubMed:17113138, ECO:0000269|PubMed:19696148, ECO:0000269|PubMed:19907496, ECO:0000269|PubMed:21111234, ECO:0000269|PubMed:23776203, ECO:0000269|PubMed:26299517}. |
Q7Z6Z7 | HUWE1 | S2362 | ochoa | E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1) | E3 ubiquitin-protein ligase which mediates ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:15567145, PubMed:15767685, PubMed:15989957, PubMed:17567951, PubMed:18488021, PubMed:19037095, PubMed:19713937, PubMed:20534529, PubMed:30217973). Regulates apoptosis by catalyzing the polyubiquitination and degradation of MCL1 (PubMed:15989957). Mediates monoubiquitination of DNA polymerase beta (POLB) at 'Lys-41', 'Lys-61' and 'Lys-81', thereby playing a role in base-excision repair (PubMed:19713937). Also ubiquitinates the p53/TP53 tumor suppressor and core histones including H1, H2A, H2B, H3 and H4 (PubMed:15567145, PubMed:15767685, PubMed:15989956). Ubiquitinates MFN2 to negatively regulate mitochondrial fusion in response to decreased stearoylation of TFRC (PubMed:26214738). Ubiquitination of MFN2 also takes place following induction of mitophagy; AMBRA1 acts as a cofactor for HUWE1-mediated ubiquitination (PubMed:30217973). Regulates neural differentiation and proliferation by catalyzing the polyubiquitination and degradation of MYCN (PubMed:18488021). May regulate abundance of CDC6 after DNA damage by polyubiquitinating and targeting CDC6 to degradation (PubMed:17567951). Mediates polyubiquitination of isoform 2 of PA2G4 (PubMed:19037095). Acts in concert with MYCBP2 to regulate the circadian clock gene expression by promoting the lithium-induced ubiquination and degradation of NR1D1 (PubMed:20534529). Binds to an upstream initiator-like sequence in the preprodynorphin gene (By similarity). Mediates HAPSTR1 degradation, but is also a required cofactor in the pathway by which HAPSTR1 governs stress signaling (PubMed:35776542). Acts as a regulator of the JNK and NF-kappa-B signaling pathways by mediating assembly of heterotypic 'Lys-63'-/'Lys-48'-linked branched ubiquitin chains that are then recognized by TAB2: HUWE1 mediates branching of 'Lys-48'-linked chains of substrates initially modified with 'Lys-63'-linked conjugates by TRAF6 (PubMed:27746020). 'Lys-63'-/'Lys-48'-linked branched ubiquitin chains protect 'Lys-63'-linkages from CYLD deubiquitination (PubMed:27746020). Ubiquitinates PPARA in hepatocytes (By similarity). {ECO:0000250|UniProtKB:P51593, ECO:0000250|UniProtKB:Q7TMY8, ECO:0000269|PubMed:15567145, ECO:0000269|PubMed:15767685, ECO:0000269|PubMed:15989956, ECO:0000269|PubMed:15989957, ECO:0000269|PubMed:17567951, ECO:0000269|PubMed:18488021, ECO:0000269|PubMed:19037095, ECO:0000269|PubMed:19713937, ECO:0000269|PubMed:20534529, ECO:0000269|PubMed:26214738, ECO:0000269|PubMed:27746020, ECO:0000269|PubMed:30217973, ECO:0000269|PubMed:35776542}. |
Q7Z6Z7 | HUWE1 | S3263 | ochoa | E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1) | E3 ubiquitin-protein ligase which mediates ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:15567145, PubMed:15767685, PubMed:15989957, PubMed:17567951, PubMed:18488021, PubMed:19037095, PubMed:19713937, PubMed:20534529, PubMed:30217973). Regulates apoptosis by catalyzing the polyubiquitination and degradation of MCL1 (PubMed:15989957). Mediates monoubiquitination of DNA polymerase beta (POLB) at 'Lys-41', 'Lys-61' and 'Lys-81', thereby playing a role in base-excision repair (PubMed:19713937). Also ubiquitinates the p53/TP53 tumor suppressor and core histones including H1, H2A, H2B, H3 and H4 (PubMed:15567145, PubMed:15767685, PubMed:15989956). Ubiquitinates MFN2 to negatively regulate mitochondrial fusion in response to decreased stearoylation of TFRC (PubMed:26214738). Ubiquitination of MFN2 also takes place following induction of mitophagy; AMBRA1 acts as a cofactor for HUWE1-mediated ubiquitination (PubMed:30217973). Regulates neural differentiation and proliferation by catalyzing the polyubiquitination and degradation of MYCN (PubMed:18488021). May regulate abundance of CDC6 after DNA damage by polyubiquitinating and targeting CDC6 to degradation (PubMed:17567951). Mediates polyubiquitination of isoform 2 of PA2G4 (PubMed:19037095). Acts in concert with MYCBP2 to regulate the circadian clock gene expression by promoting the lithium-induced ubiquination and degradation of NR1D1 (PubMed:20534529). Binds to an upstream initiator-like sequence in the preprodynorphin gene (By similarity). Mediates HAPSTR1 degradation, but is also a required cofactor in the pathway by which HAPSTR1 governs stress signaling (PubMed:35776542). Acts as a regulator of the JNK and NF-kappa-B signaling pathways by mediating assembly of heterotypic 'Lys-63'-/'Lys-48'-linked branched ubiquitin chains that are then recognized by TAB2: HUWE1 mediates branching of 'Lys-48'-linked chains of substrates initially modified with 'Lys-63'-linked conjugates by TRAF6 (PubMed:27746020). 'Lys-63'-/'Lys-48'-linked branched ubiquitin chains protect 'Lys-63'-linkages from CYLD deubiquitination (PubMed:27746020). Ubiquitinates PPARA in hepatocytes (By similarity). {ECO:0000250|UniProtKB:P51593, ECO:0000250|UniProtKB:Q7TMY8, ECO:0000269|PubMed:15567145, ECO:0000269|PubMed:15767685, ECO:0000269|PubMed:15989956, ECO:0000269|PubMed:15989957, ECO:0000269|PubMed:17567951, ECO:0000269|PubMed:18488021, ECO:0000269|PubMed:19037095, ECO:0000269|PubMed:19713937, ECO:0000269|PubMed:20534529, ECO:0000269|PubMed:26214738, ECO:0000269|PubMed:27746020, ECO:0000269|PubMed:30217973, ECO:0000269|PubMed:35776542}. |
Q86VY9 | TMEM200A | S471 | ochoa | Transmembrane protein 200A | None |
Q8IWC1 | MAP7D3 | S441 | ochoa | MAP7 domain-containing protein 3 | Promotes the assembly and stability of microtubules. {ECO:0000269|PubMed:22142902, ECO:0000269|PubMed:24927501}. |
Q8IYF3 | TEX11 | S190 | ochoa | Testis-expressed protein 11 (Protein ZIP4 homolog) (ZIP4H) | Regulator of crossing-over during meiosis. Involved in initiation and/or maintenance of chromosome synapsis and formation of crossovers. {ECO:0000250|UniProtKB:Q14AT2}. |
Q8IYN2 | TCEAL8 | S43 | ochoa | Transcription elongation factor A protein-like 8 (TCEA-like protein 8) (Transcription elongation factor S-II protein-like 8) | May be involved in transcriptional regulation. |
Q8N163 | CCAR2 | S478 | ochoa | Cell cycle and apoptosis regulator protein 2 (Cell division cycle and apoptosis regulator protein 2) (DBIRD complex subunit KIAA1967) (Deleted in breast cancer gene 1 protein) (DBC-1) (DBC.1) (NET35) (p30 DBC) | Core component of the DBIRD complex, a multiprotein complex that acts at the interface between core mRNP particles and RNA polymerase II (RNAPII) and integrates transcript elongation with the regulation of alternative splicing: the DBIRD complex affects local transcript elongation rates and alternative splicing of a large set of exons embedded in (A + T)-rich DNA regions (PubMed:22446626). Inhibits SIRT1 deacetylase activity leading to increasing levels of p53/TP53 acetylation and p53-mediated apoptosis (PubMed:18235501, PubMed:18235502, PubMed:23352644). Inhibits SUV39H1 methyltransferase activity (PubMed:19218236). Mediates ligand-dependent transcriptional activation by nuclear hormone receptors (PubMed:19131338). Plays a critical role in maintaining genomic stability and cellular integrity following UV-induced genotoxic stress (PubMed:23398316). Regulates the circadian expression of the core clock components NR1D1 and BMAL1 (PubMed:23398316). Enhances the transcriptional repressor activity of NR1D1 through stabilization of NR1D1 protein levels by preventing its ubiquitination and subsequent degradation (PubMed:23398316). Represses the ligand-dependent transcriptional activation function of ESR2 (PubMed:20074560). Acts as a regulator of PCK1 expression and gluconeogenesis by a mechanism that involves, at least in part, both NR1D1 and SIRT1 (PubMed:24415752). Negatively regulates the deacetylase activity of HDAC3 and can alter its subcellular localization (PubMed:21030595). Positively regulates the beta-catenin pathway (canonical Wnt signaling pathway) and is required for MCC-mediated repression of the beta-catenin pathway (PubMed:24824780). Represses ligand-dependent transcriptional activation function of NR1H2 and NR1H3 and inhibits the interaction of SIRT1 with NR1H3 (PubMed:25661920). Plays an important role in tumor suppression through p53/TP53 regulation; stabilizes p53/TP53 by affecting its interaction with ubiquitin ligase MDM2 (PubMed:25732823). Represses the transcriptional activator activity of BRCA1 (PubMed:20160719). Inhibits SIRT1 in a CHEK2 and PSEM3-dependent manner and inhibits the activity of CHEK2 in vitro (PubMed:25361978). {ECO:0000269|PubMed:18235501, ECO:0000269|PubMed:18235502, ECO:0000269|PubMed:19131338, ECO:0000269|PubMed:19218236, ECO:0000269|PubMed:20074560, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:21030595, ECO:0000269|PubMed:22446626, ECO:0000269|PubMed:23352644, ECO:0000269|PubMed:23398316, ECO:0000269|PubMed:24415752, ECO:0000269|PubMed:24824780, ECO:0000269|PubMed:25361978, ECO:0000269|PubMed:25661920, ECO:0000269|PubMed:25732823}. |
Q8N3U4 | STAG2 | S1177 | ochoa | Cohesin subunit SA-2 (SCC3 homolog 2) (Stromal antigen 2) | Component of cohesin complex, a complex required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The cohesin complex may also play a role in spindle pole assembly during mitosis. {ECO:0000269|PubMed:12034751}. |
Q8N565 | MREG | S39 | ochoa | Melanoregulin (Dilute suppressor protein homolog) | Probably functions as a cargo-recognition protein that couples cytoplasmic vesicles to the transport machinery. Plays a role in hair pigmentation, a process that involves shedding of melanosome-containing vesicles from melanocytes, followed by phagocytosis of the melanosome-containing vesicles by keratinocytes. Functions on melanosomes as receptor for RILP and the complex formed by RILP and DCTN1, and thereby contributes to retrograde melanosome transport from the cell periphery to the center. Overexpression causes accumulation of late endosomes and/or lysosomes at the microtubule organising center (MTOC) at the center of the cell. Probably binds cholesterol and requires the presence of cholesterol in membranes to function in microtubule-mediated retrograde organelle transport. Binds phosphatidylinositol 3-phosphate, phosphatidylinositol 4-phosphate, phosphatidylinositol 5-phosphate and phosphatidylinositol 3,5-bisphosphate, but not phosphatidylinositol 3,4-bisphosphate or phosphatidylinositol 4,5-bisphosphate (By similarity). Required for normal phagosome clearing and normal activation of lysosomal enzymes in lysosomes from retinal pigment epithelium cells (PubMed:19240024). Required for normal degradation of the lipofuscin component N-retinylidene-N-retinylethanolamine (A2E) in the eye. May function in membrane fusion and regulate the biogenesis of disk membranes of photoreceptor rod cells (By similarity). {ECO:0000250|UniProtKB:Q6NVG5, ECO:0000269|PubMed:19240024}. |
Q8N573 | OXR1 | S355 | ochoa | Oxidation resistance protein 1 | May be involved in protection from oxidative damage. {ECO:0000269|PubMed:11114193, ECO:0000269|PubMed:15060142}. |
Q8NDI1 | EHBP1 | S730 | ochoa | EH domain-binding protein 1 | May play a role in actin reorganization. Links clathrin-mediated endocytosis to the actin cytoskeleton. May act as Rab effector protein and play a role in vesicle trafficking (PubMed:14676205, PubMed:27552051). Required for perinuclear sorting and insulin-regulated recycling of SLC2A4/GLUT4 in adipocytes (By similarity). {ECO:0000250|UniProtKB:Q69ZW3, ECO:0000269|PubMed:14676205, ECO:0000305|PubMed:27552051}. |
Q8NEG4 | FAM83F | S61 | ochoa | Protein FAM83F | None |
Q8NEY8 | PPHLN1 | S244 | ochoa | Periphilin-1 (CDC7 expression repressor) (CR) (Gastric cancer antigen Ga50) | Component of the HUSH complex, a multiprotein complex that mediates epigenetic repression. The HUSH complex is recruited to genomic loci rich in H3K9me3 and is probably required to maintain transcriptional silencing by promoting recruitment of SETDB1, a histone methyltransferase that mediates further deposition of H3K9me3. In the HUSH complex, contributes to the maintenance of the complex at chromatin (PubMed:26022416). Acts as a transcriptional corepressor and regulates the cell cycle, probably via the HUSH complex (PubMed:15474462, PubMed:17963697). The HUSH complex is also involved in the silencing of unintegrated retroviral DNA: some part of the retroviral DNA formed immediately after infection remains unintegrated in the host genome and is transcriptionally repressed (PubMed:30487602). May be involved in epithelial differentiation by contributing to epidermal integrity and barrier formation (PubMed:12853457). {ECO:0000269|PubMed:15474462, ECO:0000269|PubMed:17963697, ECO:0000269|PubMed:26022416, ECO:0000269|PubMed:30487602, ECO:0000305|PubMed:12853457}. |
Q8NEZ4 | KMT2C | S2811 | ochoa | Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) (PubMed:25561738). Part of chromatin remodeling machinery predominantly forms H3K4me1 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:22266653, PubMed:24081332, PubMed:25561738). Likely plays a redundant role with KMT2D in enriching H3K4me1 mark on primed and active enhancer elements (PubMed:24081332). {ECO:0000269|PubMed:22266653, ECO:0000269|PubMed:24081332, ECO:0000269|PubMed:25561738}. |
Q8TAQ2 | SMARCC2 | S754 | ochoa | SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2) | Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner (PubMed:11018012). Can stimulate the ATPase activity of the catalytic subunit of these complexes (PubMed:10078207). May be required for CoREST dependent repression of neuronal specific gene promoters in non-neuronal cells (PubMed:12192000). Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). Critical regulator of myeloid differentiation, controlling granulocytopoiesis and the expression of genes involved in neutrophil granule formation (By similarity). {ECO:0000250|UniProtKB:Q6PDG5, ECO:0000269|PubMed:10078207, ECO:0000269|PubMed:11018012, ECO:0000269|PubMed:12192000, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}. |
Q8TD26 | CHD6 | S1714 | ochoa | Chromodomain-helicase-DNA-binding protein 6 (CHD-6) (EC 3.6.4.-) (ATP-dependent helicase CHD6) (Radiation-induced gene B protein) | ATP-dependent chromatin-remodeling factor (PubMed:17027977, PubMed:28533432). Regulates transcription by disrupting nucleosomes in a largely non-sliding manner which strongly increases the accessibility of chromatin; nucleosome disruption requires ATP (PubMed:28533432). Activates transcription of specific genes in response to oxidative stress through interaction with NFE2L2. {ECO:0000269|PubMed:16314513, ECO:0000269|PubMed:17027977, ECO:0000269|PubMed:28533432}.; FUNCTION: (Microbial infection) Acts as a transcriptional repressor of different viruses including influenza virus or papillomavirus. During influenza virus infection, the viral polymerase complex localizes CHD6 to inactive chromatin where it gets degraded in a proteasome independent-manner. {ECO:0000269|PubMed:20631145, ECO:0000269|PubMed:21899694, ECO:0000269|PubMed:23408615}. |
Q8TF01 | PNISR | S467 | ochoa | Arginine/serine-rich protein PNISR (PNN-interacting serine/arginine-rich protein) (SR-related protein) (SR-rich protein) (Serine/arginine-rich-splicing regulatory protein 130) (SRrp130) (Splicing factor, arginine/serine-rich 130) (Splicing factor, arginine/serine-rich 18) | None |
Q8WWK9 | CKAP2 | S534 | ochoa | Cytoskeleton-associated protein 2 (CTCL tumor antigen se20-10) (Tumor- and microtubule-associated protein) | Possesses microtubule stabilizing properties. Involved in regulating aneuploidy, cell cycling, and cell death in a p53/TP53-dependent manner (By similarity). {ECO:0000250}. |
Q92551 | IP6K1 | S174 | ochoa | Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1) | Converts inositol hexakisphosphate (InsP6) to diphosphoinositol pentakisphosphate (InsP7/PP-InsP5). Converts 1,3,4,5,6-pentakisphosphate (InsP5) to PP-InsP4. |
Q92598 | HSPH1 | S509 | ochoa | Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein) (Heat shock protein family H member 1) | Acts as a nucleotide-exchange factor (NEF) for chaperone proteins HSPA1A and HSPA1B, promoting the release of ADP from HSPA1A/B thereby triggering client/substrate protein release (PubMed:24318877). Prevents the aggregation of denatured proteins in cells under severe stress, on which the ATP levels decrease markedly. Inhibits HSPA8/HSC70 ATPase and chaperone activities (By similarity). {ECO:0000250|UniProtKB:Q60446, ECO:0000250|UniProtKB:Q61699, ECO:0000269|PubMed:24318877}. |
Q96EP0 | RNF31 | S840 | ochoa | E3 ubiquitin-protein ligase RNF31 (EC 2.3.2.31) (HOIL-1-interacting protein) (HOIP) (RING finger protein 31) (RING-type E3 ubiquitin transferase RNF31) (Zinc in-between-RING-finger ubiquitin-associated domain protein) | E3 ubiquitin-protein ligase component of the LUBAC complex which conjugates linear ('Met-1'-linked) polyubiquitin chains to substrates and plays a key role in NF-kappa-B activation and regulation of inflammation (PubMed:17006537, PubMed:19136968, PubMed:20005846, PubMed:21455173, PubMed:21455180, PubMed:21455181, PubMed:22863777, PubMed:28189684, PubMed:28481331). LUBAC conjugates linear polyubiquitin to IKBKG and RIPK1 and is involved in activation of the canonical NF-kappa-B and the JNK signaling pathways (PubMed:17006537, PubMed:19136968, PubMed:20005846, PubMed:21455173, PubMed:21455180, PubMed:21455181, PubMed:22863777, PubMed:28189684). Linear ubiquitination mediated by the LUBAC complex interferes with TNF-induced cell death and thereby prevents inflammation (PubMed:21455173, PubMed:28189684). LUBAC is recruited to the TNF-R1 signaling complex (TNF-RSC) following polyubiquitination of TNF-RSC components by BIRC2 and/or BIRC3 and to conjugate linear polyubiquitin to IKBKG and possibly other components contributing to the stability of the complex (PubMed:20005846, PubMed:27458237). The LUBAC complex is also involved in innate immunity by conjugating linear polyubiquitin chains at the surface of bacteria invading the cytosol to form the ubiquitin coat surrounding bacteria (PubMed:28481331, PubMed:34012115). LUBAC is not able to initiate formation of the bacterial ubiquitin coat, and can only promote formation of linear polyubiquitins on pre-existing ubiquitin (PubMed:28481331). Recruited to the surface of bacteria by RNF213, which initiates the bacterial ubiquitin coat (PubMed:34012115). The bacterial ubiquitin coat acts as an 'eat-me' signal for xenophagy and promotes NF-kappa-B activation (PubMed:28481331, PubMed:34012115). Together with OTULIN, the LUBAC complex regulates the canonical Wnt signaling during angiogenesis (PubMed:23708998). RNF31 is required for linear ubiquitination of BCL10, thereby promoting TCR-induced NF-kappa-B activation (PubMed:27777308). Binds polyubiquitin of different linkage types (PubMed:23708998). {ECO:0000269|PubMed:17006537, ECO:0000269|PubMed:19136968, ECO:0000269|PubMed:20005846, ECO:0000269|PubMed:21455173, ECO:0000269|PubMed:21455180, ECO:0000269|PubMed:21455181, ECO:0000269|PubMed:22863777, ECO:0000269|PubMed:23708998, ECO:0000269|PubMed:27458237, ECO:0000269|PubMed:27777308, ECO:0000269|PubMed:28189684, ECO:0000269|PubMed:28481331, ECO:0000269|PubMed:34012115}. |
Q96PE2 | ARHGEF17 | S861 | ochoa | Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4) | Acts as a guanine nucleotide exchange factor (GEF) for RhoA GTPases. {ECO:0000269|PubMed:12071859}. |
Q96QK1 | VPS35 | S228 | ochoa | Vacuolar protein sorting-associated protein 35 (hVPS35) (Maternal-embryonic 3) (Vesicle protein sorting 35) | Acts as a component of the retromer cargo-selective complex (CSC). The CSC is believed to be the core functional component of retromer or respective retromer complex variants acting to prevent missorting of selected transmembrane cargo proteins into the lysosomal degradation pathway. The recruitment of the CSC to the endosomal membrane involves RAB7A and SNX3. The CSC seems to associate with the cytoplasmic domain of cargo proteins predominantly via VPS35; however, these interactions seem to be of low affinity and retromer SNX proteins may also contribute to cargo selectivity thus questioning the classical function of the CSC. The SNX-BAR retromer mediates retrograde transport of cargo proteins from endosomes to the trans-Golgi network (TGN) and is involved in endosome-to-plasma membrane transport for cargo protein recycling. The SNX3-retromer mediates the retrograde endosome-to-TGN transport of WLS distinct from the SNX-BAR retromer pathway (PubMed:30213940). The SNX27-retromer is believed to be involved in endosome-to-plasma membrane trafficking and recycling of a broad spectrum of cargo proteins. The CSC seems to act as recruitment hub for other proteins, such as the WASH complex and TBC1D5 (Probable). Required for retrograde transport of lysosomal enzyme receptor IGF2R and SLC11A2. Required to regulate transcytosis of the polymeric immunoglobulin receptor (pIgR-pIgA) (PubMed:15078903, PubMed:15247922, PubMed:20164305). Required for endosomal localization of WASHC2C (PubMed:22070227, PubMed:28892079). Mediates the association of the CSC with the WASH complex via WASHC2 (PubMed:22070227, PubMed:24819384, PubMed:24980502). Required for the endosomal localization of TBC1D5 (PubMed:20923837). {ECO:0000269|PubMed:15078903, ECO:0000269|PubMed:15247922, ECO:0000269|PubMed:20164305, ECO:0000269|PubMed:20923837, ECO:0000269|PubMed:22070227, ECO:0000269|PubMed:23395371, ECO:0000269|PubMed:24819384, ECO:0000269|PubMed:24980502, ECO:0000269|PubMed:28892079, ECO:0000269|PubMed:30213940, ECO:0000303|PubMed:21725319, ECO:0000303|PubMed:22070227, ECO:0000303|PubMed:22513087, ECO:0000303|PubMed:23563491}.; FUNCTION: (Microbial infection) The heterotrimeric retromer cargo-selective complex (CSC) mediates the exit of human papillomavirus from the early endosome and the delivery to the Golgi apparatus. {ECO:0000269|PubMed:25693203, ECO:0000269|PubMed:30122350}. |
Q96R06 | SPAG5 | S159 | ochoa | Sperm-associated antigen 5 (Astrin) (Deepest) (Mitotic spindle-associated protein p126) (MAP126) | Essential component of the mitotic spindle required for normal chromosome segregation and progression into anaphase (PubMed:11724960, PubMed:12356910, PubMed:27462074). Required for chromosome alignment, normal timing of sister chromatid segregation, and maintenance of spindle pole architecture (PubMed:17664331, PubMed:27462074). In complex with SKAP, promotes stable microtubule-kinetochore attachments. May contribute to the regulation of separase activity. May regulate AURKA localization to mitotic spindle, but not to centrosomes and CCNB1 localization to both mitotic spindle and centrosomes (PubMed:18361916, PubMed:21402792). Involved in centriole duplication. Required for CDK5RAP2, CEP152, WDR62 and CEP63 centrosomal localization and promotes the centrosomal localization of CDK2 (PubMed:26297806). In non-mitotic cells, upon stress induction, inhibits mammalian target of rapamycin complex 1 (mTORC1) association and recruits the mTORC1 component RPTOR to stress granules (SGs), thereby preventing mTORC1 hyperactivation-induced apoptosis (PubMed:23953116). May enhance GSK3B-mediated phosphorylation of other substrates, such as MAPT/TAU (PubMed:18055457). {ECO:0000269|PubMed:12356910, ECO:0000269|PubMed:17664331, ECO:0000269|PubMed:18055457, ECO:0000269|PubMed:18361916, ECO:0000269|PubMed:21402792, ECO:0000269|PubMed:23953116, ECO:0000269|PubMed:26297806, ECO:0000269|PubMed:27462074, ECO:0000305|PubMed:11724960}. |
Q96RS0 | TGS1 | S158 | ochoa | Trimethylguanosine synthase (EC 2.1.1.-) (CLL-associated antigen KW-2) (Cap-specific guanine-N(2) methyltransferase) (Hepatocellular carcinoma-associated antigen 137) (Nuclear receptor coactivator 6-interacting protein) (PRIP-interacting protein with methyltransferase motif) (PIMT) (PIPMT) | Catalyzes the 2 serial methylation steps for the conversion of the 7-monomethylguanosine (m(7)G) caps of snRNAs and snoRNAs to a 2,2,7-trimethylguanosine (m(2,2,7)G) cap structure. The enzyme is specific for guanine, and N7 methylation must precede N2 methylation. Hypermethylation of the m7G cap of U snRNAs leads to their concentration in nuclear foci, their colocalization with coilin and the formation of canonical Cajal bodies (CBs). Plays a role in transcriptional regulation. {ECO:0000269|PubMed:11517327, ECO:0000269|PubMed:11912212, ECO:0000269|PubMed:16687569, ECO:0000269|PubMed:18775984}. |
Q96T23 | RSF1 | S314 | ochoa | Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex) | Regulatory subunit of the ATP-dependent RSF-1 and RSF-5 ISWI chromatin-remodeling complexes, which form ordered nucleosome arrays on chromatin and facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair (PubMed:12972596, PubMed:28801535). Binds to core histones together with SMARCA5, and is required for the assembly of regular nucleosome arrays by the RSF-5 ISWI chromatin-remodeling complex (PubMed:12972596). Directly stimulates the ATPase activity of SMARCA1 and SMARCA5 in the RSF-1 and RSF-5 ISWI chromatin-remodeling complexes, respectively (PubMed:28801535). The RSF-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the RSF-5 ISWI chromatin-remodeling complex (PubMed:28801535). The complexes do not have the ability to slide mononucleosomes to the center of a DNA template (PubMed:28801535). Facilitates transcription of hepatitis B virus (HBV) genes by the pX transcription activator. In case of infection by HBV, together with pX, it represses TNF-alpha induced NF-kappa-B transcription activation. Represses transcription when artificially recruited to chromatin by fusion to a heterogeneous DNA binding domain (PubMed:11788598, PubMed:11944984). {ECO:0000269|PubMed:11788598, ECO:0000269|PubMed:11944984, ECO:0000269|PubMed:12972596, ECO:0000269|PubMed:28801535}. |
Q99590 | SCAF11 | S1012 | ochoa | Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129) | Plays a role in pre-mRNA alternative splicing by regulating spliceosome assembly. {ECO:0000269|PubMed:9447963}. |
Q99689 | FEZ1 | S58 | ochoa|psp | Fasciculation and elongation protein zeta-1 (Zygin I) (Zygin-1) | May be involved in axonal outgrowth as component of the network of molecules that regulate cellular morphology and axon guidance machinery. Able to restore partial locomotion and axonal fasciculation to C.elegans unc-76 mutants in germline transformation experiments. May participate in the transport of mitochondria and other cargos along microtubules. {ECO:0000269|PubMed:20812761, ECO:0000269|PubMed:22354037}. |
Q9BYX7 | POTEKP | S239 | ochoa | Putative beta-actin-like protein 3 (Kappa-actin) (POTE ankyrin domain family member K) | None |
Q9BZ95 | NSD3 | S913 | ochoa | Histone-lysine N-methyltransferase NSD3 (EC 2.1.1.370) (EC 2.1.1.371) (Nuclear SET domain-containing protein 3) (Protein whistle) (WHSC1-like 1 isoform 9 with methyltransferase activity to lysine) (Wolf-Hirschhorn syndrome candidate 1-like protein 1) (WHSC1-like protein 1) | Histone methyltransferase. Preferentially dimethylates 'Lys-4' and 'Lys-27' of histone H3 forming H3K4me2 and H3K27me2. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation, while 'Lys-27' is a mark for transcriptional repression. {ECO:0000269|PubMed:16682010}. |
Q9BZI7 | UPF3B | S409 | ochoa | Regulator of nonsense transcripts 3B (Nonsense mRNA reducing factor 3B) (Up-frameshift suppressor 3 homolog B) (hUpf3B) (Up-frameshift suppressor 3 homolog on chromosome X) (hUpf3p-X) | Involved in nonsense-mediated decay (NMD) of mRNAs containing premature stop codons by associating with the nuclear exon junction complex (EJC) and serving as link between the EJC core and NMD machinery. Recruits UPF2 at the cytoplasmic side of the nuclear envelope and the subsequent formation of an UPF1-UPF2-UPF3 surveillance complex (including UPF1 bound to release factors at the stalled ribosome) is believed to activate NMD. In cooperation with UPF2 stimulates both ATPase and RNA helicase activities of UPF1. Binds spliced mRNA upstream of exon-exon junctions. In vitro, stimulates translation; the function is independent of association with UPF2 and components of the EJC core. {ECO:0000269|PubMed:11163187, ECO:0000269|PubMed:12718880, ECO:0000269|PubMed:16209946, ECO:0000269|PubMed:16601204, ECO:0000269|PubMed:18066079}. |
Q9C0D2 | CEP295 | S1205 | ochoa | Centrosomal protein of 295 kDa | Centriole-enriched microtubule-binding protein involved in centriole biogenesis (PubMed:20844083, PubMed:25131205, PubMed:27185865, PubMed:38154379). Essential for the generation of the distal portion of new-born centrioles in a CPAP- and CEP120-mediated elongation dependent manner during the cell cycle S/G2 phase after formation of the initiating cartwheel structure (PubMed:27185865). Required for the recruitment of centriolar proteins, such as POC1B, POC5 and CEP135, into the distal portion of centrioles (PubMed:27185865). Also required for centriole-to-centrosome conversion during mitotic progression, but is dispensable for cartwheel removal or centriole disengagement (PubMed:25131205). Binds to and stabilizes centriolar microtubule (PubMed:27185865). May be involved in ciliogenesis (PubMed:38154379). {ECO:0000269|PubMed:20844083, ECO:0000269|PubMed:25131205, ECO:0000269|PubMed:27185865, ECO:0000269|PubMed:32060285, ECO:0000269|PubMed:38154379}. |
Q9H0A0 | NAT10 | S987 | ochoa | RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein) (hALP) | RNA cytidine acetyltransferase that catalyzes the formation of N(4)-acetylcytidine (ac4C) modification on mRNAs, 18S rRNA and tRNAs (PubMed:25411247, PubMed:25653167, PubMed:30449621, PubMed:35679869). Catalyzes ac4C modification of a broad range of mRNAs, enhancing mRNA stability and translation (PubMed:30449621, PubMed:35679869). mRNA ac4C modification is frequently present within wobble cytidine sites and promotes translation efficiency (PubMed:30449621). Mediates the formation of ac4C at position 1842 in 18S rRNA (PubMed:25411247). May also catalyze the formation of ac4C at position 1337 in 18S rRNA (By similarity). Required for early nucleolar cleavages of precursor rRNA at sites A0, A1 and A2 during 18S rRNA synthesis (PubMed:25411247, PubMed:25653167). Catalyzes the formation of ac4C in serine and leucine tRNAs (By similarity). Requires the tRNA-binding adapter protein THUMPD1 for full tRNA acetyltransferase activity but not for 18S rRNA acetylation (PubMed:25653167). In addition to RNA acetyltransferase activity, also able to acetylate lysine residues of proteins, such as histones, microtubules, p53/TP53 and MDM2, in vitro (PubMed:14592445, PubMed:17631499, PubMed:19303003, PubMed:26882543, PubMed:27993683, PubMed:30165671). The relevance of the protein lysine acetyltransferase activity is however unsure in vivo (PubMed:30449621). Activates telomerase activity by stimulating the transcription of TERT, and may also regulate telomerase function by affecting the balance of telomerase subunit assembly, disassembly, and localization (PubMed:14592445, PubMed:18082603). Involved in the regulation of centrosome duplication by acetylating CENATAC during mitosis, promoting SASS6 proteasome degradation (PubMed:31722219). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797). {ECO:0000250|UniProtKB:P53914, ECO:0000269|PubMed:14592445, ECO:0000269|PubMed:17631499, ECO:0000269|PubMed:18082603, ECO:0000269|PubMed:19303003, ECO:0000269|PubMed:25411247, ECO:0000269|PubMed:25653167, ECO:0000269|PubMed:26882543, ECO:0000269|PubMed:27993683, ECO:0000269|PubMed:30165671, ECO:0000269|PubMed:30449621, ECO:0000269|PubMed:31722219, ECO:0000269|PubMed:34516797, ECO:0000269|PubMed:35679869}. |
Q9H0G5 | NSRP1 | S146 | ochoa | Nuclear speckle splicing regulatory protein 1 (Coiled-coil domain-containing protein 55) (Nuclear speckle-related protein 70) (NSrp70) | RNA-binding protein that mediates pre-mRNA alternative splicing regulation. {ECO:0000269|PubMed:21296756}. |
Q9H0X4 | FAM234A | S21 | ochoa | Protein FAM234A (Protein ITFG3) | None |
Q9H2P0 | ADNP | S923 | ochoa | Activity-dependent neuroprotector homeobox protein (Activity-dependent neuroprotective protein) | May be involved in transcriptional regulation. May mediate some of the neuroprotective peptide VIP-associated effects involving normal growth and cancer proliferation. Positively modulates WNT-beta-catenin/CTNN1B signaling, acting by regulating phosphorylation of, and thereby stabilizing, CTNNB1. May be required for neural induction and neuronal differentiation. May be involved in erythroid differentiation (By similarity). {ECO:0000250|UniProtKB:Q9Z103}. |
Q9H4L7 | SMARCAD1 | S239 | ochoa | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 (SMARCAD1) (EC 3.6.4.12) (ATP-dependent helicase 1) (hHEL1) | DNA helicase that possesses intrinsic ATP-dependent nucleosome-remodeling activity and is both required for DNA repair and heterochromatin organization. Promotes DNA end resection of double-strand breaks (DSBs) following DNA damage: probably acts by weakening histone DNA interactions in nucleosomes flanking DSBs. Required for the restoration of heterochromatin organization after replication. Acts at replication sites to facilitate the maintenance of heterochromatin by directing H3 and H4 histones deacetylation, H3 'Lys-9' trimethylation (H3K9me3) and restoration of silencing. {ECO:0000269|PubMed:21549307, ECO:0000269|PubMed:22960744}. |
Q9H7E2 | TDRD3 | Y190 | ochoa | Tudor domain-containing protein 3 | Scaffolding protein that specifically recognizes and binds dimethylarginine-containing proteins (PubMed:15955813). Plays a role in the regulation of translation of target mRNAs by binding Arg/Gly-rich motifs (GAR) in dimethylarginine-containing proteins. In nucleus, acts as a coactivator: recognizes and binds asymmetric dimethylation on the core histone tails associated with transcriptional activation (H3R17me2a and H4R3me2a) and recruits proteins at these arginine-methylated loci (PubMed:21172665). In cytoplasm, acts as an antiviral factor that participates in the assembly of stress granules together with G3BP1 (PubMed:35085371). {ECO:0000269|PubMed:15955813, ECO:0000269|PubMed:18632687, ECO:0000269|PubMed:21172665, ECO:0000269|PubMed:35085371}. |
Q9HAU0 | PLEKHA5 | S1037 | ochoa | Pleckstrin homology domain-containing family A member 5 (PH domain-containing family A member 5) (Phosphoinositol 3-phosphate-binding protein 2) (PEPP-2) | None |
Q9HBH0 | RHOF | S64 | ochoa | Rho-related GTP-binding protein RhoF (Rho family GTPase Rif) (Rho in filopodia) | Plasma membrane-associated small GTPase which cycles between an active GTP-bound and an inactive GDP-bound state. Causes the formation of thin, actin-rich surface projections called filopodia. Functions cooperatively with CDC42 and Rac to generate additional structures, increasing the diversity of actin-based morphology. |
Q9HBR0 | SLC38A10 | S997 | ochoa | Solute carrier family 38 member 10 (Amino acid transporter SLC38A10) | Facilitates bidirectional transport of amino acids. May act as a glutamate sensor that regulates glutamate-glutamine cycle and mTOR signaling in the brain. The transport mechanism remains to be elucidated. {ECO:0000250|UniProtKB:Q5I012}. |
Q9NS91 | RAD18 | S471 | ochoa | E3 ubiquitin-protein ligase RAD18 (EC 2.3.2.27) (Postreplication repair protein RAD18) (hHR18) (hRAD18) (RING finger protein 73) (RING-type E3 ubiquitin transferase RAD18) | E3 ubiquitin-protein ligase involved in postreplication repair of UV-damaged DNA. Postreplication repair functions in gap-filling of a daughter strand on replication of damaged DNA. Associates to the E2 ubiquitin conjugating enzyme UBE2B to form the UBE2B-RAD18 ubiquitin ligase complex involved in mono-ubiquitination of DNA-associated PCNA on 'Lys-164'. Has ssDNA binding activity. {ECO:0000269|PubMed:17108083, ECO:0000269|PubMed:21659603}. |
Q9NUA8 | ZBTB40 | S160 | ochoa | Zinc finger and BTB domain-containing protein 40 | May be involved in transcriptional regulation. |
Q9NVM9 | INTS13 | S626 | ochoa | Integrator complex subunit 13 (Cell cycle regulator Mat89Bb homolog) (Germ cell tumor 1) (Protein asunder homolog) (Sarcoma antigen NY-SAR-95) | Component of the integrator complex, a multiprotein complex that terminates RNA polymerase II (Pol II) transcription in the promoter-proximal region of genes (PubMed:38570683, PubMed:38823386). The integrator complex provides a quality checkpoint during transcription elongation by driving premature transcription termination of transcripts that are unfavorably configured for transcriptional elongation: the complex terminates transcription by (1) catalyzing dephosphorylation of the C-terminal domain (CTD) of Pol II subunit POLR2A/RPB1 and SUPT5H/SPT5, (2) degrading the exiting nascent RNA transcript via endonuclease activity and (3) promoting the release of Pol II from bound DNA (PubMed:38570683). The integrator complex is also involved in terminating the synthesis of non-coding Pol II transcripts, such as enhancer RNAs (eRNAs), small nuclear RNAs (snRNAs), telomerase RNAs and long non-coding RNAs (lncRNAs) (PubMed:32647223). Within the integrator complex, INTS13 is part of the integrator tail module and acts as a platform for the recruitment of transcription factors at promoters (PubMed:38823386, PubMed:38906142). At prophase, mediates recruitment of cytoplasmic dynein to the nuclear envelope, a step important for proper centrosome-nucleus coupling (PubMed:23097494, PubMed:23904267). At G2/M phase, may be required for proper spindle formation and execution of cytokinesis (PubMed:23097494, PubMed:23904267). {ECO:0000269|PubMed:23097494, ECO:0000269|PubMed:23904267, ECO:0000269|PubMed:32647223, ECO:0000269|PubMed:38570683, ECO:0000269|PubMed:38823386, ECO:0000269|PubMed:38906142}. |
Q9NXV6 | CDKN2AIP | S133 | ochoa | CDKN2A-interacting protein (Collaborator of ARF) | Regulates DNA damage response in a dose-dependent manner through a number of signaling pathways involved in cell proliferation, apoptosis and senescence. {ECO:0000269|PubMed:15109303, ECO:0000269|PubMed:24825908}. |
Q9NZJ5 | EIF2AK3 | S567 | ochoa | Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (HsPEK) (Protein tyrosine kinase EIF2AK3) (EC 2.7.10.2) | Metabolic-stress sensing protein kinase that phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (EIF2S1/eIF-2-alpha) in response to various stress, such as unfolded protein response (UPR) (PubMed:10026192, PubMed:10677345, PubMed:11907036, PubMed:12086964, PubMed:25925385, PubMed:31023583). Key effector of the integrated stress response (ISR) to unfolded proteins: EIF2AK3/PERK specifically recognizes and binds misfolded proteins, leading to its activation and EIF2S1/eIF-2-alpha phosphorylation (PubMed:10677345, PubMed:27917829, PubMed:31023583). EIF2S1/eIF-2-alpha phosphorylation in response to stress converts EIF2S1/eIF-2-alpha in a global protein synthesis inhibitor, leading to a global attenuation of cap-dependent translation, while concomitantly initiating the preferential translation of ISR-specific mRNAs, such as the transcriptional activators ATF4 and QRICH1, and hence allowing ATF4- and QRICH1-mediated reprogramming (PubMed:10026192, PubMed:10677345, PubMed:31023583, PubMed:33384352). The EIF2AK3/PERK-mediated unfolded protein response increases mitochondrial oxidative phosphorylation by promoting ATF4-mediated expression of COX7A2L/SCAF1, thereby increasing formation of respiratory chain supercomplexes (PubMed:31023583). In contrast to most subcellular compartments, mitochondria are protected from the EIF2AK3/PERK-mediated unfolded protein response due to EIF2AK3/PERK inhibition by ATAD3A at mitochondria-endoplasmic reticulum contact sites (PubMed:39116259). In addition to EIF2S1/eIF-2-alpha, also phosphorylates NFE2L2/NRF2 in response to stress, promoting release of NFE2L2/NRF2 from the BCR(KEAP1) complex, leading to nuclear accumulation and activation of NFE2L2/NRF2 (By similarity). Serves as a critical effector of unfolded protein response (UPR)-induced G1 growth arrest due to the loss of cyclin-D1 (CCND1) (By similarity). Involved in control of mitochondrial morphology and function (By similarity). {ECO:0000250|UniProtKB:Q9Z2B5, ECO:0000269|PubMed:10026192, ECO:0000269|PubMed:10677345, ECO:0000269|PubMed:11907036, ECO:0000269|PubMed:12086964, ECO:0000269|PubMed:25925385, ECO:0000269|PubMed:27917829, ECO:0000269|PubMed:31023583, ECO:0000269|PubMed:33384352, ECO:0000269|PubMed:39116259}. |
Q9NZN5 | ARHGEF12 | S1170 | ochoa | Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) | May play a role in the regulation of RhoA GTPase by guanine nucleotide-binding alpha-12 (GNA12) and alpha-13 (GNA13). Acts as guanine nucleotide exchange factor (GEF) for RhoA GTPase and may act as GTPase-activating protein (GAP) for GNA12 and GNA13. {ECO:0000269|PubMed:11094164}. |
Q9P289 | STK26 | S325 | ochoa | Serine/threonine-protein kinase 26 (EC 2.7.11.1) (MST3 and SOK1-related kinase) (Mammalian STE20-like protein kinase 4) (MST-4) (STE20-like kinase MST4) (Serine/threonine-protein kinase MASK) | Serine/threonine-protein kinase that acts as a mediator of cell growth (PubMed:11641781, PubMed:17360971). Modulates apoptosis (PubMed:11641781, PubMed:17360971). In association with STK24 negatively regulates Golgi reorientation in polarized cell migration upon RHO activation (PubMed:27807006). Phosphorylates ATG4B at 'Ser-383', thereby increasing autophagic flux (PubMed:29232556). Part of the striatin-interacting phosphatase and kinase (STRIPAK) complexes. STRIPAK complexes have critical roles in protein (de)phosphorylation and are regulators of multiple signaling pathways including Hippo, MAPK, nuclear receptor and cytoskeleton remodeling. Different types of STRIPAK complexes are involved in a variety of biological processes such as cell growth, differentiation, apoptosis, metabolism and immune regulation (PubMed:18782753). {ECO:0000269|PubMed:11641781, ECO:0000269|PubMed:17360971, ECO:0000269|PubMed:18782753, ECO:0000269|PubMed:27807006, ECO:0000269|PubMed:29232556}. |
Q9P2K8 | EIF2AK4 | S207 | ochoa | eIF-2-alpha kinase GCN2 (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 4) (GCN2-like protein) | Metabolic-stress sensing protein kinase that phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (EIF2S1/eIF-2-alpha) in response to low amino acid availability (PubMed:25329545, PubMed:32610081). Plays a role as an activator of the integrated stress response (ISR) required for adaptation to amino acid starvation (By similarity). EIF2S1/eIF-2-alpha phosphorylation in response to stress converts EIF2S1/eIF-2-alpha into a global protein synthesis inhibitor, leading to a global attenuation of cap-dependent translation, and thus to a reduced overall utilization of amino acids, while concomitantly initiating the preferential translation of ISR-specific mRNAs, such as the transcriptional activator ATF4, and hence allowing ATF4-mediated reprogramming of amino acid biosynthetic gene expression to alleviate nutrient depletion (PubMed:32610081). Binds uncharged tRNAs (By similarity). Required for the translational induction of protein kinase PRKCH following amino acid starvation (By similarity). Involved in cell cycle arrest by promoting cyclin D1 mRNA translation repression after the unfolded protein response pathway (UPR) activation or cell cycle inhibitor CDKN1A/p21 mRNA translation activation in response to amino acid deprivation (PubMed:26102367). Plays a role in the consolidation of synaptic plasticity, learning as well as formation of long-term memory (By similarity). Plays a role in neurite outgrowth inhibition (By similarity). Plays a proapoptotic role in response to glucose deprivation (By similarity). Promotes global cellular protein synthesis repression in response to UV irradiation independently of the stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) and p38 MAPK signaling pathways (By similarity). Plays a role in the antiviral response against alphavirus infection; impairs early viral mRNA translation of the incoming genomic virus RNA, thus preventing alphavirus replication (By similarity). {ECO:0000250|UniProtKB:P15442, ECO:0000250|UniProtKB:Q9QZ05, ECO:0000269|PubMed:25329545, ECO:0000269|PubMed:26102367, ECO:0000269|PubMed:32610081}.; FUNCTION: (Microbial infection) Plays a role in modulating the adaptive immune response to yellow fever virus infection; promotes dendritic cells to initiate autophagy and antigene presentation to both CD4(+) and CD8(+) T-cells under amino acid starvation (PubMed:24310610). {ECO:0000269|PubMed:24310610}. |
Q9UDY2 | TJP2 | S1012 | ochoa | Tight junction protein 2 (Tight junction protein ZO-2) (Zona occludens protein 2) (Zonula occludens protein 2) | Plays a role in tight junctions and adherens junctions (By similarity). Acts as a positive regulator of RANKL-induced osteoclast differentiation, potentially via mediating downstream transcriptional activity (By similarity). {ECO:0000250|UniProtKB:Q9Z0U1}. |
Q9UEW8 | STK39 | S401 | ochoa | STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39) | Effector serine/threonine-protein kinase component of the WNK-SPAK/OSR1 kinase cascade, which is involved in various processes, such as ion transport, response to hypertonic stress and blood pressure (PubMed:16669787, PubMed:18270262, PubMed:21321328, PubMed:34289367). Specifically recognizes and binds proteins with a RFXV motif (PubMed:16669787, PubMed:21321328). Acts downstream of WNK kinases (WNK1, WNK2, WNK3 or WNK4): following activation by WNK kinases, catalyzes phosphorylation of ion cotransporters, such as SLC12A1/NKCC2, SLC12A2/NKCC1, SLC12A3/NCC, SLC12A5/KCC2 or SLC12A6/KCC3, regulating their activity (PubMed:21321328). Mediates regulatory volume increase in response to hyperosmotic stress by catalyzing phosphorylation of ion cotransporters SLC12A1/NKCC2, SLC12A2/NKCC1 and SLC12A6/KCC3 downstream of WNK1 and WNK3 kinases (PubMed:12740379, PubMed:16669787, PubMed:21321328). Phosphorylation of Na-K-Cl cotransporters SLC12A2/NKCC1 and SLC12A2/NKCC1 promote their activation and ion influx; simultaneously, phosphorylation of K-Cl cotransporters SLC12A5/KCC2 and SLC12A6/KCC3 inhibit their activity, blocking ion efflux (PubMed:16669787, PubMed:19665974, PubMed:21321328). Acts as a regulator of NaCl reabsorption in the distal nephron by mediating phosphorylation and activation of the thiazide-sensitive Na-Cl cotransporter SLC12A3/NCC in distal convoluted tubule cells of kidney downstream of WNK4 (PubMed:18270262). Mediates the inhibition of SLC4A4, SLC26A6 as well as CFTR activities (By similarity). Phosphorylates RELT (By similarity). {ECO:0000250|UniProtKB:Q9Z1W9, ECO:0000269|PubMed:12740379, ECO:0000269|PubMed:16669787, ECO:0000269|PubMed:18270262, ECO:0000269|PubMed:19665974, ECO:0000269|PubMed:21321328, ECO:0000269|PubMed:34289367}. |
Q9UJU6 | DBNL | Y224 | ochoa | Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa) (HIP-55) (SH3 domain-containing protein 7) | Adapter protein that binds F-actin and DNM1, and thereby plays a role in receptor-mediated endocytosis. Plays a role in the reorganization of the actin cytoskeleton, formation of cell projections, such as neurites, in neuron morphogenesis and synapse formation via its interaction with WASL and COBL. Does not bind G-actin and promote actin polymerization by itself. Required for the formation of organized podosome rosettes (By similarity). May act as a common effector of antigen receptor-signaling pathways in leukocytes. Acts as a key component of the immunological synapse that regulates T-cell activation by bridging TCRs and the actin cytoskeleton to gene activation and endocytic processes. {ECO:0000250, ECO:0000269|PubMed:14729663}. |
Q9UKA4 | AKAP11 | S1171 | ochoa | A-kinase anchor protein 11 (AKAP-11) (A-kinase anchor protein 220 kDa) (AKAP 220) (hAKAP220) (Protein kinase A-anchoring protein 11) (PRKA11) | Binds to type II regulatory subunits of protein kinase A and anchors/targets them. |
Q9UKL3 | CASP8AP2 | S1278 | ochoa | CASP8-associated protein 2 (FLICE-associated huge protein) | Participates in TNF-alpha-induced blockade of glucocorticoid receptor (GR) transactivation at the nuclear receptor coactivator level, upstream and independently of NF-kappa-B. Suppresses both NCOA2- and NCOA3-induced enhancement of GR transactivation. Involved in TNF-alpha-induced activation of NF-kappa-B via a TRAF2-dependent pathway. Acts as a downstream mediator for CASP8-induced activation of NF-kappa-B. Required for the activation of CASP8 in FAS-mediated apoptosis. Required for histone gene transcription and progression through S phase. {ECO:0000269|PubMed:12477726, ECO:0000269|PubMed:15698540, ECO:0000269|PubMed:17003125, ECO:0000269|PubMed:17245429}. |
Q9UKX7 | NUP50 | S204 | ochoa | Nuclear pore complex protein Nup50 (50 kDa nucleoporin) (Nuclear pore-associated protein 60 kDa-like) (Nucleoporin Nup50) | Component of the nuclear pore complex that has a direct role in nuclear protein import (PubMed:20016008). Actively displaces NLSs from importin-alpha, and facilitates disassembly of the importin-alpha:beta-cargo complex and importin recycling (PubMed:20016008). Interacts with regulatory proteins of cell cycle progression including CDKN1B (By similarity). This interaction is required for correct intracellular transport and degradation of CDKN1B (By similarity). {ECO:0000250|UniProtKB:Q9JIH2, ECO:0000269|PubMed:20016008}. |
Q9ULS5 | TMCC3 | S242 | ochoa | Transmembrane and coiled-coil domain protein 3 | None |
Q9UMY1 | NOL7 | S133 | ochoa | U3 small nucleolar RNA-associated protein NOL7 (U3 snoRNA-associated protein NOL7) (Nucleolar protein 7) (Nucleolar protein of 27 kDa) | Functions as part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit that coordinates the first two steps of ribosome biogenesis in transcription of the primary transcript pre-RNA and pre-18S processing (PubMed:34516797, PubMed:37246770). During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797). This subunit is required for processing of the 5'-external transcribed spacer sequence (5'ETS) of the primary transcript pre-rRNA to yield the 18S rRNA (PubMed:37246770). Also plays a role in maintaining early pre-rRNA levels, either by assisting in its transcription or stability (PubMed:37246770). {ECO:0000269|PubMed:34516797, ECO:0000269|PubMed:37246770}. |
Q9UPQ0 | LIMCH1 | S611 | ochoa | LIM and calponin homology domains-containing protein 1 | Actin stress fibers-associated protein that activates non-muscle myosin IIa. Activates the non-muscle myosin IIa complex by promoting the phosphorylation of its regulatory subunit MRLC/MYL9. Through the activation of non-muscle myosin IIa, positively regulates actin stress fibers assembly and stabilizes focal adhesions. It therefore negatively regulates cell spreading and cell migration. {ECO:0000269|PubMed:28228547}. |
Q9UPV0 | CEP164 | S380 | ochoa | Centrosomal protein of 164 kDa (Cep164) | Plays a role in microtubule organization and/or maintenance for the formation of primary cilia (PC), a microtubule-based structure that protrudes from the surface of epithelial cells. Plays a critical role in G2/M checkpoint and nuclear divisions. A key player in the DNA damage-activated ATR/ATM signaling cascade since it is required for the proper phosphorylation of H2AX, RPA, CHEK2 and CHEK1. Plays a critical role in chromosome segregation, acting as a mediator required for the maintenance of genomic stability through modulation of MDC1, RPA and CHEK1. {ECO:0000269|PubMed:17954613, ECO:0000269|PubMed:18283122, ECO:0000269|PubMed:23348840}. |
Q9UPV0 | CEP164 | S407 | ochoa | Centrosomal protein of 164 kDa (Cep164) | Plays a role in microtubule organization and/or maintenance for the formation of primary cilia (PC), a microtubule-based structure that protrudes from the surface of epithelial cells. Plays a critical role in G2/M checkpoint and nuclear divisions. A key player in the DNA damage-activated ATR/ATM signaling cascade since it is required for the proper phosphorylation of H2AX, RPA, CHEK2 and CHEK1. Plays a critical role in chromosome segregation, acting as a mediator required for the maintenance of genomic stability through modulation of MDC1, RPA and CHEK1. {ECO:0000269|PubMed:17954613, ECO:0000269|PubMed:18283122, ECO:0000269|PubMed:23348840}. |
Q9Y2F5 | ICE1 | S1255 | ochoa | Little elongation complex subunit 1 (Interactor of little elongator complex ELL subunit 1) | Component of the little elongation complex (LEC), a complex required to regulate small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III (PubMed:22195968, PubMed:23932780). Specifically acts as a scaffold protein that promotes the LEC complex formation and recruitment and RNA polymerase II occupancy at snRNA genes in subnuclear bodies (PubMed:23932780). {ECO:0000269|PubMed:22195968, ECO:0000269|PubMed:23932780}. |
Q9Y3S1 | WNK2 | S1276 | ochoa | Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43) | Serine/threonine-protein kinase component of the WNK2-SPAK/OSR1 kinase cascade, which plays an important role in the regulation of electrolyte homeostasis, cell signaling, survival, and proliferation (PubMed:17667937, PubMed:18593598, PubMed:21733846). The WNK2-SPAK/OSR1 kinase cascade is composed of WNK2, which mediates phosphorylation and activation of downstream kinases OXSR1/OSR1 and STK39/SPAK (By similarity). Following activation, OXSR1/OSR1 and STK39/SPAK catalyze phosphorylation of ion cotransporters, regulating their activity (By similarity). Acts as an activator and inhibitor of sodium-coupled chloride cotransporters and potassium-coupled chloride cotransporters respectively (PubMed:21733846). Activates SLC12A2, SCNN1A, SCNN1B, SCNN1D and SGK1 and inhibits SLC12A5 (PubMed:21733846). Negatively regulates the EGF-induced activation of the ERK/MAPK-pathway and the downstream cell cycle progression (PubMed:17667937, PubMed:18593598). Affects MAPK3/MAPK1 activity by modulating the activity of MAP2K1 and this modulation depends on phosphorylation of MAP2K1 by PAK1 (PubMed:17667937, PubMed:18593598). WNK2 acts by interfering with the activity of PAK1 by controlling the balance of the activity of upstream regulators of PAK1 activity, RHOA and RAC1, which display reciprocal activity (PubMed:17667937, PubMed:18593598). {ECO:0000250|UniProtKB:Q9H4A3, ECO:0000269|PubMed:17667937, ECO:0000269|PubMed:18593598, ECO:0000269|PubMed:21733846}. |
Q9Y4D1 | DAAM1 | S1030 | ochoa | Disheveled-associated activator of morphogenesis 1 | Binds to disheveled (Dvl) and Rho, and mediates Wnt-induced Dvl-Rho complex formation. May play a role as a scaffolding protein to recruit Rho-GDP and Rho-GEF, thereby enhancing Rho-GTP formation. Can direct nucleation and elongation of new actin filaments. Involved in building functional cilia (PubMed:16630611, PubMed:17482208). Involved in the organization of the subapical actin network in multiciliated epithelial cells (By similarity). Together with DAAM2, required for myocardial maturation and sarcomere assembly (By similarity). During cell division, may regulate RHOA activation that signals spindle orientation and chromosomal segregation. {ECO:0000250|UniProtKB:B0DOB5, ECO:0000250|UniProtKB:Q8BPM0, ECO:0000269|PubMed:16630611, ECO:0000269|PubMed:17482208}. |
Q9Y520 | PRRC2C | S848 | ochoa | Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C) | Required for efficient formation of stress granules. {ECO:0000269|PubMed:29395067}. |
Q9Y5B9 | SUPT16H | S982 | ochoa | FACT complex subunit SPT16 (Chromatin-specific transcription elongation factor 140 kDa subunit) (FACT 140 kDa subunit) (FACTp140) (Facilitates chromatin transcription complex subunit SPT16) (hSPT16) | Component of the FACT complex, a general chromatin factor that acts to reorganize nucleosomes. The FACT complex is involved in multiple processes that require DNA as a template such as mRNA elongation, DNA replication and DNA repair. During transcription elongation the FACT complex acts as a histone chaperone that both destabilizes and restores nucleosomal structure. It facilitates the passage of RNA polymerase II and transcription by promoting the dissociation of one histone H2A-H2B dimer from the nucleosome, then subsequently promotes the reestablishment of the nucleosome following the passage of RNA polymerase II. The FACT complex is probably also involved in phosphorylation of 'Ser-392' of p53/TP53 via its association with CK2 (casein kinase II). {ECO:0000269|PubMed:10912001, ECO:0000269|PubMed:11239457, ECO:0000269|PubMed:12934006, ECO:0000269|PubMed:16713563, ECO:0000269|PubMed:9489704, ECO:0000269|PubMed:9836642}. |
Q9Y6D5 | ARFGEF2 | S1513 | ochoa | Brefeldin A-inhibited guanine nucleotide-exchange protein 2 (Brefeldin A-inhibited GEP 2) (ADP-ribosylation factor guanine nucleotide-exchange factor 2) | Promotes guanine-nucleotide exchange on ARF1 and ARF3 and to a lower extent on ARF5 and ARF6. Promotes the activation of ARF1/ARF5/ARF6 through replacement of GDP with GTP. Involved in the regulation of Golgi vesicular transport. Required for the integrity of the endosomal compartment. Involved in trafficking from the trans-Golgi network (TGN) to endosomes and is required for membrane association of the AP-1 complex and GGA1. Seems to be involved in recycling of the transferrin receptor from recycling endosomes to the plasma membrane. Probably is involved in the exit of GABA(A) receptors from the endoplasmic reticulum. Involved in constitutive release of tumor necrosis factor receptor 1 via exosome-like vesicles; the function seems to involve PKA and specifically PRKAR2B. Proposed to act as A kinase-anchoring protein (AKAP) and may mediate crosstalk between Arf and PKA pathways. {ECO:0000269|PubMed:12051703, ECO:0000269|PubMed:12571360, ECO:0000269|PubMed:15385626, ECO:0000269|PubMed:16477018, ECO:0000269|PubMed:17276987, ECO:0000269|PubMed:18625701, ECO:0000269|PubMed:20360857}. |
Q9Y6K9 | IKBKG | S43 | psp | NF-kappa-B essential modulator (NEMO) (FIP-3) (IkB kinase-associated protein 1) (IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma) (I-kappa-B kinase subunit gamma) (IKK-gamma) (IKKG) (IkB kinase subunit gamma) (NF-kappa-B essential modifier) | Regulatory subunit of the IKK core complex which phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor (PubMed:14695475, PubMed:20724660, PubMed:21518757, PubMed:9751060). Its binding to scaffolding polyubiquitin plays a key role in IKK activation by multiple signaling receptor pathways (PubMed:16547522, PubMed:18287044, PubMed:19033441, PubMed:19185524, PubMed:21606507, PubMed:27777308, PubMed:33567255). Can recognize and bind both 'Lys-63'-linked and linear polyubiquitin upon cell stimulation, with a much higher affinity for linear polyubiquitin (PubMed:16547522, PubMed:18287044, PubMed:19033441, PubMed:19185524, PubMed:21606507, PubMed:27777308). Could be implicated in NF-kappa-B-mediated protection from cytokine toxicity. Essential for viral activation of IRF3 (PubMed:19854139). Involved in TLR3- and IFIH1-mediated antiviral innate response; this function requires 'Lys-27'-linked polyubiquitination (PubMed:20724660). {ECO:0000269|PubMed:14695475, ECO:0000269|PubMed:16547522, ECO:0000269|PubMed:18287044, ECO:0000269|PubMed:19033441, ECO:0000269|PubMed:19185524, ECO:0000269|PubMed:19854139, ECO:0000269|PubMed:20724660, ECO:0000269|PubMed:21518757, ECO:0000269|PubMed:21606507, ECO:0000269|PubMed:27777308, ECO:0000269|PubMed:33567255, ECO:0000269|PubMed:9751060}.; FUNCTION: (Microbial infection) Also considered to be a mediator for HTLV-1 Tax oncoprotein activation of NF-kappa-B. {ECO:0000269|PubMed:10364167, ECO:0000269|PubMed:11064457}. |
Q9Y6M5 | SLC30A1 | S473 | ochoa | Proton-coupled zinc antiporter SLC30A1 (Solute carrier family 30 member 1) (Zinc transporter 1) | Zinc ion:proton antiporter that could function at the plasma membrane mediating zinc efflux from cells against its electrochemical gradient protecting them from intracellular zinc accumulation and toxicity (PubMed:31471319). Alternatively, could prevent the transport to the plasma membrane of CACNB2, the L-type calcium channels regulatory subunit, through a yet to be defined mechanism. By modulating the expression of these channels at the plasma membrane, could prevent calcium and zinc influx into cells. By the same mechanism, could also prevent L-type calcium channels-mediated heavy metal influx into cells (By similarity). In some cells, could also function as a zinc ion:proton antiporter mediating zinc entry into the lumen of cytoplasmic vesicles. In macrophages, can increase zinc ions concentration into the lumen of cytoplasmic vesicles containing engulfed bacteria and could help inactivate them (PubMed:32441444). Forms a complex with TMC6/EVER1 and TMC8/EVER2 at the ER membrane of keratynocytes which facilitates zinc uptake into the ER (PubMed:18158319). Down-regulates the activity of transcription factors induced by zinc and cytokines (PubMed:18158319). {ECO:0000250|UniProtKB:Q62720, ECO:0000269|PubMed:18158319, ECO:0000269|PubMed:31471319, ECO:0000269|PubMed:32441444}. |
Q9Y6Q9 | NCOA3 | S778 | ochoa | Nuclear receptor coactivator 3 (NCoA-3) (EC 2.3.1.48) (ACTR) (Amplified in breast cancer 1 protein) (AIB-1) (CBP-interacting protein) (pCIP) (Class E basic helix-loop-helix protein 42) (bHLHe42) (Receptor-associated coactivator 3) (RAC-3) (Steroid receptor coactivator protein 3) (SRC-3) (Thyroid hormone receptor activator molecule 1) (TRAM-1) | Nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. Plays a central role in creating a multisubunit coactivator complex, which probably acts via remodeling of chromatin. Involved in the coactivation of different nuclear receptors, such as for steroids (GR and ER), retinoids (RARs and RXRs), thyroid hormone (TRs), vitamin D3 (VDR) and prostanoids (PPARs). Displays histone acetyltransferase activity. Also involved in the coactivation of the NF-kappa-B pathway via its interaction with the NFKB1 subunit. |
A0A2R8Y4L2 | HNRNPA1L3 | S22 | Sugiyama | Heterogeneous nuclear ribonucleoprotein A1-like 3 (Heterogeneous nuclear ribonucleoprotein A1 pseudogene 48) | None |
P31327 | CPS1 | S569 | Sugiyama | Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I) | Involved in the urea cycle of ureotelic animals where the enzyme plays an important role in removing excess ammonia from the cell. |
Q02818 | NUCB1 | S193 | Sugiyama | Nucleobindin-1 (CALNUC) | Major calcium-binding protein of the Golgi which may have a role in calcium homeostasis (By similarity). Acts as a non-receptor guanine nucleotide exchange factor which binds to and activates alpha subunits of guanine nucleotide-binding proteins (G proteins) (By similarity). {ECO:0000250|UniProtKB:Q0P569, ECO:0000250|UniProtKB:Q63083}. |
Q08752 | PPID | S119 | Sugiyama | Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Cyclophilin-related protein) (Rotamase D) | PPIase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding (PubMed:11350175, PubMed:20676357). Proposed to act as a co-chaperone in HSP90 complexes such as in unligated steroid receptors heterocomplexes. Different co-chaperones seem to compete for association with HSP90 thus establishing distinct HSP90-co-chaperone-receptor complexes with the potential to exert tissue-specific receptor activity control. May have a preference for estrogen receptor complexes and is not found in glucocorticoid receptor complexes. May be involved in cytoplasmic dynein-dependent movement of the receptor from the cytoplasm to the nucleus. May regulate MYB by inhibiting its DNA-binding activity. Involved in regulation of AHR signaling by promoting the formation of the AHR:ARNT dimer; the function is independent of HSP90 but requires the chaperone activity. Involved in regulation of UV radiation-induced apoptosis. Promotes cell viability in anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma (ALK+ ALCL) cell lines. {ECO:0000269|PubMed:11350175, ECO:0000269|PubMed:18708059, ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:22681779, ECO:0000269|PubMed:23220213, ECO:0000269|PubMed:9659917}.; FUNCTION: (Microbial infection) May be involved in hepatitis C virus (HCV) replication and release. {ECO:0000269|PubMed:19932913, ECO:0000269|PubMed:21711559}. |
Q9UNN5 | FAF1 | S518 | Sugiyama | FAS-associated factor 1 (hFAF1) (UBX domain-containing protein 12) (UBX domain-containing protein 3A) | Ubiquitin-binding protein (PubMed:19722279). Required for the progression of DNA replication forks by targeting DNA replication licensing factor CDT1 for degradation (PubMed:26842564). Potentiates but cannot initiate FAS-induced apoptosis (By similarity). {ECO:0000250|UniProtKB:P54731, ECO:0000269|PubMed:19722279, ECO:0000269|PubMed:26842564}. |
O94768 | STK17B | S351 | Sugiyama | Serine/threonine-protein kinase 17B (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 2) | Phosphorylates myosin light chains (By similarity). Acts as a positive regulator of apoptosis. {ECO:0000250, ECO:0000269|PubMed:9786912}. |
P26641 | EEF1G | S286 | Sugiyama | Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma) | Probably plays a role in anchoring the complex to other cellular components. |
Q9UI26 | IPO11 | S214 | Sugiyama | Importin-11 (Imp11) (Ran-binding protein 11) (RanBP11) | Functions in nuclear protein import as nuclear transport receptor. Serves as receptor for nuclear localization signals (NLS) in cargo substrates. Is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (NPC) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus (By similarity). Mediates the nuclear import of UBE2E3, and of RPL12 (By similarity). {ECO:0000250, ECO:0000269|PubMed:11032817}. |
Q9UBS4 | DNAJB11 | S78 | Sugiyama | DnaJ homolog subfamily B member 11 (APOBEC1-binding protein 2) (ABBP-2) (DnaJ protein homolog 9) (ER-associated DNAJ) (ER-associated Hsp40 co-chaperone) (Endoplasmic reticulum DNA J domain-containing protein 3) (ER-resident protein ERdj3) (ERdj3) (ERj3p) (HEDJ) (Human DnaJ protein 9) (hDj-9) (PWP1-interacting protein 4) | As a co-chaperone for HSPA5 it is required for proper folding, trafficking or degradation of proteins (PubMed:10827079, PubMed:15525676, PubMed:29706351). Binds directly to both unfolded proteins that are substrates for ERAD and nascent unfolded peptide chains, but dissociates from the HSPA5-unfolded protein complex before folding is completed (PubMed:15525676). May help recruiting HSPA5 and other chaperones to the substrate. Stimulates HSPA5 ATPase activity (PubMed:10827079). It is necessary for maturation and correct trafficking of PKD1 (PubMed:29706351). {ECO:0000269|PubMed:10827079, ECO:0000269|PubMed:15525676, ECO:0000269|PubMed:29706351}. |
P49336 | CDK8 | S244 | Sugiyama | Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) (Protein kinase K35) | Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional pre-initiation complex with RNA polymerase II and the general transcription factors. Phosphorylates the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex. Phosphorylates CCNH leading to down-regulation of the TFIIH complex and transcriptional repression. Recruited through interaction with MAML1 to hyperphosphorylate the intracellular domain of NOTCH, leading to its degradation. {ECO:0000269|PubMed:10993082, ECO:0000269|PubMed:15546612, ECO:0000269|PubMed:30905399}. |
P23284 | PPIB | S139 | Sugiyama | Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP) | PPIase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding. {ECO:0000269|PubMed:20676357}. |
Q9C0C2 | TNKS1BP1 | S1229 | Sugiyama | 182 kDa tankyrase-1-binding protein | None |
Q14BN4 | SLMAP | S280 | Sugiyama | Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein) | Associates with the striatin-interacting phosphatase and kinase (STRIPAK) core complex, forming the extended (SIKE1:SLMAP)STRIPAK complex (PubMed:29063833, PubMed:30622739). The (SIKE1:SLMAP)STRIPAK complex dephosphorylates STK3 leading to the inhibition of Hippo signaling and the control of cell growth (PubMed:29063833, PubMed:30622739). May play a role during myoblast fusion (By similarity). {ECO:0000250|UniProtKB:Q3URD3, ECO:0000269|PubMed:29063833, ECO:0000269|PubMed:30622739}. |
Q99700 | ATXN2 | S451 | Sugiyama | Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) | Involved in EGFR trafficking, acting as negative regulator of endocytic EGFR internalization at the plasma membrane. {ECO:0000269|PubMed:18602463}. |
Q00341 | HDLBP | S216 | Sugiyama | Vigilin (High density lipoprotein-binding protein) (HDL-binding protein) | Appears to play a role in cell sterol metabolism. It may function to protect cells from over-accumulation of cholesterol. |
Q08378 | GOLGA3 | S1036 | Sugiyama | Golgin subfamily A member 3 (Golgi complex-associated protein of 170 kDa) (GCP170) (Golgin-160) | Golgi auto-antigen; probably involved in maintaining Golgi structure. |
Q99961 | SH3GL1 | S120 | Sugiyama | Endophilin-A2 (EEN fusion partner of MLL) (Endophilin-2) (Extra eleven-nineteen leukemia fusion gene protein) (EEN) (SH3 domain protein 2B) (SH3 domain-containing GRB2-like protein 1) | Implicated in endocytosis. May recruit other proteins to membranes with high curvature (By similarity). {ECO:0000250}. |
Q9BRQ0 | PYGO2 | S349 | Sugiyama | Pygopus homolog 2 | Involved in signal transduction through the Wnt pathway. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-75153 | Apoptotic execution phase | 0.000011 | 4.978 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 0.000185 | 3.733 |
R-HSA-2470946 | Cohesin Loading onto Chromatin | 0.000364 | 3.439 |
R-HSA-373753 | Nephrin family interactions | 0.000401 | 3.397 |
R-HSA-2468052 | Establishment of Sister Chromatid Cohesion | 0.000777 | 3.110 |
R-HSA-352238 | Breakdown of the nuclear lamina | 0.000792 | 3.101 |
R-HSA-68884 | Mitotic Telophase/Cytokinesis | 0.001170 | 2.932 |
R-HSA-8957275 | Post-translational protein phosphorylation | 0.003876 | 2.412 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 0.004606 | 2.337 |
R-HSA-4419969 | Depolymerization of the Nuclear Lamina | 0.003898 | 2.409 |
R-HSA-114608 | Platelet degranulation | 0.003401 | 2.468 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 0.004406 | 2.356 |
R-HSA-1640170 | Cell Cycle | 0.002226 | 2.652 |
R-HSA-109581 | Apoptosis | 0.003337 | 2.477 |
R-HSA-5635851 | GLI proteins bind promoters of Hh responsive genes to promote transcription | 0.005388 | 2.269 |
R-HSA-2995383 | Initiation of Nuclear Envelope (NE) Reformation | 0.006063 | 2.217 |
R-HSA-381426 | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-l... | 0.007964 | 2.099 |
R-HSA-68877 | Mitotic Prometaphase | 0.008617 | 2.065 |
R-HSA-68886 | M Phase | 0.009120 | 2.040 |
R-HSA-73887 | Death Receptor Signaling | 0.009320 | 2.031 |
R-HSA-3371556 | Cellular response to heat stress | 0.010529 | 1.978 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 0.011524 | 1.938 |
R-HSA-193648 | NRAGE signals death through JNK | 0.011493 | 1.940 |
R-HSA-5357801 | Programmed Cell Death | 0.011990 | 1.921 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 0.012103 | 1.917 |
R-HSA-140342 | Apoptosis induced DNA fragmentation | 0.013616 | 1.866 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 0.016199 | 1.791 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 0.016199 | 1.791 |
R-HSA-8854518 | AURKA Activation by TPX2 | 0.018537 | 1.732 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 0.019196 | 1.717 |
R-HSA-8950505 | Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulati... | 0.017735 | 1.751 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 0.017364 | 1.760 |
R-HSA-9006821 | Alternative Lengthening of Telomeres (ALT) | 0.026593 | 1.575 |
R-HSA-9673013 | Diseases of Telomere Maintenance | 0.026593 | 1.575 |
R-HSA-9670621 | Defective Inhibition of DNA Recombination at Telomere | 0.026593 | 1.575 |
R-HSA-9670613 | Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | 0.026593 | 1.575 |
R-HSA-9670615 | Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | 0.026593 | 1.575 |
R-HSA-9933947 | Formation of the non-canonical BAF (ncBAF) complex | 0.022483 | 1.648 |
R-HSA-9933939 | Formation of the polybromo-BAF (pBAF) complex | 0.024987 | 1.602 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 0.024772 | 1.606 |
R-HSA-380287 | Centrosome maturation | 0.026759 | 1.573 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 0.021119 | 1.675 |
R-HSA-69473 | G2/M DNA damage checkpoint | 0.025754 | 1.589 |
R-HSA-6803211 | TP53 Regulates Transcription of Death Receptors and Ligands | 0.024987 | 1.602 |
R-HSA-75035 | Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 0.022483 | 1.648 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 0.019718 | 1.705 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 0.024772 | 1.606 |
R-HSA-9933946 | Formation of the embryonic stem cell BAF (esBAF) complex | 0.027598 | 1.559 |
R-HSA-3214841 | PKMTs methylate histone lysines | 0.027773 | 1.556 |
R-HSA-69278 | Cell Cycle, Mitotic | 0.028999 | 1.538 |
R-HSA-9020591 | Interleukin-12 signaling | 0.027787 | 1.556 |
R-HSA-5603027 | IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (E... | 0.039625 | 1.402 |
R-HSA-5602636 | IKBKB deficiency causes SCID | 0.039625 | 1.402 |
R-HSA-9842640 | Signaling by LTK in cancer | 0.114246 | 0.942 |
R-HSA-113507 | E2F-enabled inhibition of pre-replication complex formation | 0.114246 | 0.942 |
R-HSA-77588 | SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | 0.137814 | 0.861 |
R-HSA-9700645 | ALK mutants bind TKIs | 0.149363 | 0.826 |
R-HSA-9934037 | Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | 0.045354 | 1.343 |
R-HSA-68952 | DNA replication initiation | 0.160757 | 0.794 |
R-HSA-9931512 | Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | 0.183093 | 0.737 |
R-HSA-69109 | Leading Strand Synthesis | 0.194038 | 0.712 |
R-HSA-69091 | Polymerase switching | 0.194038 | 0.712 |
R-HSA-3000484 | Scavenging by Class F Receptors | 0.194038 | 0.712 |
R-HSA-5685939 | HDR through MMEJ (alt-NHEJ) | 0.204837 | 0.689 |
R-HSA-69166 | Removal of the Flap Intermediate | 0.215493 | 0.667 |
R-HSA-390522 | Striated Muscle Contraction | 0.102082 | 0.991 |
R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA | 0.102082 | 0.991 |
R-HSA-1221632 | Meiotic synapsis | 0.050309 | 1.298 |
R-HSA-372708 | p130Cas linkage to MAPK signaling for integrins | 0.256710 | 0.591 |
R-HSA-9845323 | Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | 0.065190 | 1.186 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 0.132823 | 0.877 |
R-HSA-9709603 | Impaired BRCA2 binding to PALB2 | 0.276503 | 0.558 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 0.043297 | 1.364 |
R-HSA-6802952 | Signaling by BRAF and RAF1 fusions | 0.076915 | 1.114 |
R-HSA-9701193 | Defective homologous recombination repair (HRR) due to PALB2 loss of function | 0.286202 | 0.543 |
R-HSA-9704331 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 0.286202 | 0.543 |
R-HSA-9701192 | Defective homologous recombination repair (HRR) due to BRCA1 loss of function | 0.286202 | 0.543 |
R-HSA-9704646 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 0.286202 | 0.543 |
R-HSA-5602498 | MyD88 deficiency (TLR2/4) | 0.295772 | 0.529 |
R-HSA-438066 | Unblocking of NMDA receptors, glutamate binding and activation | 0.305213 | 0.515 |
R-HSA-442982 | Ras activation upon Ca2+ influx through NMDA receptor | 0.305213 | 0.515 |
R-HSA-5603041 | IRAK4 deficiency (TLR2/4) | 0.305213 | 0.515 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 0.122820 | 0.911 |
R-HSA-72187 | mRNA 3'-end processing | 0.194153 | 0.712 |
R-HSA-5693554 | Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SD... | 0.341737 | 0.466 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 0.297954 | 0.526 |
R-HSA-72172 | mRNA Splicing | 0.084383 | 1.074 |
R-HSA-69186 | Lagging Strand Synthesis | 0.295772 | 0.529 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 0.162228 | 0.790 |
R-HSA-9931510 | Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock gene... | 0.350565 | 0.455 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 0.337334 | 0.472 |
R-HSA-69183 | Processive synthesis on the lagging strand | 0.226005 | 0.646 |
R-HSA-9932451 | SWI/SNF chromatin remodelers | 0.066219 | 1.179 |
R-HSA-9932444 | ATP-dependent chromatin remodelers | 0.066219 | 1.179 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 0.062953 | 1.201 |
R-HSA-5693606 | DNA Double Strand Break Response | 0.081846 | 1.087 |
R-HSA-5693548 | Sensing of DNA Double Strand Breaks | 0.183093 | 0.737 |
R-HSA-68962 | Activation of the pre-replicative complex | 0.085555 | 1.068 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 0.292529 | 0.534 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 0.292529 | 0.534 |
R-HSA-5576890 | Phase 3 - rapid repolarisation | 0.126109 | 0.899 |
R-HSA-933542 | TRAF6 mediated NF-kB activation | 0.062551 | 1.204 |
R-HSA-174430 | Telomere C-strand synthesis initiation | 0.226005 | 0.646 |
R-HSA-9931521 | The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CL... | 0.246612 | 0.608 |
R-HSA-73856 | RNA Polymerase II Transcription Termination | 0.067464 | 1.171 |
R-HSA-6803529 | FGFR2 alternative splicing | 0.314529 | 0.502 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 0.292529 | 0.534 |
R-HSA-9662834 | CD163 mediating an anti-inflammatory response | 0.172000 | 0.764 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 0.111006 | 0.955 |
R-HSA-3134973 | LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | 0.090036 | 1.046 |
R-HSA-75067 | Processing of Capped Intronless Pre-mRNA | 0.062551 | 1.204 |
R-HSA-5357956 | TNFR1-induced NF-kappa-B signaling pathway | 0.073761 | 1.132 |
R-HSA-77595 | Processing of Intronless Pre-mRNAs | 0.246612 | 0.608 |
R-HSA-6798695 | Neutrophil degranulation | 0.317448 | 0.498 |
R-HSA-9842860 | Regulation of endogenous retroelements | 0.067863 | 1.168 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 0.084777 | 1.072 |
R-HSA-432722 | Golgi Associated Vesicle Biogenesis | 0.050309 | 1.298 |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | 0.176258 | 0.754 |
R-HSA-5603029 | IkBA variant leads to EDA-ID | 0.102222 | 0.990 |
R-HSA-68689 | CDC6 association with the ORC:origin complex | 0.102222 | 0.990 |
R-HSA-113510 | E2F mediated regulation of DNA replication | 0.042162 | 1.375 |
R-HSA-879415 | Advanced glycosylation endproduct receptor signaling | 0.194038 | 0.712 |
R-HSA-2559584 | Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 0.204837 | 0.689 |
R-HSA-1855191 | Synthesis of IPs in the nucleus | 0.215493 | 0.667 |
R-HSA-1810476 | RIP-mediated NFkB activation via ZBP1 | 0.226005 | 0.646 |
R-HSA-1500620 | Meiosis | 0.038098 | 1.419 |
R-HSA-191859 | snRNP Assembly | 0.228495 | 0.641 |
R-HSA-194441 | Metabolism of non-coding RNA | 0.228495 | 0.641 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 0.243349 | 0.614 |
R-HSA-445989 | TAK1-dependent IKK and NF-kappa-B activation | 0.170077 | 0.769 |
R-HSA-9843745 | Adipogenesis | 0.138615 | 0.858 |
R-HSA-212165 | Epigenetic regulation of gene expression | 0.044351 | 1.353 |
R-HSA-1839117 | Signaling by cytosolic FGFR1 fusion mutants | 0.266673 | 0.574 |
R-HSA-5260271 | Diseases of Immune System | 0.132823 | 0.877 |
R-HSA-5602358 | Diseases associated with the TLR signaling cascade | 0.132823 | 0.877 |
R-HSA-9620244 | Long-term potentiation | 0.341737 | 0.466 |
R-HSA-111447 | Activation of BAD and translocation to mitochondria | 0.226005 | 0.646 |
R-HSA-212676 | Dopamine Neurotransmitter Release Cycle | 0.314529 | 0.502 |
R-HSA-3214815 | HDACs deacetylate histones | 0.208801 | 0.680 |
R-HSA-5357905 | Regulation of TNFR1 signaling | 0.165324 | 0.782 |
R-HSA-5632684 | Hedgehog 'on' state | 0.288042 | 0.541 |
R-HSA-69481 | G2/M Checkpoints | 0.044429 | 1.352 |
R-HSA-8866654 | E3 ubiquitin ligases ubiquitinate target proteins | 0.194153 | 0.712 |
R-HSA-2467813 | Separation of Sister Chromatids | 0.231675 | 0.635 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet fun... | 0.273147 | 0.564 |
R-HSA-75893 | TNF signaling | 0.056461 | 1.248 |
R-HSA-9909505 | Modulation of host responses by IFN-stimulated genes | 0.036048 | 1.443 |
R-HSA-1855167 | Synthesis of pyrophosphates in the cytosol | 0.058956 | 1.229 |
R-HSA-113501 | Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 0.183093 | 0.737 |
R-HSA-418359 | Reduction of cytosolic Ca++ levels | 0.183093 | 0.737 |
R-HSA-168927 | TICAM1, RIP1-mediated IKK complex recruitment | 0.226005 | 0.646 |
R-HSA-5576893 | Phase 2 - plateau phase | 0.246612 | 0.608 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 0.036858 | 1.433 |
R-HSA-937041 | IKK complex recruitment mediated by RIP1 | 0.276503 | 0.558 |
R-HSA-450321 | JNK (c-Jun kinases) phosphorylation and activation mediated by activated human ... | 0.295772 | 0.529 |
R-HSA-5357786 | TNFR1-induced proapoptotic signaling | 0.295772 | 0.529 |
R-HSA-110314 | Recognition of DNA damage by PCNA-containing replication complex | 0.332789 | 0.478 |
R-HSA-69242 | S Phase | 0.075536 | 1.122 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 0.174852 | 0.757 |
R-HSA-157579 | Telomere Maintenance | 0.179584 | 0.746 |
R-HSA-5358351 | Signaling by Hedgehog | 0.347442 | 0.459 |
R-HSA-73886 | Chromosome Maintenance | 0.111006 | 0.955 |
R-HSA-9830674 | Formation of the ureteric bud | 0.058956 | 1.229 |
R-HSA-416572 | Sema4D induced cell migration and growth-cone collapse | 0.286202 | 0.543 |
R-HSA-6784531 | tRNA processing in the nucleus | 0.243349 | 0.614 |
R-HSA-4839726 | Chromatin organization | 0.073673 | 1.133 |
R-HSA-9758274 | Regulation of NF-kappa B signaling | 0.236378 | 0.626 |
R-HSA-1483249 | Inositol phosphate metabolism | 0.234804 | 0.629 |
R-HSA-69620 | Cell Cycle Checkpoints | 0.174979 | 0.757 |
R-HSA-9927353 | Co-inhibition by BTLA | 0.090036 | 1.046 |
R-HSA-70635 | Urea cycle | 0.069956 | 1.155 |
R-HSA-937039 | IRAK1 recruits IKK complex | 0.194038 | 0.712 |
R-HSA-975144 | IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | 0.194038 | 0.712 |
R-HSA-877312 | Regulation of IFNG signaling | 0.194038 | 0.712 |
R-HSA-5684264 | MAP3K8 (TPL2)-dependent MAPK1/3 activation | 0.215493 | 0.667 |
R-HSA-8875360 | InlB-mediated entry of Listeria monocytogenes into host cell | 0.226005 | 0.646 |
R-HSA-9617324 | Negative regulation of NMDA receptor-mediated neuronal transmission | 0.305213 | 0.515 |
R-HSA-3238698 | WNT ligand biogenesis and trafficking | 0.314529 | 0.502 |
R-HSA-429947 | Deadenylation of mRNA | 0.332789 | 0.478 |
R-HSA-6790901 | rRNA modification in the nucleus and cytosol | 0.248310 | 0.605 |
R-HSA-8953854 | Metabolism of RNA | 0.182006 | 0.740 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 0.223557 | 0.651 |
R-HSA-180786 | Extension of Telomeres | 0.228495 | 0.641 |
R-HSA-199992 | trans-Golgi Network Vesicle Budding | 0.094750 | 1.023 |
R-HSA-446388 | Regulation of cytoskeletal remodeling and cell spreading by IPP complex componen... | 0.102222 | 0.990 |
R-HSA-2660826 | Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | 0.102222 | 0.990 |
R-HSA-5362798 | Release of Hh-Np from the secreting cell | 0.102222 | 0.990 |
R-HSA-2660825 | Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | 0.102222 | 0.990 |
R-HSA-8964011 | HDL clearance | 0.114246 | 0.942 |
R-HSA-193692 | Regulated proteolysis of p75NTR | 0.149363 | 0.826 |
R-HSA-9614399 | Regulation of localization of FOXO transcription factors | 0.172000 | 0.764 |
R-HSA-933543 | NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 0.172000 | 0.764 |
R-HSA-9933937 | Formation of the canonical BAF (cBAF) complex | 0.215493 | 0.667 |
R-HSA-9755779 | SARS-CoV-2 targets host intracellular signalling and regulatory pathways | 0.226005 | 0.646 |
R-HSA-416482 | G alpha (12/13) signalling events | 0.029914 | 1.524 |
R-HSA-450302 | activated TAK1 mediates p38 MAPK activation | 0.305213 | 0.515 |
R-HSA-912694 | Regulation of IFNA/IFNB signaling | 0.314529 | 0.502 |
R-HSA-177929 | Signaling by EGFR | 0.213709 | 0.670 |
R-HSA-8943724 | Regulation of PTEN gene transcription | 0.233440 | 0.632 |
R-HSA-9018519 | Estrogen-dependent gene expression | 0.153359 | 0.814 |
R-HSA-8852135 | Protein ubiquitination | 0.307845 | 0.512 |
R-HSA-9616222 | Transcriptional regulation of granulopoiesis | 0.069774 | 1.156 |
R-HSA-1606322 | ZBP1(DAI) mediated induction of type I IFNs | 0.266673 | 0.574 |
R-HSA-1474165 | Reproduction | 0.136215 | 0.866 |
R-HSA-9609736 | Assembly and cell surface presentation of NMDA receptors | 0.141956 | 0.848 |
R-HSA-9824585 | Regulation of MITF-M-dependent genes involved in pigmentation | 0.160596 | 0.794 |
R-HSA-397014 | Muscle contraction | 0.205285 | 0.688 |
R-HSA-9860276 | SLC15A4:TASL-dependent IRF5 activation | 0.102222 | 0.990 |
R-HSA-2691232 | Constitutive Signaling by NOTCH1 HD Domain Mutants | 0.194038 | 0.712 |
R-HSA-2691230 | Signaling by NOTCH1 HD Domain Mutants in Cancer | 0.194038 | 0.712 |
R-HSA-6807004 | Negative regulation of MET activity | 0.286202 | 0.543 |
R-HSA-912526 | Interleukin receptor SHC signaling | 0.323721 | 0.490 |
R-HSA-174411 | Polymerase switching on the C-strand of the telomere | 0.341737 | 0.466 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 0.263210 | 0.580 |
R-HSA-8939211 | ESR-mediated signaling | 0.266820 | 0.574 |
R-HSA-5617833 | Cilium Assembly | 0.153674 | 0.813 |
R-HSA-6794361 | Neurexins and neuroligins | 0.194153 | 0.712 |
R-HSA-8876384 | Listeria monocytogenes entry into host cells | 0.305213 | 0.515 |
R-HSA-400685 | Sema4D in semaphorin signaling | 0.341737 | 0.466 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 0.137865 | 0.861 |
R-HSA-2644603 | Signaling by NOTCH1 in Cancer | 0.233440 | 0.632 |
R-HSA-3247509 | Chromatin modifying enzymes | 0.130751 | 0.884 |
R-HSA-5576891 | Cardiac conduction | 0.318138 | 0.497 |
R-HSA-68875 | Mitotic Prophase | 0.108827 | 0.963 |
R-HSA-435368 | Zinc efflux and compartmentalization by the SLC30 family | 0.090036 | 1.046 |
R-HSA-210990 | PECAM1 interactions | 0.172000 | 0.764 |
R-HSA-9735871 | SARS-CoV-1 targets host intracellular signalling and regulatory pathways | 0.226005 | 0.646 |
R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | 0.233440 | 0.632 |
R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 0.233440 | 0.632 |
R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 0.233440 | 0.632 |
R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | 0.233440 | 0.632 |
R-HSA-69275 | G2/M Transition | 0.299396 | 0.524 |
R-HSA-453274 | Mitotic G2-G2/M phases | 0.305416 | 0.515 |
R-HSA-70171 | Glycolysis | 0.189663 | 0.722 |
R-HSA-446652 | Interleukin-1 family signaling | 0.198034 | 0.703 |
R-HSA-1433559 | Regulation of KIT signaling | 0.215493 | 0.667 |
R-HSA-1912420 | Pre-NOTCH Processing in Golgi | 0.276503 | 0.558 |
R-HSA-5687128 | MAPK6/MAPK4 signaling | 0.131773 | 0.880 |
R-HSA-68882 | Mitotic Anaphase | 0.042190 | 1.375 |
R-HSA-1169408 | ISG15 antiviral mechanism | 0.307845 | 0.512 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 0.042986 | 1.367 |
R-HSA-3214842 | HDMs demethylate histones | 0.341737 | 0.466 |
R-HSA-5578775 | Ion homeostasis | 0.213709 | 0.670 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 0.177560 | 0.751 |
R-HSA-389948 | Co-inhibition by PD-1 | 0.341755 | 0.466 |
R-HSA-432142 | Platelet sensitization by LDL | 0.266673 | 0.574 |
R-HSA-6802957 | Oncogenic MAPK signaling | 0.131773 | 0.880 |
R-HSA-982772 | Growth hormone receptor signaling | 0.058956 | 1.229 |
R-HSA-351906 | Apoptotic cleavage of cell adhesion proteins | 0.137814 | 0.861 |
R-HSA-264870 | Caspase-mediated cleavage of cytoskeletal proteins | 0.149363 | 0.826 |
R-HSA-391160 | Signal regulatory protein family interactions | 0.215493 | 0.667 |
R-HSA-446353 | Cell-extracellular matrix interactions | 0.226005 | 0.646 |
R-HSA-2028269 | Signaling by Hippo | 0.256710 | 0.591 |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | 0.283080 | 0.548 |
R-HSA-983712 | Ion channel transport | 0.308431 | 0.511 |
R-HSA-9764725 | Negative Regulation of CDH1 Gene Transcription | 0.233440 | 0.632 |
R-HSA-2672351 | Stimuli-sensing channels | 0.220693 | 0.656 |
R-HSA-8863678 | Neurodegenerative Diseases | 0.062551 | 1.204 |
R-HSA-8862803 | Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's dis... | 0.062551 | 1.204 |
R-HSA-9734009 | Defective Intrinsic Pathway for Apoptosis | 0.073761 | 1.132 |
R-HSA-2173796 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 0.119397 | 0.923 |
R-HSA-6804760 | Regulation of TP53 Activity through Methylation | 0.266673 | 0.574 |
R-HSA-9645723 | Diseases of programmed cell death | 0.144051 | 0.841 |
R-HSA-9830369 | Kidney development | 0.268179 | 0.572 |
R-HSA-9022699 | MECP2 regulates neuronal receptors and channels | 0.069956 | 1.155 |
R-HSA-435354 | Zinc transporters | 0.215493 | 0.667 |
R-HSA-1980143 | Signaling by NOTCH1 | 0.312781 | 0.505 |
R-HSA-70326 | Glucose metabolism | 0.259854 | 0.585 |
R-HSA-5633007 | Regulation of TP53 Activity | 0.220299 | 0.657 |
R-HSA-9008059 | Interleukin-37 signaling | 0.085555 | 1.068 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 0.119397 | 0.923 |
R-HSA-6804115 | TP53 regulates transcription of additional cell cycle genes whose exact role in ... | 0.314529 | 0.502 |
R-HSA-9764560 | Regulation of CDH1 Gene Transcription | 0.283080 | 0.548 |
R-HSA-9700206 | Signaling by ALK in cancer | 0.078595 | 1.105 |
R-HSA-2262752 | Cellular responses to stress | 0.327382 | 0.485 |
R-HSA-3000170 | Syndecan interactions | 0.323721 | 0.490 |
R-HSA-186797 | Signaling by PDGF | 0.243349 | 0.614 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 0.078595 | 1.105 |
R-HSA-162582 | Signal Transduction | 0.273310 | 0.563 |
R-HSA-9725371 | Nuclear events stimulated by ALK signaling in cancer | 0.174852 | 0.757 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 0.213705 | 0.670 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 0.333418 | 0.477 |
R-HSA-1474228 | Degradation of the extracellular matrix | 0.321802 | 0.492 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 0.203534 | 0.691 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 0.111438 | 0.953 |
R-HSA-8866910 | TFAP2 (AP-2) family regulates transcription of growth factors and their receptor... | 0.246612 | 0.608 |
R-HSA-9856649 | Transcriptional and post-translational regulation of MITF-M expression and activ... | 0.288042 | 0.541 |
R-HSA-1433557 | Signaling by SCF-KIT | 0.151218 | 0.820 |
R-HSA-381119 | Unfolded Protein Response (UPR) | 0.061427 | 1.212 |
R-HSA-9833482 | PKR-mediated signaling | 0.332442 | 0.478 |
R-HSA-2122948 | Activated NOTCH1 Transmits Signal to the Nucleus | 0.350565 | 0.455 |
R-HSA-5633008 | TP53 Regulates Transcription of Cell Death Genes | 0.307845 | 0.512 |
R-HSA-381038 | XBP1(S) activates chaperone genes | 0.040650 | 1.391 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 0.116982 | 0.932 |
R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 0.213709 | 0.670 |
R-HSA-1266695 | Interleukin-7 signaling | 0.341737 | 0.466 |
R-HSA-1500931 | Cell-Cell communication | 0.170514 | 0.768 |
R-HSA-381070 | IRE1alpha activates chaperones | 0.048875 | 1.311 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 0.179584 | 0.746 |
R-HSA-447115 | Interleukin-12 family signaling | 0.041962 | 1.377 |
R-HSA-6794362 | Protein-protein interactions at synapses | 0.356788 | 0.448 |
R-HSA-167243 | Tat-mediated HIV elongation arrest and recovery | 0.359276 | 0.445 |
R-HSA-167238 | Pausing and recovery of Tat-mediated HIV elongation | 0.359276 | 0.445 |
R-HSA-8949613 | Cristae formation | 0.359276 | 0.445 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 0.365706 | 0.437 |
R-HSA-6807505 | RNA polymerase II transcribes snRNA genes | 0.366439 | 0.436 |
R-HSA-167287 | HIV elongation arrest and recovery | 0.367870 | 0.434 |
R-HSA-167290 | Pausing and recovery of HIV elongation | 0.367870 | 0.434 |
R-HSA-171319 | Telomere Extension By Telomerase | 0.367870 | 0.434 |
R-HSA-5620971 | Pyroptosis | 0.367870 | 0.434 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 0.369350 | 0.433 |
R-HSA-9679506 | SARS-CoV Infections | 0.373651 | 0.428 |
R-HSA-9709570 | Impaired BRCA2 binding to RAD51 | 0.376349 | 0.424 |
R-HSA-418360 | Platelet calcium homeostasis | 0.376349 | 0.424 |
R-HSA-1236974 | ER-Phagosome pathway | 0.380811 | 0.419 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 0.384292 | 0.415 |
R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC... | 0.384715 | 0.415 |
R-HSA-9933387 | RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | 0.384715 | 0.415 |
R-HSA-114452 | Activation of BH3-only proteins | 0.384715 | 0.415 |
R-HSA-9013508 | NOTCH3 Intracellular Domain Regulates Transcription | 0.384715 | 0.415 |
R-HSA-8986944 | Transcriptional Regulation by MECP2 | 0.390315 | 0.409 |
R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus | 0.392970 | 0.406 |
R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus | 0.392970 | 0.406 |
R-HSA-2129379 | Molecules associated with elastic fibres | 0.392970 | 0.406 |
R-HSA-182971 | EGFR downregulation | 0.392970 | 0.406 |
R-HSA-186763 | Downstream signal transduction | 0.392970 | 0.406 |
R-HSA-9679191 | Potential therapeutics for SARS | 0.394741 | 0.404 |
R-HSA-69190 | DNA strand elongation | 0.401114 | 0.397 |
R-HSA-9675126 | Diseases of mitotic cell cycle | 0.401114 | 0.397 |
R-HSA-109582 | Hemostasis | 0.402094 | 0.396 |
R-HSA-8953897 | Cellular responses to stimuli | 0.404423 | 0.393 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 0.405545 | 0.392 |
R-HSA-1855170 | IPs transport between nucleus and cytosol | 0.409149 | 0.388 |
R-HSA-159227 | Transport of the SLBP independent Mature mRNA | 0.409149 | 0.388 |
R-HSA-5083635 | Defective B3GALTL causes PpS | 0.409149 | 0.388 |
R-HSA-5685938 | HDR through Single Strand Annealing (SSA) | 0.409149 | 0.388 |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | 0.409149 | 0.388 |
R-HSA-68616 | Assembly of the ORC complex at the origin of replication | 0.409149 | 0.388 |
R-HSA-442742 | CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 0.409149 | 0.388 |
R-HSA-1839124 | FGFR1 mutant receptor activation | 0.409149 | 0.388 |
R-HSA-176187 | Activation of ATR in response to replication stress | 0.409149 | 0.388 |
R-HSA-8939243 | RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not kno... | 0.409149 | 0.388 |
R-HSA-354192 | Integrin signaling | 0.409149 | 0.388 |
R-HSA-6804758 | Regulation of TP53 Activity through Acetylation | 0.409149 | 0.388 |
R-HSA-1989781 | PPARA activates gene expression | 0.412717 | 0.384 |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 0.413785 | 0.383 |
R-HSA-5693537 | Resolution of D-Loop Structures | 0.417077 | 0.380 |
R-HSA-390471 | Association of TriC/CCT with target proteins during biosynthesis | 0.417077 | 0.380 |
R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 0.417077 | 0.380 |
R-HSA-9818027 | NFE2L2 regulating anti-oxidant/detoxification enzymes | 0.417077 | 0.380 |
R-HSA-400206 | Regulation of lipid metabolism by PPARalpha | 0.419862 | 0.377 |
R-HSA-9843970 | Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | 0.424899 | 0.372 |
R-HSA-9675136 | Diseases of DNA Double-Strand Break Repair | 0.424899 | 0.372 |
R-HSA-9701190 | Defective homologous recombination repair (HRR) due to BRCA2 loss of function | 0.424899 | 0.372 |
R-HSA-168638 | NOD1/2 Signaling Pathway | 0.424899 | 0.372 |
R-HSA-9735869 | SARS-CoV-1 modulates host translation machinery | 0.424899 | 0.372 |
R-HSA-5686938 | Regulation of TLR by endogenous ligand | 0.424899 | 0.372 |
R-HSA-180746 | Nuclear import of Rev protein | 0.424899 | 0.372 |
R-HSA-1368108 | BMAL1:CLOCK,NPAS2 activates circadian expression | 0.424899 | 0.372 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 0.429501 | 0.367 |
R-HSA-9006936 | Signaling by TGFB family members | 0.430525 | 0.366 |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | 0.432236 | 0.364 |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | 0.432236 | 0.364 |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | 0.432236 | 0.364 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 0.432617 | 0.364 |
R-HSA-5693616 | Presynaptic phase of homologous DNA pairing and strand exchange | 0.432617 | 0.364 |
R-HSA-381042 | PERK regulates gene expression | 0.432617 | 0.364 |
R-HSA-9860927 | Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZ... | 0.432617 | 0.364 |
R-HSA-3371511 | HSF1 activation | 0.440232 | 0.356 |
R-HSA-114604 | GPVI-mediated activation cascade | 0.440232 | 0.356 |
R-HSA-6804757 | Regulation of TP53 Degradation | 0.440232 | 0.356 |
R-HSA-5610787 | Hedgehog 'off' state | 0.441345 | 0.355 |
R-HSA-9020702 | Interleukin-1 signaling | 0.445870 | 0.351 |
R-HSA-5173214 | O-glycosylation of TSR domain-containing proteins | 0.447745 | 0.349 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 0.447745 | 0.349 |
R-HSA-5689896 | Ovarian tumor domain proteases | 0.447745 | 0.349 |
R-HSA-442755 | Activation of NMDA receptors and postsynaptic events | 0.450374 | 0.346 |
R-HSA-1566948 | Elastic fibre formation | 0.455157 | 0.342 |
R-HSA-5693579 | Homologous DNA Pairing and Strand Exchange | 0.455157 | 0.342 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 0.455157 | 0.342 |
R-HSA-913531 | Interferon Signaling | 0.462463 | 0.335 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 0.462470 | 0.335 |
R-HSA-167200 | Formation of HIV-1 elongation complex containing HIV-1 Tat | 0.462470 | 0.335 |
R-HSA-168276 | NS1 Mediated Effects on Host Pathways | 0.462470 | 0.335 |
R-HSA-69541 | Stabilization of p53 | 0.462470 | 0.335 |
R-HSA-9931509 | Expression of BMAL (ARNTL), CLOCK, and NPAS2 | 0.462470 | 0.335 |
R-HSA-6806003 | Regulation of TP53 Expression and Degradation | 0.462470 | 0.335 |
R-HSA-8964043 | Plasma lipoprotein clearance | 0.462470 | 0.335 |
R-HSA-201556 | Signaling by ALK | 0.462470 | 0.335 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 0.463762 | 0.334 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 0.463762 | 0.334 |
R-HSA-9833110 | RSV-host interactions | 0.463762 | 0.334 |
R-HSA-157118 | Signaling by NOTCH | 0.465048 | 0.333 |
R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade | 0.468183 | 0.330 |
R-HSA-72306 | tRNA processing | 0.468984 | 0.329 |
R-HSA-9670095 | Inhibition of DNA recombination at telomere | 0.469686 | 0.328 |
R-HSA-3371568 | Attenuation phase | 0.469686 | 0.328 |
R-HSA-167246 | Tat-mediated elongation of the HIV-1 transcript | 0.469686 | 0.328 |
R-HSA-427389 | ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 0.469686 | 0.328 |
R-HSA-167152 | Formation of HIV elongation complex in the absence of HIV Tat | 0.469686 | 0.328 |
R-HSA-9843743 | Transcriptional regulation of brown and beige adipocyte differentiation | 0.469686 | 0.328 |
R-HSA-9844594 | Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | 0.469686 | 0.328 |
R-HSA-167169 | HIV Transcription Elongation | 0.469686 | 0.328 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 0.469686 | 0.328 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 0.469686 | 0.328 |
R-HSA-1251985 | Nuclear signaling by ERBB4 | 0.469686 | 0.328 |
R-HSA-451927 | Interleukin-2 family signaling | 0.469686 | 0.328 |
R-HSA-418346 | Platelet homeostasis | 0.472581 | 0.326 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 0.475855 | 0.323 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 0.476805 | 0.322 |
R-HSA-9929491 | SPOP-mediated proteasomal degradation of PD-L1(CD274) | 0.476805 | 0.322 |
R-HSA-5625886 | Activated PKN1 stimulates transcription of AR (androgen receptor) regulated gene... | 0.476805 | 0.322 |
R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus | 0.476805 | 0.322 |
R-HSA-69239 | Synthesis of DNA | 0.476958 | 0.322 |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 0.481313 | 0.318 |
R-HSA-1236975 | Antigen processing-Cross presentation | 0.481313 | 0.318 |
R-HSA-5610780 | Degradation of GLI1 by the proteasome | 0.483830 | 0.315 |
R-HSA-5655302 | Signaling by FGFR1 in disease | 0.483830 | 0.315 |
R-HSA-174417 | Telomere C-strand (Lagging Strand) Synthesis | 0.483830 | 0.315 |
R-HSA-69002 | DNA Replication Pre-Initiation | 0.485645 | 0.314 |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | 0.485645 | 0.314 |
R-HSA-9678108 | SARS-CoV-1 Infection | 0.486085 | 0.313 |
R-HSA-937061 | TRIF (TICAM1)-mediated TLR4 signaling | 0.489955 | 0.310 |
R-HSA-166166 | MyD88-independent TLR4 cascade | 0.489955 | 0.310 |
R-HSA-379716 | Cytosolic tRNA aminoacylation | 0.490760 | 0.309 |
R-HSA-73762 | RNA Polymerase I Transcription Initiation | 0.490760 | 0.309 |
R-HSA-512988 | Interleukin-3, Interleukin-5 and GM-CSF signaling | 0.490760 | 0.309 |
R-HSA-9710421 | Defective pyroptosis | 0.497598 | 0.303 |
R-HSA-2173789 | TGF-beta receptor signaling activates SMADs | 0.497598 | 0.303 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 0.502749 | 0.299 |
R-HSA-3214858 | RMTs methylate histone arginines | 0.504344 | 0.297 |
R-HSA-8864260 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 0.504344 | 0.297 |
R-HSA-449147 | Signaling by Interleukins | 0.506897 | 0.295 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 0.506968 | 0.295 |
R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery | 0.511000 | 0.292 |
R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere | 0.511000 | 0.292 |
R-HSA-774815 | Nucleosome assembly | 0.511000 | 0.292 |
R-HSA-76009 | Platelet Aggregation (Plug Formation) | 0.511000 | 0.292 |
R-HSA-69613 | p53-Independent G1/S DNA Damage Checkpoint | 0.511000 | 0.292 |
R-HSA-69601 | Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | 0.511000 | 0.292 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 0.511162 | 0.291 |
R-HSA-1474244 | Extracellular matrix organization | 0.512406 | 0.290 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 0.515336 | 0.288 |
R-HSA-72165 | mRNA Splicing - Minor Pathway | 0.517567 | 0.286 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 0.517567 | 0.286 |
R-HSA-9675135 | Diseases of DNA repair | 0.517567 | 0.286 |
R-HSA-6811440 | Retrograde transport at the Trans-Golgi-Network | 0.524046 | 0.281 |
R-HSA-1592230 | Mitochondrial biogenesis | 0.527711 | 0.278 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 0.529256 | 0.276 |
R-HSA-425410 | Metal ion SLC transporters | 0.530439 | 0.275 |
R-HSA-5693538 | Homology Directed Repair | 0.531788 | 0.274 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 0.535842 | 0.271 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 0.535842 | 0.271 |
R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | 0.536746 | 0.270 |
R-HSA-69580 | p53-Dependent G1/S DNA damage checkpoint | 0.536746 | 0.270 |
R-HSA-69563 | p53-Dependent G1 DNA Damage Response | 0.536746 | 0.270 |
R-HSA-73893 | DNA Damage Bypass | 0.536746 | 0.270 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 0.547858 | 0.261 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 0.547858 | 0.261 |
R-HSA-3371571 | HSF1-dependent transactivation | 0.549109 | 0.260 |
R-HSA-1169091 | Activation of NF-kappaB in B cells | 0.549109 | 0.260 |
R-HSA-912446 | Meiotic recombination | 0.549109 | 0.260 |
R-HSA-5358346 | Hedgehog ligand biogenesis | 0.549109 | 0.260 |
R-HSA-112382 | Formation of RNA Pol II elongation complex | 0.555166 | 0.256 |
R-HSA-68949 | Orc1 removal from chromatin | 0.555166 | 0.256 |
R-HSA-9692916 | SARS-CoV-1 activates/modulates innate immune responses | 0.555166 | 0.256 |
R-HSA-75955 | RNA Polymerase II Transcription Elongation | 0.561143 | 0.251 |
R-HSA-69206 | G1/S Transition | 0.563539 | 0.249 |
R-HSA-9012852 | Signaling by NOTCH3 | 0.572857 | 0.242 |
R-HSA-109606 | Intrinsic Pathway for Apoptosis | 0.578597 | 0.238 |
R-HSA-6791312 | TP53 Regulates Transcription of Cell Cycle Genes | 0.584260 | 0.233 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 0.589697 | 0.229 |
R-HSA-9029569 | NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflu... | 0.589848 | 0.229 |
R-HSA-9909396 | Circadian clock | 0.593725 | 0.226 |
R-HSA-429914 | Deadenylation-dependent mRNA decay | 0.595361 | 0.225 |
R-HSA-379724 | tRNA Aminoacylation | 0.600799 | 0.221 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 0.606166 | 0.217 |
R-HSA-450294 | MAP kinase activation | 0.606166 | 0.217 |
R-HSA-1442490 | Collagen degradation | 0.606166 | 0.217 |
R-HSA-9707616 | Heme signaling | 0.611460 | 0.214 |
R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | 0.611460 | 0.214 |
R-HSA-5173105 | O-linked glycosylation | 0.615329 | 0.211 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 0.615329 | 0.211 |
R-HSA-69615 | G1/S DNA Damage Checkpoints | 0.616683 | 0.210 |
R-HSA-2426168 | Activation of gene expression by SREBF (SREBP) | 0.616683 | 0.210 |
R-HSA-373755 | Semaphorin interactions | 0.616683 | 0.210 |
R-HSA-8848021 | Signaling by PTK6 | 0.616683 | 0.210 |
R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases | 0.616683 | 0.210 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 0.619220 | 0.208 |
R-HSA-5690714 | CD22 mediated BCR regulation | 0.621837 | 0.206 |
R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signali... | 0.621837 | 0.206 |
R-HSA-936837 | Ion transport by P-type ATPases | 0.621837 | 0.206 |
R-HSA-6807070 | PTEN Regulation | 0.622333 | 0.206 |
R-HSA-195721 | Signaling by WNT | 0.622512 | 0.206 |
R-HSA-6782315 | tRNA modification in the nucleus and cytosol | 0.631938 | 0.199 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 0.636046 | 0.197 |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | 0.636887 | 0.196 |
R-HSA-167172 | Transcription of the HIV genome | 0.641770 | 0.193 |
R-HSA-1650814 | Collagen biosynthesis and modifying enzymes | 0.641770 | 0.193 |
R-HSA-5218859 | Regulated Necrosis | 0.641770 | 0.193 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 0.645605 | 0.190 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 0.649368 | 0.188 |
R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | 0.651342 | 0.186 |
R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins | 0.651342 | 0.186 |
R-HSA-448424 | Interleukin-17 signaling | 0.651342 | 0.186 |
R-HSA-204005 | COPII-mediated vesicle transport | 0.651342 | 0.186 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 0.655883 | 0.183 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 0.656031 | 0.183 |
R-HSA-3906995 | Diseases associated with O-glycosylation of proteins | 0.656031 | 0.183 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 0.660658 | 0.180 |
R-HSA-72312 | rRNA processing | 0.661594 | 0.179 |
R-HSA-9856651 | MITF-M-dependent gene expression | 0.662301 | 0.179 |
R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane | 0.665223 | 0.177 |
R-HSA-69052 | Switching of origins to a post-replicative state | 0.665223 | 0.177 |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | 0.665475 | 0.177 |
R-HSA-674695 | RNA Polymerase II Pre-transcription Events | 0.669727 | 0.174 |
R-HSA-1226099 | Signaling by FGFR in disease | 0.669727 | 0.174 |
R-HSA-1236394 | Signaling by ERBB4 | 0.669727 | 0.174 |
R-HSA-69306 | DNA Replication | 0.671749 | 0.173 |
R-HSA-3000171 | Non-integrin membrane-ECM interactions | 0.674170 | 0.171 |
R-HSA-74160 | Gene expression (Transcription) | 0.676337 | 0.170 |
R-HSA-73854 | RNA Polymerase I Promoter Clearance | 0.678554 | 0.168 |
R-HSA-9024446 | NR1H2 and NR1H3-mediated signaling | 0.682879 | 0.166 |
R-HSA-162587 | HIV Life Cycle | 0.684014 | 0.165 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 0.687021 | 0.163 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 0.687146 | 0.163 |
R-HSA-4086400 | PCP/CE pathway | 0.687146 | 0.163 |
R-HSA-73864 | RNA Polymerase I Transcription | 0.687146 | 0.163 |
R-HSA-216083 | Integrin cell surface interactions | 0.687146 | 0.163 |
R-HSA-1655829 | Regulation of cholesterol biosynthesis by SREBP (SREBF) | 0.691357 | 0.160 |
R-HSA-5654738 | Signaling by FGFR2 | 0.695510 | 0.158 |
R-HSA-6806834 | Signaling by MET | 0.695510 | 0.158 |
R-HSA-2151201 | Transcriptional activation of mitochondrial biogenesis | 0.699608 | 0.155 |
R-HSA-9707564 | Cytoprotection by HMOX1 | 0.707641 | 0.150 |
R-HSA-73857 | RNA Polymerase II Transcription | 0.710485 | 0.148 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 0.711576 | 0.148 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 0.719290 | 0.143 |
R-HSA-141424 | Amplification of signal from the kinetochores | 0.719290 | 0.143 |
R-HSA-9909615 | Regulation of PD-L1(CD274) Post-translational modification | 0.719290 | 0.143 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 0.724016 | 0.140 |
R-HSA-438064 | Post NMDA receptor activation events | 0.726798 | 0.139 |
R-HSA-390466 | Chaperonin-mediated protein folding | 0.726798 | 0.139 |
R-HSA-5683057 | MAPK family signaling cascades | 0.730469 | 0.136 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 0.732012 | 0.135 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 0.732012 | 0.135 |
R-HSA-9694516 | SARS-CoV-2 Infection | 0.734342 | 0.134 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 0.737234 | 0.132 |
R-HSA-202424 | Downstream TCR signaling | 0.737687 | 0.132 |
R-HSA-112310 | Neurotransmitter release cycle | 0.737687 | 0.132 |
R-HSA-9711123 | Cellular response to chemical stress | 0.746573 | 0.127 |
R-HSA-156842 | Eukaryotic Translation Elongation | 0.748144 | 0.126 |
R-HSA-391251 | Protein folding | 0.748144 | 0.126 |
R-HSA-174824 | Plasma lipoprotein assembly, remodeling, and clearance | 0.748144 | 0.126 |
R-HSA-2559583 | Cellular Senescence | 0.749912 | 0.125 |
R-HSA-68867 | Assembly of the pre-replicative complex | 0.751537 | 0.124 |
R-HSA-983695 | Antigen activates B Cell Receptor (BCR) leading to generation of second messenge... | 0.751537 | 0.124 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 0.753814 | 0.123 |
R-HSA-1474290 | Collagen formation | 0.754884 | 0.122 |
R-HSA-73894 | DNA Repair | 0.754901 | 0.122 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 0.757264 | 0.121 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 0.764658 | 0.117 |
R-HSA-446728 | Cell junction organization | 0.766931 | 0.115 |
R-HSA-190236 | Signaling by FGFR | 0.770958 | 0.113 |
R-HSA-9614085 | FOXO-mediated transcription | 0.774045 | 0.111 |
R-HSA-168898 | Toll-like Receptor Cascades | 0.775968 | 0.110 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 0.777090 | 0.110 |
R-HSA-1483255 | PI Metabolism | 0.783059 | 0.106 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 0.787010 | 0.104 |
R-HSA-9633012 | Response of EIF2AK4 (GCN2) to amino acid deficiency | 0.788868 | 0.103 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 0.788868 | 0.103 |
R-HSA-9860931 | Response of endothelial cells to shear stress | 0.788868 | 0.103 |
R-HSA-163125 | Post-translational modification: synthesis of GPI-anchored proteins | 0.791714 | 0.101 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 0.795497 | 0.099 |
R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane | 0.800026 | 0.097 |
R-HSA-211000 | Gene Silencing by RNA | 0.800026 | 0.097 |
R-HSA-199991 | Membrane Trafficking | 0.800388 | 0.097 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 0.805383 | 0.094 |
R-HSA-202403 | TCR signaling | 0.808008 | 0.093 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 0.813152 | 0.090 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 0.813152 | 0.090 |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | 0.815672 | 0.088 |
R-HSA-9855142 | Cellular responses to mechanical stimuli | 0.818159 | 0.087 |
R-HSA-597592 | Post-translational protein modification | 0.820011 | 0.086 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 0.821059 | 0.086 |
R-HSA-5628897 | TP53 Regulates Metabolic Genes | 0.823032 | 0.085 |
R-HSA-909733 | Interferon alpha/beta signaling | 0.825420 | 0.083 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 0.825420 | 0.083 |
R-HSA-418990 | Adherens junctions interactions | 0.831865 | 0.080 |
R-HSA-9759194 | Nuclear events mediated by NFE2L2 | 0.839088 | 0.076 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 0.843402 | 0.074 |
R-HSA-162909 | Host Interactions of HIV factors | 0.845516 | 0.073 |
R-HSA-162906 | HIV Infection | 0.846978 | 0.072 |
R-HSA-194138 | Signaling by VEGF | 0.849660 | 0.071 |
R-HSA-9824446 | Viral Infection Pathways | 0.854013 | 0.069 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 0.874022 | 0.058 |
R-HSA-5653656 | Vesicle-mediated transport | 0.874149 | 0.058 |
R-HSA-421270 | Cell-cell junction organization | 0.881445 | 0.055 |
R-HSA-2871837 | FCERI mediated NF-kB activation | 0.888544 | 0.051 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 0.893005 | 0.049 |
R-HSA-2173782 | Binding and Uptake of Ligands by Scavenger Receptors | 0.897287 | 0.047 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 0.900047 | 0.046 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 0.904049 | 0.044 |
R-HSA-9610379 | HCMV Late Events | 0.906628 | 0.043 |
R-HSA-9711097 | Cellular response to starvation | 0.907892 | 0.042 |
R-HSA-212436 | Generic Transcription Pathway | 0.908077 | 0.042 |
R-HSA-877300 | Interferon gamma signaling | 0.909138 | 0.041 |
R-HSA-2408522 | Selenoamino acid metabolism | 0.915123 | 0.039 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 0.915400 | 0.038 |
R-HSA-5619102 | SLC transporter disorders | 0.918524 | 0.037 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 0.923893 | 0.034 |
R-HSA-9664433 | Leishmania parasite growth and survival | 0.925941 | 0.033 |
R-HSA-9662851 | Anti-inflammatory response favouring Leishmania parasite infection | 0.925941 | 0.033 |
R-HSA-5689880 | Ub-specific processing proteases | 0.925941 | 0.033 |
R-HSA-1257604 | PIP3 activates AKT signaling | 0.926734 | 0.033 |
R-HSA-168255 | Influenza Infection | 0.931761 | 0.031 |
R-HSA-3781865 | Diseases of glycosylation | 0.936261 | 0.029 |
R-HSA-72766 | Translation | 0.943257 | 0.025 |
R-HSA-9609690 | HCMV Early Events | 0.945894 | 0.024 |
R-HSA-112315 | Transmission across Chemical Synapses | 0.946478 | 0.024 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 0.948771 | 0.023 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 0.950151 | 0.022 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 0.950828 | 0.022 |
R-HSA-376176 | Signaling by ROBO receptors | 0.950828 | 0.022 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 0.956358 | 0.019 |
R-HSA-9006925 | Intracellular signaling by second messengers | 0.956878 | 0.019 |
R-HSA-112316 | Neuronal System | 0.961796 | 0.017 |
R-HSA-1643685 | Disease | 0.965485 | 0.015 |
R-HSA-202733 | Cell surface interactions at the vascular wall | 0.969536 | 0.013 |
R-HSA-5619115 | Disorders of transmembrane transporters | 0.973436 | 0.012 |
R-HSA-9609646 | HCMV Infection | 0.974506 | 0.011 |
R-HSA-5688426 | Deubiquitination | 0.976195 | 0.010 |
R-HSA-1280218 | Adaptive Immune System | 0.977822 | 0.010 |
R-HSA-392499 | Metabolism of proteins | 0.978129 | 0.010 |
R-HSA-9824443 | Parasitic Infection Pathways | 0.983337 | 0.007 |
R-HSA-9658195 | Leishmania infection | 0.983337 | 0.007 |
R-HSA-5673001 | RAF/MAP kinase cascade | 0.985071 | 0.007 |
R-HSA-1266738 | Developmental Biology | 0.985529 | 0.006 |
R-HSA-1483257 | Phospholipid metabolism | 0.986253 | 0.006 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 0.986441 | 0.006 |
R-HSA-5663205 | Infectious disease | 0.987265 | 0.006 |
R-HSA-168249 | Innate Immune System | 0.988938 | 0.005 |
R-HSA-8957322 | Metabolism of steroids | 0.990775 | 0.004 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 0.992364 | 0.003 |
R-HSA-382551 | Transport of small molecules | 0.993584 | 0.003 |
R-HSA-388396 | GPCR downstream signalling | 0.994741 | 0.002 |
R-HSA-168256 | Immune System | 0.996161 | 0.002 |
R-HSA-422475 | Axon guidance | 0.996220 | 0.002 |
R-HSA-9824439 | Bacterial Infection Pathways | 0.996341 | 0.002 |
R-HSA-425407 | SLC-mediated transmembrane transport | 0.996678 | 0.001 |
R-HSA-9675108 | Nervous system development | 0.997611 | 0.001 |
R-HSA-446203 | Asparagine N-linked glycosylation | 0.997650 | 0.001 |
R-HSA-5668914 | Diseases of metabolism | 0.997807 | 0.001 |
R-HSA-372790 | Signaling by GPCR | 0.997849 | 0.001 |
R-HSA-556833 | Metabolism of lipids | 0.999999 | 0.000 |
R-HSA-1430728 | Metabolism | 1.000000 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
FAM20C |
0.875 | 0.576 | 2 | 0.874 |
COT |
0.874 | 0.151 | 2 | 0.742 |
CLK3 |
0.868 | 0.231 | 1 | 0.898 |
DSTYK |
0.862 | 0.160 | 2 | 0.776 |
NLK |
0.856 | 0.090 | 1 | 0.892 |
PRPK |
0.856 | -0.018 | -1 | 0.838 |
CAMK2G |
0.853 | 0.058 | 2 | 0.695 |
MTOR |
0.853 | -0.036 | 1 | 0.846 |
GCN2 |
0.853 | -0.095 | 2 | 0.647 |
IKKB |
0.852 | -0.013 | -2 | 0.737 |
PKN3 |
0.852 | 0.054 | -3 | 0.847 |
ULK2 |
0.851 | -0.087 | 2 | 0.651 |
MOS |
0.851 | 0.011 | 1 | 0.886 |
NEK6 |
0.851 | 0.018 | -2 | 0.869 |
CDC7 |
0.850 | -0.049 | 1 | 0.852 |
PIM3 |
0.850 | 0.006 | -3 | 0.853 |
RAF1 |
0.850 | -0.060 | 1 | 0.864 |
TBK1 |
0.849 | -0.026 | 1 | 0.775 |
PDHK4 |
0.849 | -0.078 | 1 | 0.886 |
BMPR2 |
0.849 | 0.009 | -2 | 0.882 |
ATR |
0.849 | 0.041 | 1 | 0.881 |
CDKL1 |
0.849 | 0.032 | -3 | 0.822 |
CAMK1B |
0.849 | -0.016 | -3 | 0.882 |
MLK1 |
0.848 | -0.001 | 2 | 0.713 |
NEK7 |
0.848 | -0.029 | -3 | 0.879 |
PKCD |
0.847 | 0.062 | 2 | 0.687 |
MARK4 |
0.847 | 0.054 | 4 | 0.866 |
ERK5 |
0.847 | 0.034 | 1 | 0.856 |
MST4 |
0.845 | 0.011 | 2 | 0.720 |
IKKE |
0.845 | -0.047 | 1 | 0.771 |
TGFBR2 |
0.845 | -0.001 | -2 | 0.817 |
NIK |
0.844 | -0.038 | -3 | 0.905 |
WNK1 |
0.844 | -0.003 | -2 | 0.892 |
CHAK2 |
0.844 | -0.007 | -1 | 0.851 |
NDR2 |
0.844 | -0.050 | -3 | 0.861 |
IKKA |
0.843 | 0.064 | -2 | 0.723 |
ULK1 |
0.843 | -0.112 | -3 | 0.862 |
PDHK1 |
0.843 | -0.153 | 1 | 0.871 |
SRPK1 |
0.842 | 0.076 | -3 | 0.762 |
CDKL5 |
0.842 | 0.018 | -3 | 0.813 |
SKMLCK |
0.842 | 0.048 | -2 | 0.871 |
MLK3 |
0.840 | 0.035 | 2 | 0.667 |
PIM1 |
0.840 | 0.038 | -3 | 0.789 |
GRK1 |
0.840 | 0.069 | -2 | 0.752 |
PKN2 |
0.840 | -0.027 | -3 | 0.852 |
WNK3 |
0.840 | -0.118 | 1 | 0.854 |
CDK8 |
0.840 | 0.081 | 1 | 0.743 |
CAMLCK |
0.839 | -0.006 | -2 | 0.858 |
RIPK3 |
0.839 | -0.081 | 3 | 0.747 |
ATM |
0.839 | 0.097 | 1 | 0.827 |
NUAK2 |
0.839 | -0.042 | -3 | 0.849 |
CAMK2B |
0.839 | 0.124 | 2 | 0.714 |
BMPR1B |
0.839 | 0.157 | 1 | 0.780 |
HUNK |
0.839 | -0.116 | 2 | 0.627 |
PRKD1 |
0.838 | -0.032 | -3 | 0.843 |
RSK2 |
0.838 | 0.006 | -3 | 0.783 |
CAMK2D |
0.838 | 0.022 | -3 | 0.863 |
ICK |
0.838 | 0.021 | -3 | 0.857 |
KIS |
0.838 | 0.059 | 1 | 0.776 |
DAPK2 |
0.837 | -0.027 | -3 | 0.890 |
NDR1 |
0.837 | -0.072 | -3 | 0.852 |
GRK6 |
0.837 | -0.003 | 1 | 0.854 |
TSSK2 |
0.836 | -0.017 | -5 | 0.697 |
LATS1 |
0.836 | 0.118 | -3 | 0.883 |
TGFBR1 |
0.836 | 0.134 | -2 | 0.837 |
HIPK4 |
0.836 | 0.010 | 1 | 0.851 |
PRKD2 |
0.836 | -0.011 | -3 | 0.777 |
MAPKAPK3 |
0.836 | -0.033 | -3 | 0.794 |
BCKDK |
0.836 | -0.105 | -1 | 0.769 |
NEK9 |
0.836 | -0.109 | 2 | 0.687 |
AMPKA1 |
0.836 | -0.047 | -3 | 0.868 |
MLK4 |
0.835 | 0.019 | 2 | 0.653 |
CDK5 |
0.835 | 0.113 | 1 | 0.771 |
ANKRD3 |
0.835 | -0.077 | 1 | 0.883 |
P90RSK |
0.835 | -0.025 | -3 | 0.789 |
SRPK2 |
0.835 | 0.062 | -3 | 0.684 |
PKCB |
0.835 | 0.017 | 2 | 0.659 |
LATS2 |
0.835 | -0.037 | -5 | 0.678 |
GRK5 |
0.835 | -0.148 | -3 | 0.891 |
MLK2 |
0.834 | -0.098 | 2 | 0.691 |
TSSK1 |
0.834 | -0.006 | -3 | 0.884 |
CDK1 |
0.834 | 0.124 | 1 | 0.711 |
ALK4 |
0.834 | 0.061 | -2 | 0.861 |
MAPKAPK2 |
0.834 | 0.023 | -3 | 0.743 |
P70S6KB |
0.834 | -0.034 | -3 | 0.812 |
ALK2 |
0.833 | 0.165 | -2 | 0.839 |
PKR |
0.833 | 0.018 | 1 | 0.863 |
IRE2 |
0.832 | -0.040 | 2 | 0.651 |
RSK3 |
0.832 | -0.029 | -3 | 0.782 |
CDK19 |
0.832 | 0.068 | 1 | 0.702 |
DLK |
0.832 | -0.125 | 1 | 0.851 |
PKCG |
0.832 | -0.012 | 2 | 0.651 |
PKCA |
0.832 | 0.011 | 2 | 0.648 |
IRE1 |
0.832 | -0.091 | 1 | 0.812 |
CLK4 |
0.831 | 0.077 | -3 | 0.774 |
CLK1 |
0.831 | 0.088 | -3 | 0.749 |
PLK1 |
0.831 | -0.026 | -2 | 0.795 |
NIM1 |
0.831 | -0.096 | 3 | 0.801 |
PKACG |
0.831 | -0.021 | -2 | 0.754 |
QSK |
0.830 | 0.013 | 4 | 0.853 |
MARK2 |
0.830 | 0.056 | 4 | 0.785 |
CLK2 |
0.830 | 0.137 | -3 | 0.753 |
PKCH |
0.830 | -0.012 | 2 | 0.641 |
AURC |
0.829 | 0.024 | -2 | 0.683 |
AMPKA2 |
0.829 | -0.044 | -3 | 0.832 |
CDK2 |
0.829 | 0.088 | 1 | 0.790 |
JNK3 |
0.829 | 0.100 | 1 | 0.743 |
MARK3 |
0.829 | 0.042 | 4 | 0.822 |
DYRK2 |
0.828 | 0.069 | 1 | 0.769 |
SRPK3 |
0.828 | 0.033 | -3 | 0.737 |
SMG1 |
0.828 | 0.060 | 1 | 0.834 |
QIK |
0.828 | -0.078 | -3 | 0.855 |
MASTL |
0.828 | -0.263 | -2 | 0.812 |
ACVR2A |
0.828 | 0.060 | -2 | 0.803 |
CAMK2A |
0.828 | 0.015 | 2 | 0.684 |
CHAK1 |
0.828 | -0.077 | 2 | 0.607 |
TTBK2 |
0.827 | -0.183 | 2 | 0.565 |
ACVR2B |
0.827 | 0.072 | -2 | 0.809 |
PLK3 |
0.827 | 0.014 | 2 | 0.646 |
PKCZ |
0.827 | -0.027 | 2 | 0.662 |
NEK2 |
0.827 | -0.084 | 2 | 0.668 |
CAMK4 |
0.827 | -0.098 | -3 | 0.833 |
MSK2 |
0.827 | -0.020 | -3 | 0.759 |
YSK4 |
0.827 | -0.078 | 1 | 0.797 |
NUAK1 |
0.827 | -0.058 | -3 | 0.805 |
MELK |
0.827 | -0.065 | -3 | 0.819 |
DNAPK |
0.826 | 0.091 | 1 | 0.790 |
SIK |
0.826 | -0.012 | -3 | 0.779 |
CDK13 |
0.826 | 0.058 | 1 | 0.731 |
BRSK1 |
0.826 | -0.022 | -3 | 0.807 |
JNK2 |
0.826 | 0.101 | 1 | 0.702 |
PAK1 |
0.826 | -0.044 | -2 | 0.785 |
RSK4 |
0.826 | 0.018 | -3 | 0.748 |
PHKG1 |
0.826 | -0.066 | -3 | 0.839 |
RIPK1 |
0.825 | -0.168 | 1 | 0.839 |
GRK4 |
0.825 | -0.108 | -2 | 0.803 |
CDK7 |
0.825 | 0.032 | 1 | 0.754 |
GRK7 |
0.825 | 0.058 | 1 | 0.805 |
BMPR1A |
0.825 | 0.151 | 1 | 0.761 |
P38A |
0.825 | 0.076 | 1 | 0.783 |
MNK2 |
0.825 | -0.028 | -2 | 0.815 |
AURB |
0.825 | 0.017 | -2 | 0.680 |
CDK3 |
0.824 | 0.137 | 1 | 0.654 |
CDK18 |
0.824 | 0.071 | 1 | 0.686 |
MEK1 |
0.824 | -0.128 | 2 | 0.685 |
PRKD3 |
0.824 | -0.038 | -3 | 0.754 |
PAK3 |
0.824 | -0.081 | -2 | 0.784 |
MARK1 |
0.824 | 0.018 | 4 | 0.839 |
ERK2 |
0.824 | 0.060 | 1 | 0.756 |
ERK1 |
0.824 | 0.076 | 1 | 0.709 |
VRK2 |
0.822 | -0.180 | 1 | 0.895 |
MSK1 |
0.822 | 0.018 | -3 | 0.767 |
P38G |
0.822 | 0.091 | 1 | 0.630 |
MYLK4 |
0.822 | -0.002 | -2 | 0.779 |
ERK7 |
0.822 | 0.061 | 2 | 0.513 |
MNK1 |
0.822 | -0.026 | -2 | 0.815 |
TLK2 |
0.821 | -0.029 | 1 | 0.839 |
PKACB |
0.821 | 0.029 | -2 | 0.695 |
BRSK2 |
0.821 | -0.071 | -3 | 0.833 |
PINK1 |
0.821 | -0.051 | 1 | 0.864 |
AURA |
0.820 | 0.033 | -2 | 0.652 |
CHK1 |
0.820 | -0.062 | -3 | 0.852 |
P38B |
0.820 | 0.085 | 1 | 0.721 |
SGK3 |
0.820 | -0.010 | -3 | 0.775 |
CDK17 |
0.820 | 0.067 | 1 | 0.637 |
DRAK1 |
0.819 | -0.063 | 1 | 0.792 |
PERK |
0.819 | -0.114 | -2 | 0.839 |
CDK12 |
0.818 | 0.051 | 1 | 0.708 |
HIPK1 |
0.818 | 0.059 | 1 | 0.780 |
PRKX |
0.818 | 0.053 | -3 | 0.676 |
NEK5 |
0.818 | -0.050 | 1 | 0.859 |
PKG2 |
0.818 | -0.012 | -2 | 0.694 |
PAK2 |
0.818 | -0.079 | -2 | 0.772 |
AKT2 |
0.817 | 0.005 | -3 | 0.691 |
PLK4 |
0.817 | -0.101 | 2 | 0.492 |
SNRK |
0.817 | -0.173 | 2 | 0.555 |
HRI |
0.817 | -0.134 | -2 | 0.850 |
CAMK1G |
0.817 | -0.051 | -3 | 0.771 |
BRAF |
0.817 | -0.053 | -4 | 0.867 |
PKCT |
0.817 | -0.022 | 2 | 0.643 |
CDK16 |
0.817 | 0.089 | 1 | 0.656 |
CDK9 |
0.817 | 0.025 | 1 | 0.737 |
MEKK2 |
0.816 | -0.069 | 2 | 0.676 |
WNK4 |
0.816 | -0.077 | -2 | 0.894 |
PIM2 |
0.816 | -0.014 | -3 | 0.757 |
SSTK |
0.816 | -0.015 | 4 | 0.839 |
PRP4 |
0.816 | 0.032 | -3 | 0.787 |
DCAMKL1 |
0.816 | -0.044 | -3 | 0.791 |
MEKK1 |
0.815 | -0.113 | 1 | 0.835 |
ZAK |
0.815 | -0.114 | 1 | 0.803 |
MEKK3 |
0.815 | -0.135 | 1 | 0.820 |
DYRK1A |
0.815 | 0.031 | 1 | 0.820 |
PAK6 |
0.815 | -0.037 | -2 | 0.720 |
HIPK2 |
0.815 | 0.072 | 1 | 0.686 |
PHKG2 |
0.815 | -0.057 | -3 | 0.804 |
CDK14 |
0.814 | 0.055 | 1 | 0.726 |
NEK8 |
0.814 | -0.051 | 2 | 0.686 |
MEK5 |
0.814 | -0.213 | 2 | 0.683 |
IRAK4 |
0.813 | -0.113 | 1 | 0.822 |
TAO3 |
0.813 | -0.013 | 1 | 0.828 |
MST3 |
0.813 | -0.044 | 2 | 0.695 |
P38D |
0.813 | 0.096 | 1 | 0.651 |
MAPKAPK5 |
0.812 | -0.100 | -3 | 0.739 |
DYRK4 |
0.812 | 0.079 | 1 | 0.700 |
AKT1 |
0.812 | 0.018 | -3 | 0.709 |
GRK2 |
0.811 | -0.066 | -2 | 0.705 |
TLK1 |
0.811 | -0.090 | -2 | 0.825 |
HIPK3 |
0.811 | 0.021 | 1 | 0.789 |
DCAMKL2 |
0.811 | -0.062 | -3 | 0.817 |
SMMLCK |
0.810 | -0.040 | -3 | 0.834 |
CDK10 |
0.809 | 0.063 | 1 | 0.711 |
PKCI |
0.809 | -0.039 | 2 | 0.649 |
DYRK1B |
0.809 | 0.052 | 1 | 0.730 |
DYRK3 |
0.808 | 0.045 | 1 | 0.779 |
PKCE |
0.808 | 0.006 | 2 | 0.639 |
TAO2 |
0.807 | -0.058 | 2 | 0.713 |
EEF2K |
0.807 | -0.010 | 3 | 0.874 |
CAMK1D |
0.807 | -0.012 | -3 | 0.691 |
CAMKK1 |
0.807 | -0.103 | -2 | 0.753 |
PASK |
0.807 | -0.036 | -3 | 0.869 |
MST2 |
0.806 | -0.020 | 1 | 0.827 |
GAK |
0.806 | -0.017 | 1 | 0.838 |
PKACA |
0.806 | 0.012 | -2 | 0.650 |
CDK6 |
0.805 | 0.073 | 1 | 0.707 |
TNIK |
0.804 | 0.024 | 3 | 0.886 |
TAK1 |
0.804 | -0.015 | 1 | 0.859 |
P70S6K |
0.803 | -0.075 | -3 | 0.723 |
GCK |
0.803 | -0.017 | 1 | 0.824 |
NEK11 |
0.803 | -0.167 | 1 | 0.832 |
TTBK1 |
0.803 | -0.177 | 2 | 0.499 |
DAPK3 |
0.802 | 0.007 | -3 | 0.809 |
PLK2 |
0.802 | 0.028 | -3 | 0.826 |
CK1E |
0.802 | -0.075 | -3 | 0.536 |
PDK1 |
0.801 | -0.071 | 1 | 0.859 |
HGK |
0.801 | -0.038 | 3 | 0.880 |
CK2A2 |
0.801 | 0.067 | 1 | 0.697 |
MINK |
0.801 | -0.020 | 1 | 0.816 |
JNK1 |
0.801 | 0.060 | 1 | 0.694 |
GSK3A |
0.801 | -0.013 | 4 | 0.390 |
CAMKK2 |
0.800 | -0.133 | -2 | 0.758 |
IRAK1 |
0.800 | -0.200 | -1 | 0.743 |
CDK4 |
0.800 | 0.058 | 1 | 0.696 |
PKN1 |
0.799 | -0.037 | -3 | 0.734 |
MPSK1 |
0.799 | -0.090 | 1 | 0.788 |
NEK4 |
0.799 | -0.134 | 1 | 0.817 |
GSK3B |
0.799 | -0.059 | 4 | 0.380 |
LRRK2 |
0.797 | -0.130 | 2 | 0.694 |
MEKK6 |
0.797 | -0.151 | 1 | 0.821 |
MST1 |
0.797 | -0.061 | 1 | 0.816 |
LKB1 |
0.796 | -0.156 | -3 | 0.866 |
MAP3K15 |
0.796 | -0.132 | 1 | 0.799 |
VRK1 |
0.796 | -0.095 | 2 | 0.674 |
LOK |
0.795 | -0.087 | -2 | 0.770 |
NEK1 |
0.795 | -0.110 | 1 | 0.830 |
GRK3 |
0.795 | -0.069 | -2 | 0.662 |
HPK1 |
0.795 | -0.051 | 1 | 0.809 |
KHS2 |
0.795 | 0.021 | 1 | 0.823 |
AKT3 |
0.795 | 0.002 | -3 | 0.624 |
DAPK1 |
0.794 | -0.014 | -3 | 0.788 |
KHS1 |
0.794 | -0.012 | 1 | 0.811 |
CAMK1A |
0.794 | -0.026 | -3 | 0.655 |
SLK |
0.794 | -0.069 | -2 | 0.706 |
MAK |
0.793 | 0.060 | -2 | 0.732 |
SGK1 |
0.793 | 0.002 | -3 | 0.610 |
PAK5 |
0.793 | -0.074 | -2 | 0.656 |
MRCKB |
0.793 | -0.009 | -3 | 0.747 |
PDHK3_TYR |
0.792 | 0.090 | 4 | 0.876 |
CK1D |
0.792 | -0.065 | -3 | 0.485 |
ROCK2 |
0.792 | -0.004 | -3 | 0.799 |
MOK |
0.791 | 0.035 | 1 | 0.785 |
MRCKA |
0.791 | -0.024 | -3 | 0.766 |
CHK2 |
0.791 | -0.046 | -3 | 0.632 |
YSK1 |
0.791 | -0.093 | 2 | 0.676 |
CK1G1 |
0.790 | -0.112 | -3 | 0.545 |
CK2A1 |
0.790 | 0.042 | 1 | 0.675 |
STK33 |
0.789 | -0.166 | 2 | 0.498 |
OSR1 |
0.788 | -0.018 | 2 | 0.661 |
PAK4 |
0.788 | -0.071 | -2 | 0.665 |
PDHK4_TYR |
0.787 | 0.071 | 2 | 0.725 |
MEK2 |
0.786 | -0.217 | 2 | 0.649 |
RIPK2 |
0.786 | -0.216 | 1 | 0.767 |
BUB1 |
0.786 | -0.032 | -5 | 0.661 |
TTK |
0.786 | -0.022 | -2 | 0.817 |
CK1A2 |
0.786 | -0.089 | -3 | 0.480 |
TESK1_TYR |
0.785 | -0.062 | 3 | 0.899 |
ALPHAK3 |
0.784 | 0.061 | -1 | 0.764 |
NEK3 |
0.783 | -0.151 | 1 | 0.797 |
PDHK1_TYR |
0.783 | 0.031 | -1 | 0.877 |
SBK |
0.783 | -0.016 | -3 | 0.565 |
BMPR2_TYR |
0.782 | 0.031 | -1 | 0.848 |
MAP2K6_TYR |
0.782 | 0.002 | -1 | 0.852 |
MAP2K7_TYR |
0.781 | -0.143 | 2 | 0.704 |
DMPK1 |
0.781 | -0.003 | -3 | 0.758 |
ROCK1 |
0.781 | -0.012 | -3 | 0.761 |
MYO3B |
0.781 | -0.043 | 2 | 0.690 |
PINK1_TYR |
0.781 | -0.093 | 1 | 0.870 |
MAP2K4_TYR |
0.780 | -0.103 | -1 | 0.852 |
PKG1 |
0.780 | -0.039 | -2 | 0.623 |
PBK |
0.779 | -0.106 | 1 | 0.762 |
EPHA6 |
0.779 | 0.027 | -1 | 0.864 |
MYO3A |
0.778 | -0.050 | 1 | 0.806 |
HASPIN |
0.778 | -0.039 | -1 | 0.685 |
LIMK2_TYR |
0.777 | -0.067 | -3 | 0.919 |
PKMYT1_TYR |
0.777 | -0.156 | 3 | 0.854 |
RET |
0.776 | -0.052 | 1 | 0.846 |
TAO1 |
0.776 | -0.084 | 1 | 0.761 |
ASK1 |
0.775 | -0.140 | 1 | 0.785 |
EPHB4 |
0.775 | 0.014 | -1 | 0.854 |
TYK2 |
0.773 | -0.111 | 1 | 0.843 |
TYRO3 |
0.773 | -0.044 | 3 | 0.802 |
BIKE |
0.773 | -0.035 | 1 | 0.698 |
TXK |
0.773 | 0.106 | 1 | 0.819 |
ROS1 |
0.772 | -0.076 | 3 | 0.774 |
CRIK |
0.772 | -0.033 | -3 | 0.710 |
LIMK1_TYR |
0.772 | -0.169 | 2 | 0.706 |
YES1 |
0.771 | 0.028 | -1 | 0.847 |
ABL2 |
0.770 | 0.029 | -1 | 0.805 |
YANK3 |
0.770 | -0.095 | 2 | 0.334 |
CSF1R |
0.770 | -0.040 | 3 | 0.781 |
MST1R |
0.770 | -0.120 | 3 | 0.801 |
INSRR |
0.769 | 0.016 | 3 | 0.750 |
JAK2 |
0.769 | -0.109 | 1 | 0.843 |
JAK3 |
0.768 | -0.064 | 1 | 0.827 |
LCK |
0.768 | 0.058 | -1 | 0.838 |
BLK |
0.768 | 0.086 | -1 | 0.849 |
HCK |
0.767 | 0.019 | -1 | 0.839 |
FER |
0.767 | -0.027 | 1 | 0.878 |
DDR1 |
0.767 | -0.103 | 4 | 0.796 |
EPHA4 |
0.766 | 0.004 | 2 | 0.647 |
ITK |
0.765 | 0.005 | -1 | 0.808 |
FGR |
0.765 | -0.072 | 1 | 0.853 |
SRMS |
0.764 | 0.017 | 1 | 0.850 |
STLK3 |
0.764 | -0.159 | 1 | 0.770 |
EPHB1 |
0.764 | -0.023 | 1 | 0.849 |
FGFR2 |
0.764 | -0.055 | 3 | 0.790 |
FLT3 |
0.764 | -0.060 | 3 | 0.789 |
EPHB3 |
0.763 | -0.016 | -1 | 0.844 |
ABL1 |
0.763 | -0.036 | -1 | 0.795 |
PDGFRB |
0.763 | -0.101 | 3 | 0.804 |
TEC |
0.763 | 0.017 | -1 | 0.771 |
NEK10_TYR |
0.762 | -0.076 | 1 | 0.736 |
EPHB2 |
0.762 | 0.012 | -1 | 0.837 |
KIT |
0.761 | -0.071 | 3 | 0.783 |
TEK |
0.761 | -0.072 | 3 | 0.731 |
KDR |
0.760 | -0.094 | 3 | 0.747 |
TNNI3K_TYR |
0.760 | -0.097 | 1 | 0.829 |
TNK2 |
0.759 | -0.084 | 3 | 0.741 |
BTK |
0.759 | -0.040 | -1 | 0.787 |
MERTK |
0.759 | -0.010 | 3 | 0.761 |
BMX |
0.759 | 0.002 | -1 | 0.753 |
JAK1 |
0.758 | -0.092 | 1 | 0.784 |
FYN |
0.758 | 0.065 | -1 | 0.815 |
FGFR1 |
0.758 | -0.107 | 3 | 0.761 |
AXL |
0.758 | -0.074 | 3 | 0.766 |
TNK1 |
0.757 | -0.128 | 3 | 0.775 |
WEE1_TYR |
0.757 | -0.078 | -1 | 0.751 |
EPHA7 |
0.757 | -0.012 | 2 | 0.650 |
FRK |
0.755 | -0.028 | -1 | 0.864 |
LTK |
0.754 | -0.077 | 3 | 0.729 |
FGFR3 |
0.754 | -0.065 | 3 | 0.763 |
PDGFRA |
0.754 | -0.191 | 3 | 0.800 |
ALK |
0.754 | -0.110 | 3 | 0.710 |
AAK1 |
0.753 | -0.016 | 1 | 0.592 |
MET |
0.753 | -0.105 | 3 | 0.769 |
LYN |
0.753 | -0.001 | 3 | 0.699 |
FLT1 |
0.753 | -0.096 | -1 | 0.816 |
EPHA5 |
0.752 | 0.022 | 2 | 0.649 |
ERBB2 |
0.751 | -0.102 | 1 | 0.800 |
EPHA3 |
0.751 | -0.086 | 2 | 0.619 |
EPHA1 |
0.751 | -0.070 | 3 | 0.744 |
NTRK1 |
0.751 | -0.122 | -1 | 0.798 |
PTK6 |
0.751 | -0.158 | -1 | 0.721 |
INSR |
0.750 | -0.085 | 3 | 0.723 |
DDR2 |
0.749 | -0.035 | 3 | 0.730 |
FLT4 |
0.748 | -0.150 | 3 | 0.743 |
EPHA8 |
0.748 | -0.019 | -1 | 0.827 |
NTRK2 |
0.748 | -0.148 | 3 | 0.745 |
EGFR |
0.747 | -0.010 | 1 | 0.709 |
MATK |
0.746 | -0.090 | -1 | 0.730 |
CK1A |
0.745 | -0.118 | -3 | 0.390 |
SRC |
0.744 | -0.036 | -1 | 0.811 |
NTRK3 |
0.744 | -0.101 | -1 | 0.756 |
PTK2B |
0.743 | -0.070 | -1 | 0.783 |
PTK2 |
0.743 | 0.003 | -1 | 0.774 |
FGFR4 |
0.743 | -0.034 | -1 | 0.764 |
CSK |
0.741 | -0.105 | 2 | 0.643 |
SYK |
0.740 | 0.013 | -1 | 0.775 |
EPHA2 |
0.738 | -0.028 | -1 | 0.793 |
YANK2 |
0.738 | -0.112 | 2 | 0.367 |
CK1G3 |
0.736 | -0.084 | -3 | 0.342 |
IGF1R |
0.736 | -0.084 | 3 | 0.659 |
MUSK |
0.735 | -0.126 | 1 | 0.703 |
ERBB4 |
0.729 | -0.031 | 1 | 0.709 |
FES |
0.717 | -0.132 | -1 | 0.716 |
ZAP70 |
0.716 | -0.049 | -1 | 0.690 |
CK1G2 |
0.716 | -0.086 | -3 | 0.448 |